2005

Pfizer's 'What Are You Doing New Year's Eve?' Viagra Ad Encourages Use as 'Party Drug,' Says AHF
PRNewswire - December 30, 2005
-- AIDS Healthcare Foundation Calls Ad Campaign Reckless and Irresponsible and Urges World s Largest Pharmaceutical Company to Curb Direct to Consumer Drug Advertising LOS ANGELES, Dec. 30 /PRNewswire/ -- AIDS Healthcare Foundation, (AHF) the nation s largest AIDS group and a direct provider of HIV/AIDS medical care to


Huntington Hospital HIV Physician Leads Fourth Trip to Africa
PRNewswire - December 27, 2005
PASADENA, Calif., Dec. 27 /PRNewswire/ -- For the fourth time in the new millennium, a team of Huntington Hospital medical professionals, led by Kimberly Shriner, MD, will travel to Arusha, Tanzania (East Africa) bringing medical care and supplies to the Upone Charitable Medical Centre, an outpatient AIDS clinic. The


New Drug Application for Investigational HIV Protease Inhibitor TMC114 Submitted to U.S. Food & Drug Administration
PRNewswire - December 27, 2005
-- HIV/AIDS compound marks first regulatory submission by Tibotec Pharmaceuticals Ltd. CO CORK, Ireland , Dec. 27 /PRNewswire/ -- Tibotec Pharmaceuticals Ltd. today announced the submission of a New Drug Application to the United States Food and Drug Administration ( FDA ) for


AIDS Healthcare Foundation Calls on Gov. Schwarzenegger to Reverse 5% Medi-Cal Provider Cuts: 'Potentially Devastating' Cuts set to Take Effect January 1st
PRNewswire - December 21, 2005
LOS ANGELES, Dec. 21 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the largest AIDS organization in the United States , which currently operates free AIDS treatment clinics in the US, Africa and Central America -- including 12 free AIDS treatment clinics throughout California, joined the California Medical Associat


Calypte Expands Use of HIV-1 BED Incidence EIA Test
PRNewswire - December 21, 2005
LAKE OSWEGO, Ore., Dec. 21 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (Amex: HIV) today announced the addition of dried blood spot samples as a new indication for use with the Calypte HIV-1 BED Incidence EIA. The Calypte HIV-1 BED Incidence EIA Dried Blood Spot Control Pack is now available as an accessor


On A Budget This Holiday Season? Shop at Boomerangs.
PRNewswire - December 20, 2005
BOSTON, Dec. 20 /PRNewswire/ -- Boomerangs, AIDS Action Committee s award- winning resale store, specializes in new and vintage clothing for men, women, and children. As well, Boomerangs offers a variety of affordable new and previously loved gifts, housewares, electronics and furniture. We have forged tremendous relat


2005 a Landmark Year for Adolescent Vaccines: Progress Paves the Way for Improved Protection
PRNewswire - December 19, 2005
NEW YORK, Dec. 19 /PRNewswire/ -- In the world of disease prevention, adolescents have traditionally gotten short shrift from the medical community. For years, adolescents have had little in the way of vaccine protection, but the year 2005 brought with it new vaccines for this age group, with many more pushing their wa


New Data Show Two-Thirds of Patients Achieve Undetectable Viral Load With FUZEON(R) and Investigational Protease Inhibitor
PRNewswire - December 19, 2005
WASHINGTON, Dec. 19 /PRNewswire-FirstCall/ -- New clinical data presented at the 45th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) demonstrate that the highest rates of viral suppression with an experimental boosted protease inhibitor (PI), TMC-114/ ritonav


Federal Grant Funds Research on Novel HIV Therapy: Award Supports Both Bench and Bedside Studies
PRNewswire - December 19, 2005
PHILADELPHIA, Dec. 19 /PRNewswire/ -- An immunology researcher at The Children s Hospital of Philadelphia leads a multi-center $6.7 million program project grant recently awarded by the National Institute of Mental Health (NIMH) to explore a novel approach to HIV treatment. Encompassing basic science research, animal s


Tibotec Presents Phase 2b Data on 2 Investigational HIV Compounds at ICAAC: TMC114 and TMC125 Demonstrate Activity Against Drug Resistant HIV
PRNewswire - December 19, 2005
WASHINGTON D.C., December 19 /PRNewswire/ -- Tibotec Pharmaceuticals Ltd. presented the primary 24-week efficacy and safety results from the POWER 2 trial on TMC114, a protease inhibitor (PI), in treatment-experienced patients and the first long-term clinical results of TMC125, a non-nucleoside reverse transcriptase in


Patients With HIV-Associated Wasting Gain More Weight With Concentrated Form of Megestrol Acetate, Study Shows
PRNewswire - December 19, 2005
SPRING VALLEY, N.Y., Dec. 19 /PRNewswire/ -- Patients with HIV-associated unintended weight loss were shown to gain more weight, more rapidly when taking a daily regimen of megestrol acetate concentrated suspension 575 mg/5mL (MA-CS 575 mg/5 mL) than those patients receiving megestrol acetate oral suspension 800 mg/20


Data Indicates Tanox HIV Drug Candidate Active In Vitro Against CCR5 and CXCR4 Viruses and Synergistic with Entry Inhibitor
PRNewswire - December 17, 2005
-- TNX-355 Data Presented at 2005 ICAAC WASHINGTON, Dec. 17 /PRNewswire-FirstCall/ -- Tanox, Inc. (Nasdaq: TNOX) today presented data on its lead HIV drug candidate, TNX-355, at the American Society for Microbiology s Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). The presentation highlighted


Sangamo BioSciences Announces Breakthrough Results at ICAAC Demonstrating Protection of Cells From HIV Infection Following Treatment with Zinc Finger Nucleases
PRNewswire - December 17, 2005
-- CCR5 ZFP Therapeutic Expected to Enter Human Clinical Trials in 2006 RICHMOND, Calif., Dec. 17 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced that data from its program to develop a ZFP Therapeutic(TM) for HIV/AIDS were presented at the 45th Annual Interscience Conference on Antim


Additional Phase 2 Data Supports Further Development of Tanox's Novel HIV Therapy: Company Presents In-Depth Analysis of TNX-355 Phase 2 Results at 45th ICAAC Meeting
PRNewswire - December 17, 2005
WASHINGTON, Dec. 17 /PRNewswire-FirstCall/ -- Tanox, Inc. (Nasdaq: TNOX) today presented further analysis of a Phase 2 study of its novel HIV antibody, TNX-355, in a late-breaking submission at the American Society for Microbiology s Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). The company,


GSK and Vertex Pharmaceuticals Announce Presentation of Data Supporting Development of Investigational HIV Protease Inhibitor Brecanavir
PRNewswire - December 16, 2005
-- Positive Data Presented at 45th Annual ICAAC CAMBRIDGE, Mass., Dec. 16 /PRNewswire-FirstCall/ -- GlaxoSmithKline (GSK) and Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) presented positive results today from a study evaluating the safety, tolerability and antiviral activity of the investigational HIV-1 protease


More Than 100,000 People Unite to Support AIDS Prevention and Care Programs Through Bristol-Myers Squibb 2005 World AIDS Day Campaign
PRNewswire - December 16, 2005
-- Company s Annual Light to Unite Campaign Provides $100,000 for the National AIDS Fund WASHINGTON, Dec. 16 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company (NYSE: BMY) today presented a $100,000 donation to the National AIDS Fund to provide funding for AIDS service organizations across the


SERONO LABS Pleads Guilty to the Illegal Marketing of AIDS Drug, Reports U.S. Attorney
PRNewswire - December 15, 2005
-- Company to pay $136.9 million criminal fine as part of $704 million global settlement BOSTON, Dec. 15 /PRNewswire/ -- The U.S. subsidiary, SERONO LABORATORIES, INC., of Swiss Corporation SERONO, S.A., pleaded guilty and was sentenced today in federal court on criminal charges in connection with several illegal schem


Monogram Presents Data Demonstrating Cost-Effectiveness of PhenoSense GT(TM) and Leadership in Advancing HIV Resistance Testing
PRNewswire - December 15, 2005
-- Five Abstracts Presented at ICAAC SOUTH SAN FRANCISCO, Calif., Dec. 15 /PRNewswire-FirstCall/ -- Monogram BioSciences, Inc. (Nasdaq: MGRM) today announced the presentation of five abstracts related to its portfolio of HIV resistance assays at the 45th Annual Interscience Conference on Antimicrobial Agents and Chemot


GMHC Announces Departure Of Executive Director
PRNewswire - December 15, 2005
NEW YORK, Dec. 15 /PRNewswire/ -- Gay Men s Health Crisis (GMHC) today announced that its Executive Director, Ana Oliveira, will be leaving the agency to pursue other professional interests and that an interim Executive Director will be named by the Board of Directors in the next 30 days. Ana has been an outstanding as


AIDS Healthcare Foundation and Los Angeles County Department of Health Services Launch Partner Notification System: www.inSPOTLA.org
PRNewswire - December 14, 2005
What: Press Conference * AIDS Healthcare Foundation and the Los Angeles County Department of Health Services (DHS) to unveil http://www.inSPOTLA.org, a new website designed to facilitate partner notification, as well as access to testing and treatment services, in the Los Angeles area Who: Jonathan E. Fieldin


AIDS Action Committee Provides Utility Assistance for People Living with HIV/AIDS in Seven Counties
PRNewswire - December 14, 2005
-- Heat costs in New England expected to exceed last year s levels this winter; demonstrably affects low-income households at risk for homelessness BOSTON, Dec. 14 /PRNewswire/ -- Heating costs are expected to rise this winter over last year s cost levels and are already higher now than last year at this time. To ward


Medical Services Increases Presence in Middle East with Approvals in Lebanon
PRNewswire - December 13, 2005
EDMONTON, Alberta, Dec. 13 /PRNewswire-FirstCall/ -- Medical Services International Inc. (OTC: MSITF) is pleased to announce that it has received regulatory approval to sell its VScan HIV 1&2 test kits in Lebanon . The distributor for Lebanon has already placed an order for in excess of 100,000 VScan HIV test kits


MedMira Completes CE Mark Facilities Inspection
PRNewswire - December 8, 2005
-- MiraCare Rapid HIV Antibody Test Poised for Sales in European Market HALIFAX, Dec. 8 /PRNewswire-FirstCall/ - MedMira Inc., ( MedMira ) (TSX Venture: MIR, NASDAQ: MMIRF) the global market leader in flow-through rapid diagnostic technology, announced today that it has successfully completed its quality systems assess


Procyon receives regulatory approval to commence Phase 1 clinical trial for its lead HIV protease inhibitor, PPL-100
PRNewswire - December 8, 2005
-- Potentially high genetic barrier of PPL-100 makes it a promising candidate for first-line treatment of resistant HIV patients TICKER: PBP (TSX) MONTREAL, Dec. 8 /PRNewswire-FirstCall/ - Procyon Biopharma Inc. (TSX:PBP), a biotechnology company developing innovative therapeutics in the fields of cancer and HIV/AIDS,


New IFPMA Survey highlights Major Contributions of Pharmaceutical Sector's Public-Private Health Partnerships in the Developing World
PRNewswire - December 7, 2005
-- Industry Programs Since Proclamation of Millennium Development Goals Have Provided More Than a Half-Billion Health Interventions Valued at $4.4 Billion GENEVA, Switzerland , December 7 /PRNewswire/ -- The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) today announced the results of


AHF to Roll Out Frank, Unconventional 'HIV - Not Fabulous' Social Marketing & HIV Prevention Campaign in Los Angeles
PRNewswire - December 6, 2005
-- CDC-Funded, Two-year HIV Prevention Social Marketing Campaign Will Feature Graphic Images of AIDS Patients With a Simple Tagline Urging HIV Negative Gay Men to Stay Negative -- AIDS Healthcare Foundation, the Nation s Largest AIDS Group, to Oversee the Campaign Which is Backed by LA County s Office of AIDS Programs


GMAD Honors Notable Recipients for the Prestigious Charles Angel Awards
PRNewswire - December 2, 2005
NEW YORK, Dec. 2 /PRNewswire/ -- Gay Men of African Descent (GMAD) will host its 13th Annual Charles Angel Awards Dinner on Tuesday, December 6th to honor and showcase those who have made notable contributions to uplift, include and inform the nation about issues that affect our society. The event will Honor the Past -


Nigeria Successfully Implementing A National Blood Safety Program Led By Safe Blood for Africa Foundation(TM) To Fight The Spread of HIV/AIDS
PRNewswire - December 1, 2005
-- Nigerian President Olusegun Obasanjo Continues His Commitment To Transform Nigeria s Current Blood Transfusion System ABUJA, Nigeria, Dec. 1 /PRNewswire/ -- In a continuing effort in his commitment to transform Nigeria s blood transfusion system, His Excellency and Head of the African Union, President Olusegun Obasa


HIV/AIDS Conference Shifts Focus from Education to Action
PRNewswire - December 1, 2005
-- Disturbing Voices Conference Turns Attention from Defining the Pandemic to Providing Practical Applications for Addressing Crisis Both Locally and Globally LAKE FOREST, Calif., Dec. 1 /PRNewswire/ -- Dr. Rick and Kay Warren concluded the second day of the Disturbing Voices International HIV/AIDS Conference at Saddle


Eudoxa: WTO Must Eradicate Tariffs on AIDS Medicines
PRNewswire - December 1, 2005
-- Swedish Think Tank Urges Hong Kong Ministerial to Address Regressive Nature of Tariffs on Medicines STOCKHOLM, Sweden , Dec. 1 /PRNewswire/ -- The WTO must mark World AIDS Day by calling for the elimination of tariffs on AIDS medicines says Swedish Think Tank Eudoxa.


'Silence Is Deadly, And So Is Ignorance': Dr. Rick Warren Tests Negative For HIV, But Positive for Determination
PRNewswire - December 1, 2005
LAKE FOREST, Calif., Dec. 1 /PRNewswire/ -- Dr. Rick Warren voluntarily submitted to a free HIV screening in front of media and staffers at a World AIDS Day press briefing today, which closed out the Disturbing Voices HIV/AIDS Conference held at Saddleback Valley Community Church this week. I am taking this test public


Henan Province Opens First Blood Safety Training Center Through Joint Venture of Chinese Ministry of Health and U.S.-Based Safe Blood For China(TM) Foundation
PRNewswire - December 1, 2005
-- Vice Minister Huang Jiefu and Henan Health Department Officials Also Participate In Ribbon-Cutting Ceremony For New Center To Help Prevent Spread of HIV/AIDS HENAN PROVINCE, China, Dec. 1 /PRNewswire/ -- Taking a major step forward in the fight against HIV/AIDS in China, Vice Minister Huang Jiefu opened this week th


First Children's HIV/AIDS Medical Center Opens in Lesotho; Public-Private Partnership Provides Staffing, Funding
PRNewswire - December 1, 2005
-- Operated By Baylor College of Medicine and the Government of Lesotho ; Funded By Bristol-Myers Squibb s SECURE THE FUTURE(R) Initiative MASERU, Lesotho, Dec. 1 /PRNewswire-FirstCall/ -- The first medical center dedicated to caring for HIV/AIDS-infected infants and children in Lesotho, operated by Baylor College of M


Wyeth Enters into $32 Million Contract with National Institutes of Health (NIH) for Ongoing HIV Vaccine Research
PRNewswire - December 1, 2005
MADISON, N.J., Dec. 1 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, the pharmaceutical division of Wyeth (NYSE: WYE), has been awarded a five-year, $32 million contract from the Division of AIDS of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), for


USAID's Telling Our Story Project Documents the Global HIV/AIDS Pandemic
PRNewswire - December 1, 2005
WORLD AIDS DAY 2005 WASHINGTON, Dec. 1 /PRNewswire/ -- Every day, the American people, through their compassion and generosity, provide needed, lifesaving assistance to vulnerable populations in developing countries, particularly those affected by HIV/AIDS. This year s theme for World AIDS Day on December 1 is Stop AID


KNOW HIV/AIDS Creates New PSAs Filmed at HIV/AIDS Support Groups in Los Angeles and El Salvador
PRNewswire - December 1, 2005
-- Viacom and the Kaiser Family Foundation Team Up With DDB Seattle to Develop New Documentary-Style PSAs in Support of World AIDS Day NEW YORK, Dec. 1 /PRNewswire-FirstCall/ -- As part of their KNOW HIV/AIDS public education initiative, Viacom Inc. and the Kaiser Family Foundation partnered with DDB Seattle to produce


Corporate Leaders, Government Officials and AIDS Experts Join HIV-Infected Youth in First-of-Its-Kind International Videoconference
PRNewswire - December 1, 2005
-- Panels of Young People in New Jersey and Uganda Sharing Stories of Hope and Challenges in Preventing and Treating HIV/AIDS NEWARK, N.J., Dec. 1 /PRNewswire/ -- Corporate leaders, government officials and experts in pediatric AIDS joined HIV-infected young people, including Elizabeth Glaser s son Jake Glaser, in Car


Remarks by President Bush and Mrs. Bush on World AIDS Day
PRNewswire - December 1, 2005
WASHINGTON, Dec. 1 /PRNewswire/ -- The following is a transcript of remarks by President Bush and Mrs. Bush on World AIDS Day: Room 450 -- Dwight D. Eisenhower Executive Office Building 10:08 A.M. EST MRS. BUSH: Good morning, everyone. Good morning and thank you all very, very much for joining us on this important day,


Statement by Mike Leavitt, Secretary of Health and Human Services, Regarding World AIDS Day
PRNewswire - December 1, 2005
WASHINGTON, Dec. 1 /PRNewswire/ -- World AIDS Day 2005 reminds us of the tragic scope of the HIV/AIDS pandemic, the advances we have made -- and, most importantly, the work yet to be done. We in this department and across the federal government, under President Bush s leadership in the fight against AIDS, mark this day


Celebrities and leaders in the fight against HIV/AIDS join forces with Cole, Viacom and the Kaiser Family Foundation to help erase stigma
PRNewswire - December 1, 2005
NEW YORK, Dec. 1 -- Kenneth Cole, in conjunction with KNOW HIV/AIDS, a joint public education initiative of Viacom Inc. and the Kaiser Family Foundation, today unveiled the We All Have AIDS campaign, which brings together key entertainment, political, social and scientific leaders in an effort to foster needed solidari


AIDS Action Committee Honors World AIDS Day 2005
PRNewswire - November 30, 2005
BOSTON, Nov. 30 /PRNewswire/ -- For this World AIDS Day, Dec. 1, 2005, AIDS Action Committee of Massachusetts, Inc. (AAC): * Makes http://www.aac.org the Go to site to navigate World AIDS Day events * Manages Living our Lives, HIV Conference for Women as part of a 10- agency collaboration * Offers contact for media wit


PacifiCare Partners With NCLR/CSULB Center for Latino Community Health and the Latino Coalition Against AIDS to Educate Latinas About the Risk of AIDS
PRNewswire - November 30, 2005
* Latinas and HIV/AIDS Summit at University Student Ballroom at California State University, Long Beach * Leading HIV/AIDS experts and other dignitaries/celebrities including U.S. Rep. Hilda Solis and actress Lupe Ontiveros to attend * World AIDS Day Dec. 1 LONG BEACH, Calif., Nov. 30 /PRNewswire/ -- The California Sta


Saddleback HIV/AIDS Conference Provides a 'Wake-Up Call and a 'Kick in the Butt' to the Church'
PRNewswire - November 30, 2005
-- First-Ever Church-Sponsored International Health Conference Challenges Attendees to Show Compassion and Provide Relief to HIV/AIDS Victims Locally and Globally LAKE FOREST, Calif., Nov. 30 /PRNewswire/ -- Dr. Rick Warren and his wife Kay Tuesday opened the historic two-day Disturbing Voices HIV/AIDS conference -- th


AHF Global & 'LifeLine Durban' Unveil New Partnership at 'Ithembalabantu,' Free AIDS Clinic in South Africa
PRNewswire - November 30, 2005
-- Respected South African NGO Will Provide Social Services & Linkages to Complement Free AIDS Care and ARV Treatment at Clinic Run by US Largest AIDS Organization DURBAN, South Africa and LOS ANGELES, Nov. 30 /PRNewswire/ -- As nations around the world commemorate World AIDS Day, AIDS Healthcare Foundation (AHF) t


Wear the Red Ribbon on December 1: World AIDS Day
PRNewswire - November 30, 2005
ALEXANDRIA, Va., Nov. 30 /PRNewswire/ -- December 1 is World AIDS Day and activities throughout the globe will focus on education, outreach and awareness. This year, all people concerned with HIV/AIDS are encouraged to wear a red ribbon -- a sign of support for people living with HIV and a symbol of hope for the future


Number of Pills Affects Adherence to HIV Treatment Regimens
PRNewswire - November 30, 2005
-- Patients Taking Combination Pills Three Times More Likely to Refill Prescriptions on Time * HIV positive patients taking COMBIVIR achieved a >/= 95 percent adherence rate more than twice as often as patients taking lamivudine and zidovudine separately. * Mean adherence was higher for patients taking COMBIVIR (85 per


Global Business Coalition on HIV/AIDS Announces the Creation of a New Best Practice AIDS Standard for Corporate AIDS Programs
PRNewswire - November 29, 2005
NEW YORK, Nov. 29 /PRNewswire/ -- In response to growing demand from its 200 member companies, the Global Business Coalition on HIV/AIDS (GBC) announced today the creation of the first measurement system for business and AIDS -- a new Best Practice AIDS Standard for corporate HIV/AIDS programs. The Best Practice AIDS S


Halting HIV/AIDS Needs Bold Responses - World AIDS Day, 1 December
PRNewswire - November 29, 2005
MANILA, Philippines , Nov. 29 /Xinhua-PRNewswire/ -- Calling for genuine commitment and stronger political will, Dr Shigeru Omi, WHO Regional Director for the Western Pacific, today urged Member States to act boldly and urgently to change the course of the HIV/AIDS epidemic. Despite measures designed to prevent the


AnorMED announces enrollment of HIV patients into XACT study for AMD070 a first in class CXCR4 HIV entry inhibitor
PRNewswire - November 29, 2005
VANCOUVER, Nov. 29 /PRNewswire-FirstCall/ - AnorMED Inc. (AMEX:AOM; TSX:AOM) announced today the enrollment of HIV patients into its new clinical trial to evaluate the potential of AMD070 as a new anti-HIV drug. Novel anti-HIV targets are urgently needed. This is especially true for those HIV patients harboring types o


NIDA Unveils Campaign to Send Teens the Message About the Link Between Drug Abuse and HIV
PRNewswire - November 29, 2005
WASHINGTON, Nov. 29 /PRNewswire/ -- Drug Abuse and HIV: Learn the Link is the message of a new public awareness campaign announced November 29, 2005, by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. Drug abuse prevention is HIV prevention, says NIDA Director Dr. Nora D.


4-year Delay on LA Bathhouse Regulations Continues as Infections Rise
PRNewswire - November 29, 2005
-- According to AHF, Despite Los Angeles County s Own Bathhouse Study Conducted in 2001-2002 at Two LA Area Bathhouses Which Showed an Alarming 11% HIV Positive Rate Among Men who Have Sex with Men (MSM), Bureaucratic Delays Stall Roll Out of County Health Regulations Calling for Better Access to HIV & STD Testing


First Blood Safety Training Center in Henan Province Opens Through Joint Venture of Chinese Ministry of Health and U.S.-Based Safe Blood for China(TM) Foundation
PRNewswire - Tuesday November 29
HENAN PROVINCE -- Taking a major step forward in the fight against HIV/AIDS in China, Vice Minister Huang Jiefu opened today the country s first joint venture blood safety training center in Henan Province funded and operated by the Washington DC-based Safe Blood International Foundation. He was joined in the launch ce


'DINE OUT ANN ARBOR' Unites Area Restaurants in the Fight Against AIDS, on Friday, December 2nd
PRNewswire - November 28, 2005
ANN ARBOR, Mich., Nov. 28 /PRNewswire/ -- What s on your plate Friday, December 2nd? DINE OUT ANN ARBOR will give area residents the opportunity to fight AIDS by doing something they frequently do: Eat Out! Nearly 50 restaurants from Ann Arbor and neighboring cities will participate in the Sixth Annual DINE OUT ANN ARB


World AIDS Day: 'Raising Awareness' is not Enough: Teleconference 11/29 at 1pm ET to Discuss 'Keeping the Promise' on AIDS
PRNewswire - November 28, 2005
WASHINGTON, Nov. 28 /PRNewswire/ -- World AIDS Day will be commemorated this Thursday, December 1, but AIDS experts are saying the event must go beyond raising awareness to holding President Bush, other world leaders, and the US Congress, to their promises. This year, Keeping the Promise is the global theme of World AI


Barbados Inaugural 'Passions Ball' Supports National HIV/AIDS Commission
PRNewswire - November 28, 2005
BRIDGETOWN, Barbados , Nov. 28 /PRNewswire/ -- On December 3, 2005, the Barbados Tourism Authority will unveil the inaugural Passions of Barbados Ball, at the Ronald Reagan Building, Washington DC. This unprecedented fundraising gala is in support of the National HIV/AIDS Commission of Barbados and proceeds will be pre


Enchanting Night On Ice To Support The Fight Against AIDS: Blades Against AIDS 3, a World AIDS Day Benefit for Body Positive
PRNewswire - November 28, 2005
NEW YORK, Nov. 28 /PRNewswire/ -- Lace up your glass slippers and join Body Positive at its annual fundraiser, Blades Against AIDS 3 . Skate the night away while raising valuable funds needed to fight HIV/AIDS. Co-produced by the New York City Gay Hockey Association, 64events.com and Out of Bounds, Blades Against AIDS


VH1 Observes World AIDS Day With Special Programming to Increase Awareness of the Silent Killer: HIV/AIDS Related Programming to Air Thursday, December 1, 2005
PRNewswire - November 28, 2005
-- VH1 Classic and VH1 Soul to Premiere VH1 News Presents: Tracking The Monster: Ashley Judd and India .Arie Confront AIDS in Africa NEW YORK, Nov. 28 /PRNewswire/ -- December 1, World AIDS Day is an international day of action for HIV/AIDS. While most families gear up for the holidays, VH1 will provide special program


'Celebrities Unite Against Aids' Press Conference: Beijing
PRNewswire - November 24, 2005
* Sent by WHO China on behalf of Positive Art Workshop BEIJING, Nov. 24 /Xinhua-PRNewswire/ -- For World AIDS Day 2005, Positive Art Workshop (PAW) and Hard Rock Cafe (HRC) are proud to co-organise the Unite Against AIDS campaign. A press conference -- Celebrities Unite Against AIDS is to be held on 28 November 2005 (


Boehringer Ingelheim Announces 48-Week Results from Aptivus(R) (tipranavir) RESIST Studies
PRNewswire - November 21, 2005
RIDGEFIELD, Conn., Nov. 21 /PRNewswire/ -- New data on Aptivus(R) (tipranavir) capsules from a 48-week combined analysis of the RESIST-1 and RESIST-2 studies were presented at the 10th European AIDS Conference (EACS) in Dublin. The RESIST trials are randomized, controlled, open-label Phase 3 trials designed to study AP


Drug Company Support is Critical to Advancing AIDS Prevention Effort: Statement by IPM CEO, Dr. Zeda Rosenberg, on New AIDS Statistics
PRNewswire - November 21, 2005
-- Joint United Nations Programme on HIV/AIDS ( UNAIDS ) Releases the UNAIDS/WHO 2005 AIDS Epidemic Update SILVER SPRINGS, Md., Nov. 21 /PRNewswire/ -- Zeda Rosenberg, Sc.D., Chief Executive Officer of the International Partnership for Microbicides (IPM), issued the following statement upon reviewing the 2005 AIDS Epid


UN's Latest World AIDS Stats Cast Pall on Global Efforts, Says AHF
PRNewswire - November 21, 2005
LOS ANGELES, Nov. 21 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the nation s largest AIDS group which operates free AIDS treatment clinics in the US, Africa, Central America, and Asia, today expressed concern over the latest worldwide HIV/AIDS statistics, released earlier today in a joint report by the


African Nations Should Drop Debilitating Taxes and Tariffs on Medicines
PRNewswire - November 21, 2005
-- Failure to Compromise on Agricultural Subsidies in the WTO Gives African Nations Leadership Opportunity WASHINGTON, Nov. 21 /PRNewswire/ -- With the failure of the European Union, specifically the French to greatly reduce their agricultural tariffs, the African Union has a rare moment to assert its commitment to the


Statement of Dr. Musimbi Kanyoro, General Secretary, World YWCA; A Call to Action to Accelerate Worldwide Distribution of The Female Condom
PRNewswire - November 20, 2005
GENEVA, Nov. 20 /PRNewswire/ -- As World AIDS Day approaches, leaders of the YWCA across Africa are coming together to call on national governments and international donors to accelerate distribution of the female condom to women in developing countries. The global AIDS pandemic is rapidly evolving into a pandemic for


CDC's Latest HIV Stats Show Need for Stepped Up Prevention Efforts, Says AHF: HIV Rates Up 8% Among Gay Men, Down 5% Among African Americans
PRNewswire - November 18, 2005
-- US Largest AIDS Group Calls for Increased and More Innovative Prevention and Outreach; Notes HIV Rates Still Remain Highest Among Blacks, Who Were Eight Times as Likely as Whites to Be Diagnosed With HIV in 2004 LOS ANGELES, Nov. 18 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the largest AIDS organization in t


Living Our Lives: A World AIDS Day Conference on Women to Occur in December
PRNewswire - November 18, 2005
BOSTON, Nov. 18 /PRNewswire/ -- On Thursday, December 1, 2005, World AIDS Day, a 10-member AIDS organization collaborative will host Living our Lives, an informational conference, featuring guest presentations and workshop sessions on various issues that affect women. The conference will be held at U Mass/Boston s new


New Data Show a Kaletra(R) (Lopinavir/Ritonavir)-Based Regimen Demonstrated Continued Efficacy and Favorable Resistance Profile for Patients Through Seven Years of Initial HIV Therapy
PRNewswire - November 18, 2005
DUBLIN, Nov. 18 /PRNewswire-FirstCall/ -- The longest clinical study of any HIV treatment -- seven years (360 weeks) -- of Kaletra (R) ( lopinavir / ritonavir )-based therapy study results demonstrated patients taking Kaletra in combinati


FDA Approves Updated Labeling for GSK's LEXIVA
PRNewswire - November 18, 2005
-- Co-administration With Esomeprazole Does Not Affect Blood Levels of LEXIVA RESEARCH TRIANGLE PARK, N.C., Nov. 18 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) today announced that the U.S. Food and Drug Administration ( FDA ) approved GSK s application to add clinical data to the prescribing information for


48-Week Clinical Trial Data Provides Information Regarding Switching from an Existing Protease Inhibitor-Based Regimen to a Reyataz(R) (atazanavir sulfate)-Based Regimen
PRNewswire - November 18, 2005
-- SWAN Study Key Results Presented at the Tenth European AIDS Conference DUBLIN, Ireland , Nov. 18 /PRNewswire-FirstCall/ -- In a 48-week study presented today at the Tenth European AIDS Conference (EACS), 7% of HIV-1- infected patients who switched from a stable, protease inhibitor-based (PI) anti-HIV regimen to a re


Tibotec Announces Start of TMC125 Phase III Trials
PRNewswire - November 17, 2005
CORK, Ireland , November 17 /PRNewswire-FirstCall/ -- - Innovative Trial Design Offers Two Investigational Antiretrovirals in Combination Tibotec Pharmaceuticals Ltd. announced today the opening of its pivotal phase III clinical trial program for its investigational non-nucleoside reverse transcriptase (NNRTI), TMC125.


Transgene and the International AIDS Vaccine Initiative (IAVI) Sign Manufacturing Agreement
PRNewswire - November 17, 2005
STRASBOURG, France , November 17 /PRNewswire-FirstCall/ -- Transgene today announced its agreement with the International AIDS Vaccine Initiative (IAVI) for process development and manufacturing of an AIDS vaccine candidate for use in clinical trials. The vaccine candidate uses the Adenovirus-35 vector technology and e


BET Unveils World AIDS Day Programming Lineup as Part of the Rap-It-Up HIV/AIDS Public Education Initiative
PRNewswire - November 16, 2005
-- The Network Rounds Out 8th Year of Quality HIV/AIDS Programming with Premiere of 2005 Rap-It-Up/BASS Film MULTITUDE OF MERCIES on December 1 at 9:00 p.m. ET/PT WASHINGTON, Nov. 16 /PRNewswire/ -- BET and the Kaiser Family Foundation today announced a line up of special HIV-themed programming to mark World AIDS Day o


Procyon reports new data for its lead HIV protease inhibitor, PPL-100, showing a potentially high genetic barrier against the HIV virus
PRNewswire - November 16, 2005
-- Mutations developed against PPL-100 may potentially confer hypersensitivity to other HIV protease inhibitors TICKER:PBP (TSX) MONTREAL, Nov. 16 /PRNewswire-FirstCall/ - Procyon Biopharma Inc. (TSX:PBP), a biotechnology company developing innovative therapeutics in the fields of cancer and HIV/AIDS, announced today r


Procyon to host conference call and webcast today to explain new data for PPL-100: Potentially high genetic barrier against the HIV virus
PRNewswire - November 16, 2005
-- Mutations developed against PPL-100 may potentially confer hypersensitivity to other HIV protease inhibitors TICKER: PBP (TSX) MONTREAL, Nov. 16 /PRNewswire-FirstCall/ - Procyon Biopharma Inc. (TSX: PBP), a biotechnology company developing innovative therapeutics in the fields of cancer and HIV/AIDS, announced today


Defenders of Property Rights Optimistic Brazil is Backing Away from U.S. AIDS Drug Patent Threat
PRNewswire - November 16, 2005
-- Brazilian Health Minister Announces AIDS Situation Under Control, Not a TRIPS-defined Health Emergency in Statement to Country s Health Council WASHINGTON, Nov. 16 /PRNewswire/ -- Defenders of Property Rights (DPR) today announced its optimism that the Brazilian government has backed away from its threats to seize A


The Wide Open State - Now Wide Open for Emerging Technology: Recognized as an Important Treatment Tool, virco(R)TYPE HIV-1 Now Approved for Texas Medicaid
PRNewswire - November 15, 2005
RARITAN, N.J., Nov. 15 /PRNewswire/ -- The Texas Medicaid Program is now providing coverage for virco(R)TYPE HIV-1 with the current procedure code of 0023T, as of November 1, 2005. The decision to cover the predictive phenotype that utilizes bioinformatics technology also provides coverage for HIV genotypes and convent


Celgene Receives Approvable Letter From FDA for THALOMID(R) in Treatment of Newly Diagnosed Multiple Myeloma
PRNewswire - November 15, 2005
SUMMIT, N.J., Nov. 15 /PRNewswire-FirstCall/ -- Celgene Corporation (Nasdaq: CELG) today announced the U.S. Food and Drug Administration ( FDA ) issued an approvable letter in response to the Company s sNDA for multiple myeloma (MM). The FDA has requested revised product labeling with the specific indication of newly d


Gen-Probe Awarded Prestigious National Medal of Technology for Development of Nucleic Acid Tests for Blood Screening
PRNewswire - November 15, 2005
SAN DIEGO, Nov. 15 /PRNewswire-FirstCall/ -- President George W. Bush has named Gen-Probe Incorporated (Nasdaq: GPRO) a 2004 National Medal of Technology Laureate in recognition of the Company s pioneering work in developing innovative nucleic acid tests to safeguard the nation s donated blood supply from viruses such


Statement From AIDS Action Committee of Massachusetts, Inc. Executive Director, Rebecca Haag - Nov. 14, 2005
PRNewswire - November 14, 2005
BOSTON, Nov. 14 /PRNewswire/ -- We salute the House of Representatives for the strong statement made today to reduce the spread of HIV/AIDS by overwhelmingly passing statewide Pharmacy Access legislation which brings us closer to enacting this law that will save lives in Massachusetts, said Rebecca Haag, Executive Dire


Consumer Sexual Health Group Welcomes FDA Condom Guidelines, Seeks Refinements
PRNewswire - November 14, 2005
WASHINGTON, Nov. 14 /PRNewswire/ -- Condoms are an essential tool in reducing the risk of sexually transmitted infections, says James R. Allen, MD, MPH, president and CEO of the American Social Health Association (ASHA), and we respect the work of the FDA in crafting a science-based guideline that can serve as a basis


Body Positive Releases New HIV/AIDS Resource Directory: The Principal Source of Information for Individuals and Organizations
PRNewswire - November 14, 2005
NEW YORK, Nov. 14 /PRNewswire/ -- Body Positive announced today the availability of its 2006 HIV/AIDS Resource Directory -- the first new edition of this authoritative guide to services provided to people living with HIV/AIDS in the New York metro area in five years. At more than 40 indexed and cross-referenced pages a


International Concert Series to Raise Awareness and Funds for Children Affected by AIDS
PRNewswire - November 14, 2005
-- Ten Concerts to be Produced Bi-Annually at Exotic Wonders of the World; Proceeds to Benefit UNICEF and HIV/AIDS Charities NEW YORK, Nov. 14 /PRNewswire/ -- The 8th Wonder of the World, a leading entertainment company formed by Tantra and East West Entertainment, today announced they will produce a series of concerts


GLOBE Study Demonstrates Telbivudine Provides Significantly Greater Response on Antiviral Measures vs. Lamivudine in Patients With Chronic Hepatitis B, the 10th Leading Cause of Death Worldwide
PRNewswire - November 14, 2005
* Achieving early viral suppression is associated with improved clinical outcomes * 95% of telbivudine-treated patients who have undetectable virus at 6 months remain so at one year SAN FRANCISCO, Nov. 14 /PRNewswire/ -- Results from the ongoing GLOBE study demonstrate that the investigational drug telbivudine provides


Celebs Contribute to World AIDS Day Auction BID 2 BEAT AIDS: Begins December 1, 2005 to Benefit LIFEbeat
PRNewswire - November 14, 2005
-- Featuring Memorabilia From Tom Cruise, Kanye West, The Simpsons, Madonna, Britney, Mariah, Lil Kim, Joni Mitchell, 50 Cent, Brooke Shields & More! NEW YORK, Nov. 14 /PRNewswire/ -- LIFEbeat, the Music Industry Fights AIDS honors World AIDS Day on December 1st with BID 2 BEAT AIDS, an eBay auction featuring nearl


Pegasys(R) Shows Encouraging Interim Results for Hepatitis C Patients in Whom Peg-Intron(R) Therapy Failed
PRNewswire - November 11, 2005
-- Study Results May Offer New Hope for Patients Who Had Not Responded to Treatment SAN FRANCISCO, Nov. 11 /PRNewswire/ -- Roche announced today plans to present interim results from a study showing that re-treatment with Pegasys(R) (peginterferon alpha-2a) plus Copegus(R) (ribavirin, USP) reduced viral levels in hepat


New Studies with Pegasys(R) plus Copegus(R) in Hepatitis C Treatment to be Presented at AASLD Annual Meeting
PRNewswire - November 11, 2005
SAN FRANCISCO, Nov. 11 /PRNewswire/ -- A series of studies related to the treatment of hepatitis C with Pegasys(R) (peginterferon alpha-2a) plus Copegus(R) (ribavirin, USP) will be presented at the 56th American Association for the Study of Liver Disease (AASLD) annual meeting, which begins here today. The following st


HBO Films' Oscar(R)-Nominated 'YESTERDAY' About AIDS in Africa to Premiere at Woodruff Arts Center November 10
PRNewswire - November 10, 2005
-- HBO and Comcast Will Host Premiere of Dramatic Film in Partnership with AID Atlanta, Celebrate diversity Through the Arts and the National Black Arts Festival ATLANTA, Nov. 10 /PRNewswire/ -- Nominated for Best Foreign Language Film at the Oscars(R) this year, the HBO Films presentation of YESTERDAY will have its At


Worldwide Shortage of Glaxo's AIDS Drug, AZT, Alarms Patients, Advocates, Says AHF
PRNewswire - November 9, 2005
-- AIDS Healthcare Foundation Says Patent Protection Issues Led to Global Shortage of Glaxo s Life-saving AIDS Drug; Notes AZT Shortage Echoes Global Shortage of Bird Flu Drug, Tamiflu -- In Two Weeks, Patients in Africa, Elsewhere May Be Forced to Scramble to Find Non-AZT Drug Regimens; AIDS Group Alarmed That Patient


Syphilis Rates Among Gay Men Skyrocket, Notes AHF
PRNewswire - November 8, 2005
-- Men Who Have Sex With Men (MSM) Account for 64% of All Adult Syphilis Cases in 2004, Up From Only 5% in 1999. US Largest AIDS Group Calls for Stepped Up STD & HIV Prevention and Testing LOS ANGELES, Nov. 8 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the largest AIDS organization in the US which operates fr


Cellegy Announces Results of Data Monitoring Committee Review of Savvy(R) Ghana Phase 3 HIV Prevention Trial
PRNewswire - November 8, 2005
-- Safety Profile Satisfactory, But Recommendation to Discontinue Trial Because of Low HIV Seroconversion Rate in Trial Population -- Conference Call Scheduled for Tuesday, November 8th at 11:00am (Eastern) HUNTINGDON VALLEY, Pa., Nov. 8 /PRNewswire-FirstCall/ -- Cellegy Pharmaceuticals, Inc. (Nasdaq: CLGY) announced t


Clinical Care Options Launches Upgraded User Interface for Its Specialty Portals
PRNewswire - November 8, 2005
RESTON, Va., Nov. 8 /PRNewswire/ -- Clinical Care Options (CCO), a leader in the development of innovative interactive medical education for healthcare professionals, has launched a new version of its Web site with an improved user interface, making it easier and faster to access and navigate the state-of-the-art educa


Tanox to Present Two Abstracts on TNX-355 at 2005 ICAAC
PRNewswire - November 7, 2005
HOUSTON, Nov. 7 /PRNewswire-FirstCall/ -- Tanox, Inc. (Nasdaq: TNOX) will present two abstracts on its novel HIV antibody, TNX-355, at the American Society for Microbiology s Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Dec. 16-19, 2005 in Washington, D.C. The presentations include a late-b


Worldwide Orphans Foundation Begins Treating Children in Ethiopia With HIV/AIDS
PRNewswire - November 7, 2005
NEW YORK, Nov. 7 /PRNewswire/ -- Worldwide Orphans Foundation (WWO) has received its final certification from the Ethiopian government and has begun to treat orphans with HIV/AIDS. The Ministry of Health designated Barlow House/WWO as a Center for Pediatric HIV/AIDS treatment in Addis Ababa. According to Dr. Jane Arons


Health Canada Approves INSTI(TM) for HIV Testing in Doctors' Offices
PRNewswire - November 7, 2005
RICHMOND, BC, Nov. 7 /PRNewswire/ - bioLytical(TM) Laboratories announced today, INSTI(TM) HIV, a rapid HIV test kit developed by the company, has received market approval from Health Canada . INSTI(TM) HIV is the only immediate detection kit available in Canada for use in a point-of-care setting such as a doctor s off


LabCorp(R) Launches Enhanced HIV Screening Assay
PRNewswire - November 7, 2005
-- Revolutionary Procedure Helps Identify Newly Infected HIV Patients Up to Six Weeks Sooner than Standard HIV Antibody Screening BURLINGTON, N.C., Nov. 7 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced the introduction of an enhanced HIV Screening Assay t


Fattah Leads Congressional Effort to Clean Up Africa's Blood Supply
PRNewswire - November 4, 2005
WASHINGTON, Nov. 4 /PRNewswire/ -- In Sub-Saharan Africa 24.5 million individuals are living with HIV and every 25 seconds another person is infected with the disease. Blood transfusions are directly linked to the escalation in the number of HIV cases. Congressman Chaka Fattah (D-PA), a member of the powerful House App


Avian Flu: What's Missing from the White House Plan
PRNewswire - November 3, 2005
WASHINGTON, Nov. 3 /PRNewswire/ -- An analysis released today of the White House s Avian Flu Plan argues the plan offers far too little help to countries so they can respond to an outbreak before it reaches the US. It warns that unless the plan is broadened, America will not be safe and its moral credibility could be d


FDA Advisers to Discuss OraQuick Advance, First At-home HIV/AIDS Test Made by OraSure; Healthcare Industry Today Offers Extended News Coverage
PRNewswire - November 3, 2005
WASHINGTON, Nov. 3 /PRNewswire/ -- In an effort to popularize HIV testing, the U.S. Food and Drug Administration is considering whether to allow the use of the first HIV test a person can take entirely at home. The test, made by OraSure Technology, relies on a swab on the inside of the mouth and provides results in abo


Roche Announces Expansion of First Major Study to Examine Efficacy of Pegasys(R) in Hepatitis C Treatment in Latinos
PRNewswire - November 3, 2005
-- Roche Continues Commitment to Examining Treatment Options for All Patients - NUTLEY, N.J., Nov. 3 /PRNewswire/ -- Roche announced today that the company is investing more resources in treating the Latino community by expanding the largest study to date comparing hepatitis C treatment response rates in Latinos and no


Net 1 UEPS Technologies, Inc. Announces Net1/JSI Co-operation on HIV/AIDS Drug Distribution
PRNewswire - November 3, 2005
JOHANNESBURG, South Africa , Nov. 3 /PRNewswire-FirstCall/ -- On September 27, 2005, the Washington, D.C.-based President s Emergency Plan for AIDS Relief, through the U.S. Agency for International Development (USAID), announced a contract to strengthen the lifeline of essential drugs and supplies for people living wit


Clinical Data on Thalidomide Reported in Recurrent Epithelial Ovarian Cancer
PRNewswire - November 3, 2005
-- Oral Presentation at the Chemotherapy Foundation Symposium Reported 50% of Patients Achieved Overall Response in Median Progression Free Survival SUMMIT, N.J., Nov. 3 /PRNewswire-FirstCall/ -- Celgene Corporation (Nasdaq: CELG) announced today that preliminary clinical data was reported at the XXIII Chemotherapy Fou


South African TV Special 'Takalani Sesame's Talk to Me' Honored with Prestigious Japan Prize
PRNewswire - November 2, 2005
-- Independent Research Finds Parents Exposed to TV Special Twice as Likely to Talk to Their Kids About HIV and AIDS NEW YORK and CAPE TOWN, South Africa , Nov. 2 /PRNewswire/ -- Takalani Sesame Presents: Talk to Me, the TV special based on the multi-media initiative aimed at conveying messages about talking to childre


Study Identifies Several New Bacterial Species Associated With Common Infection in Women
PRNewswire - November 2, 2005
-- Research Has Implications for Improving Detection and Treatment of Bacterial Vaginosis and Other Infections With Multiple Bacterial Sources SEATTLE, Nov. 2 /PRNewswire/ -- Despite being one of the most common infections among women, scientists and doctors know little about the causes of bacterial vaginosis (BV), a u


Monogram Biosciences Announces Medicaid Coverage for HIV Drug Resistance Testing in Texas
PRNewswire - November 2, 2005
-- Thousands of Patients Now Eligible for Coverage for PhenoSense(TM) Testing, Which Can Significantly Improve Management of HIV Care SOUTH SAN FRANCISCO, Calif., Nov. 2 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (Nasdaq: MGRM) today announced that the Texas Medicaid Program has initiated a benefit coverage p


HBO Films' Oscar(R)-Nominated 'YESTERDAY' to Premiere at the Byron Carlyle Theater November 15
PRNewswire - November 2, 2005
-- HBO and the Miami International Film Festival to host Florida Premiere of Dramatic Film about AIDS in Africa -- Screening to be followed by conversation with HIV/AIDS educators including Dr. Marilyn Volker, university professor of sexuality, drawing parallels between AIDS in Africa and South Florida MIAMI, Nov. 2 /P


Chicago Afrobeat Project to Celebrate Debut Album with Two Performances at Martyrs' Live in Chicago on November 12, 2005
PRNewswire - November 1, 2005
CHICAGO, Nov. 1 /PRNewswire/ -- Chicago Afrobeat Project (CAbP) will celebrate the release of the band s first studio recording on November 12, 2005 with two shows at Martyrs located at 3855 N. Lincoln Ave. in Chicago, Ill. The 21+ evening performance will feature special guests Fareed Haque, Morikeba Kouyate, Howard L


Dynavax Initiates US-Based Phase 1 Clinical Trial of HEPLISAV(TM) Hepatitis B Vaccine in Dialysis Population
PRNewswire - November 1, 2005
BERKELEY, Calif., Nov. 1 /PRNewswire-FirstCall/ -- Dynavax Technologies Corporation (Nasdaq: DVAX) announced the initiation of a Phase 1 clinical trial of HEPLISAV, its ISS-based hepatitis B (HBV) vaccine in patients with end-stage renal failure (pre-dialysis). The trial will be conducted at multiple centers in the


AHF Criticizes Abbott For AIDS Drug Price Hike
PRNewswire - October 31, 2005
LOS ANGELES, Oct. 31 /PRNewswire/ -- In response to the announcement by Abbott Laboratories Inc., that the new reformulation of its HIV/AIDS drug, Kaletra ( lopinavir / ritonavir ), has been approved


Merck and Bristol-Myers Squibb License New AIDS Drugs to IPM for Development as Microbicides to Protect Women from HIV
PRNewswire - October 31, 2005
-- New Nature study shows potential of entry inhibitor compounds as HIV prevention tool NEW YORK, Oct. 31 /PRNewswire/ -- In a first-of-its-kind joint announcement, two of the world s leading pharmaceutical companies, Merck & Co. , Inc. and Bristol-Myers Squibb have each announced today that they have signed se


Abbott Receives FDA Approval for New Kaletra(R) (Lopinavir/Ritonavir) Tablet Formulation for HIV Patients
PRNewswire - October 31, 2005
-- New formulation offers patients more convenient form of the leading HIV protease inhibitor . ABBOTT PARK, Ill., Oct. 31 /PRNewswire-FirstCall/ -- Abbott announced today that it has received U.S. Food and Drug Administration ( FDA ) approval for a new tablet formulation of its HIV protease inhibitor (PI)


Pamela Anderson, Linda Evangelista, Missy Elliott Among Celebrity Supporters of M.A.C Aids Fund Kids Helping Kids Holiday Card Program
PRNewswire - October 31, 2005
-- M.A.C Aids Fund Launches 11th Annual Kids Helping Kids Card Campaign with $250,000 Goal, Featuring Children s Artwork To Benefit Families in Africa NEW YORK, Oct. 31 /PRNewswire/ -- Kids Helping Kids is an annual holiday card initiative of the M.A.C AIDS Fund (M.A.F) with 100 percent of sales going to support pediat


July 4th HIV/AIDS Awareness Concert and Fundraiser Philadelphia Freedom Concert & Ball, Raised Net Total of $1.1 Million for Elton John AIDS Foundation and Dr. Magnus Hirschfeld Fund
PRNewswire - October 28, 2005
-- Regional AIDS Organizations Enthusiastic PHILADELPHIA, Oct. 28 /PRNewswire/ -- The July 4 Philadelphia Freedom Concert and Ball headlined by Sir Elton John, drew well over 500,000 people to the Benjamin Franklin Parkway, was seen by a television audience of over a half-million others and raised a net total of $1.1 m


Cellegy Announces Update to Savvy Phase 3 HIV Prevention Trials
PRNewswire - October 27, 2005
HUNTINGDON VALLEY, Pa., Oct. 27 /PRNewswire-FirstCall/ -- Cellegy Pharmaceuticals, Inc. (Nasdaq: CLGY) announced today that 100% enrollment has been achieved in the Savvy(R) (C31G vaginal gel) Phase 3 HIV prevention trial in Ghana based on current projected enrollment. A total of 2,142 subjects are now enrolled in Ghan


Schering-Plough Discontinues Phase II Study of Vicriviroc in Treatment-Naive HIV Patients, Continues Phase II Study in Treatment-Experienced HIV Patients
PRNewswire - October 27, 2005
KENILWORTH, N.J., Oct. 27 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today reported that it has discontinued a Phase II study with its investigational CCR5 receptor antagonist, vicriviroc, used in combination with Combivir in treatment-naive HIV patients.


The MALE Center Launches New, Exciting Event Series in November
PRNewswire - October 26, 2005
BOSTON, Oct. 26 /PRNewswire/ -- Beginning Nov. 5, The MALE Center, AIDS Action Committee s new community resource and wellness center for gay and bisexual men in Boston, will host a series of monthly on-site events as part of a new program to serve the interests of gay and bisexual men in Boston. Once a week, each mont


AHF to Unveil New 'Yes On 79' Ad: 'Drug Companies Think Californians are Idiots'
PRNewswire - October 26, 2005
-- 30-Second TV Ad Reminds Voters that the Drug Industry Backs $80 Million Campaign to Defeat the Health, Consumer and Senior Advocate-Backed Prop 79 WHAT:Roll Out of New TV Ad for Yes on Proposition 79 Campaign (Cheaper Drugs More Californians Can Count On) WHEN:Tomorrow, Thursday, October 27, 2005, 11:00 a.m. WHE


Mattel Announces Signature Partnership With Children Affected by AIDS Foundation (CAAF)
PRNewswire - October 26, 2005
-- Partnership to Support the First International Program for CAAF Focused on Children Orphaned by AIDS EL SEGUNDO, Calif., Oct. 26 /PRNewswire-FirstCall/ -- Mattel, Inc. (NYSE: MAT) and the Mattel Children s Foundation today announced the launch of a global signature partnership with the Children Affected by AIDS Foun


AHF & AFABI to Open New, Free AIDS Clinic in Tijuana
PRNewswire - October 26, 2005
-- AIDS Healthcare Foundation (AHF) and Agencia Familiar Binacional, A.C. (AFABI) to Host Ribbon-cutting Ceremony and Clinic Dedication This Friday, October 28th at 3pm -- US Largest AIDS Group Joins Forces and Partners With Respected Local Mexican NGO to Extend HIV/AIDS Medical Care and Access to Life-saving Anti-retr


Entertainment Production Company -- 8th Wonder of the World -- Announces First of Ten Concerts Around the World to Raise Awareness for HIV/AIDS
PRNewswire - October 26, 2005
-- MTV Asia, YouthAIDS and Lou Pearlman Join Hands with 8th Wonder of the World Concert Series -- Kick off event at the Taj Mahal, February 25, 2006 NEW YORK, Oct. 26 /PRNewswire/ -- 8th Wonder of the World, a semi-annual concert series to benefit HIV/AIDS efforts will be hosted at the natural and man-made Wonders of t


Tanox Reports Positive Results From Phase 2 Clinical Trial of TNX-355, an Entry Inhibitor to Treat HIV: Trial Meets Primary Endpoint
PRNewswire - October 26, 2005
-- Drug Candidate Significantly Reduces Level of Virus in Treatment-Experienced Patients -- Company to Host Conference Call Today at 10 a.m., EDT HOUSTON, Oct. 26 /PRNewswire-FirstCall/ -- Tanox, Inc. (Nasdaq: TNOX) today reported positive Phase 2 clinical results of its novel HIV drug candidate, TNX-355. The 24-week r


Tibotec Announces U.S. Expanded Access Program for TMC114: Program Will Provide Early Access for HIV-1 Infected Patients Who Have Limited Treatment Options
PRNewswire - October 26, 2005
YARDLEY, Pennsylvania, October 26 /PRNewswire-FirstCall/ -- Tibotec Pharmaceuticals Ltd. announced today the opening of its expanded access program (EAP) for its investigational protease inhibitor (PI), TMC114, in the U.S. The program will provide access for HIV-1 infected patients who need the compound to construct a


Campaign to End AIDS Rally
PRNewswire - October 23, 2005
-- Monday, October 24, 2005 -- LOVE Park -- 11:00 a.m. -- Thousands of AIDS activists kicked off a 21-day march to Washington, D.C., as part of The Campaign to End AIDS ( http://www.c2ea.org ). PHILADELPHIA, Oct. 23 /PRNewswire/ -- On Monday, October 24, 2005, Philadelphians will have a unique chance to join numbers of


Family-Friendly Celebrity Fundraiser to Tackle L.A. Foster Care Crisis
PRNewswire - October 21, 2005
-- Celebrities Host 7th Annual Children s Circle Fundraiser to Benefit Programs for Kids With Chronic and Terminal Medical Conditions on October 23rd LOS ANGELES, Oct. 21 /PRNewswire/ -- This Sunday, October 23rd, families in the L.A. community will have the opportunity to make a difference in the lives of L.A. foster


New Harris Poll Finds Different Religious Groups Have Very Different Attitudes to Some Health Policies and Programs
PRNewswire - October 20, 2005
ROCHESTER, N.Y., Oct. 20 /PRNewswire/ -- A new Harris Poll finds that large majorities of the U.S. adult public support each of 12 different healthcare policies, programs and practices, including some which are highly controversial. However, people who consider themselves very religious or born-again Christians and, pa


Nigeria's Creditors Should be Ashamed, Says Global AIDS Alliance
PRNewswire - October 20, 2005
-- Nigeria to Send $12.4 Billion to World s Richest Nations WASHINGTON, Oct. 20 /PRNewswire/ -- Today Nigeria reached an agreement with its largest creditors, grouped in what is known as the Paris Club. The agreement will lead to the cancellation of a large portion of Nigeria s massive $35.9 billion debt, 85.8% of whic


GlaxoSmithKline Biologicals and Aeras Global TB Vaccine Foundation Partner to Develop New TB Vaccine
PRNewswire - October 20, 2005
PARIS, Oct. 20 /PRNewswire-FirstCall/ -- GlaxoSmithKline Biologicals (GSK Biologicals) and the Aeras Global TB Vaccine Foundation (Aeras) today announced a new public-private partnership to develop GSK Biologicals tuberculosis candidate vaccine Mtb72F/AS02A, which has shown promising results in preclinical studies. In


Distinguished Achievement Awards Go to Seven Leading Researchers for Groundbreaking Discoveries; $6.5 Million in No-Strings-Attached Grants Support 13 Scientists for Cutting Edge Biomedical Research Across Three Continents
PRNewswire - October 20, 2005
-- Freedom to Discover Program Recognizes Achievements and Encourages Risk-Taking by Scientists with Focus on Basic Science and New Therapies for Alzheimer s Disease, Obesity, HIV/AIDS and Cancer NEW YORK, Oct. 20 /PRNewswire/ -- Honoring groundbreaking achievements as well as supporting cutting-edge research are the t


India's HIV/AIDS Pandemic Threatens Economic and Social Fabric
PRNewswire - October 20, 2005
-- FXB President Demands Reforms to Strengthen Community Support for AIDS-Related Orphans CHENNAI, India , TAMIL, India and NADU, India, Oct. 20 /PRNewswire/ -- Albina du Boisrouvray, president of the Association Francois-Xavier Bagnoud (FXB), warned the 5th International Conference on AIDS India here today that withou


Sontra and EpiVax Form Research Collaboration to Develop Therapeutic Topical Vaccines
PRNewswire - October 20, 2005
-- EpiVax s HIV Vaccine to be Delivered Topically with SonoPrep Skin Permeation Device FRANKLIN, Mass. & PROVIDENCE, R.I., Oct. 20 /PRNewswire-FirstCall/ -- Sontra Medical Corporation (Nasdaq: SONT) and EpiVax, Inc. announced today that they have formed a research collaboration to investigate the topical delivery o


Maxygen Announces $14.4 Million in U.S. Government Funding to Advance HIV Vaccine Research
PRNewswire - October 20, 2005
REDWOOD CITY, Calif., Oct. 20 /PRNewswire-FirstCall/ -- Maxygen, Inc. (Nasdaq: MAXY) today announced that it has been awarded grants and a contract totaling $14.4 million from the National Institutes of Health (NIH) and the United States Department of Defense to advance research for development of a preventative HIV va


GlaxoSmithKline Initiates New HIV/AIDS Collaboration in Kenya: Improved Healthcare for Thousands Expected
PRNewswire - October 19, 2005
PHILADELPHIA, LONDON, and NAIROBI, Kenya , Oct. 19 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) today announced a new $1.8 million program to improve and scale up HIV/AIDS healthcare services at 60 facilities in Kenya. The program, a collaboration with AMREF (African Medical and Research Foundation), Elizabeth


League Launches 'NBA CARES' Global Outreach Initiative Supporting Education, Youth and Family Development, and Health-Related Causes
PRNewswire - October 18, 2005
- The NBA, Players and Teams Commit To Raise $100 Million, Volunteer 1 Million Hours and Build 100 Youth Sites - NEW YORK, Oct. 18 /PRNewswire-FirstCall/ -- The NBA, its players and teams unveiled a new initiative called NBA CARES, Commissioner David Stern announced today. Through NBA CARES, the league, players and tea


Bioject Announces B2000 Technology to Be Used in Phase 2 NIH-Sponsored Clinical Trial for HIV Vaccine
PRNewswire - October 18, 2005
BEDMINSTER, N.J., Oct. 18 /PRNewswire-FirstCall/ -- Bioject Medical Technologies, Inc. (Nasdaq: BJCT), a leading developer of needle-free drug delivery systems, today announced that the company s needle-free technology for vaccine delivery will be used in a National Institutes of Health (NIH)- sponsored Phase 2 clinica


TB Alliance and Bayer Launch Historic Global Drug Trials for Tuberculosis: Phase II Trials to Study Potential of Moxifloxacin to Shorten TB Treatment
PRNewswire - October 17, 2005
-- Partners Commit to Affordable Pricing for Patients in the Developing World NEW YORK, and LEVERKUSEN, Germany , Oct. 17 /PRNewswire/ -- The Global Alliance for TB Drug Development (TB Alliance) and Bayer Healthcare AG today announced a partnership to coordinate a global clinical trial program to study the potential o


Procyon announces positive preclinical results for its lead HIV protease inhibitor, PPL-100
PRNewswire - October 17, 2005
MONTREAL, Oct. 17 /PRNewswire-FirstCall/ - Procyon Biopharma Inc. (TSX:PBP) today announced preclinical results from its lead HIV protease inhibitor, PPL-100, development program. The recently completed preclinical safety studies show that PPL-100 is a safe drug. Earlier this year, the company had reported on the favor


SERONO to Pay $704 Million for the Illegal Marketing of AIDS Drug, Reports U.S. Attorney
PRNewswire - October 17, 2005
BOSTON, Oct. 17 /PRNewswire/ -- Swiss corporation SERONO, S.A., together with its U.S. subsidiaries, SERONO, INC., SERONO HOLDING, INC., SERONO LABORATORIES, INC. and related entities ( SERONO ) have agreed to pay a total of $704,000,000 to resolve criminal charges and civil liabilities in connection with several illeg


Whistleblower AHF Applauds Serono's $704M Settlement With Government for Illegal Marketing of AIDS Drug, Serostim
PRNewswire - October 17, 2005
LOS ANGELES, Oct. 17 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the largest AIDS organization in the US which operates free AIDS treatment clinics in the US, Africa, Central America and Asia, including 14 clinics in California and Florida, today welcomed the news of multi-national drug giant, Serono Inc. s, sett


3rd Annual National Latino Aids Awareness Day Unites Over 46 States From Coast to Coast
PRNewswire - October 17, 2005
-- The Last Day Of Hispanic Heritage Month Will Be Reserved To Spread The Message: Love Your Life, Protect Yourself, Get Tested For HIV NEW YORK, Oct. 17 /PRNewswire/ -- To mark a special day of awareness and prevention against HIV/AIDS in the Latino community, the Latino Commission on AIDS and the Hispanic Federation,


New HIV/AIDS Care Center - Big Boost for The AIDS Support Organization (TASO) and Uganda Infrastructure
PRNewswire - October 14, 2005
-- Pfizer /TASO Partnership to Improve Training, Counseling, Treatment and Care for Thousands Living with HIV/AIDS MBARARA, Uganda , Oct. 14 /PRNewswire-FirstCall/ -- The AIDS Support Organization (TASO), with support from Pfizer Inc, opened a new AIDS counseling and training center here today that will play an importa


AHF Urges FDA to Fast Track Approval of Rapid HIV Test Kits for Home Use
PRNewswire - October 13, 2005
-- US Largest AIDS Organization Says Approval of Home Testing Could Improve HIV Prevention Efforts LOS ANGELES, Oct. 13 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), which offers free HIV/AIDS treatment at its 14 clinics in California and Florida and is the operator of the largest free alternative HIV testing progr


Hispanic Women and HIV/AIDS Focus of New Study Released in Celebration of National Latino AIDS Awareness Day
PRNewswire - October 13, 2005
WASHINGTON, Oct. 13 /PRNewswire/ -- Congressional and Latino community leaders announce highlights of The National Latino AIDS Awareness Day festivities and the release of a new study on Hispanic women and HIV/AIDS. National Latino AIDS Awareness day was founded to call for expansion of resources for preventing spread


Updated HIV/AIDS Treatment Guidelines Support Use of FUZEON Plus an Active Boosted Protease Inhibitor to Achieve New Treatment Goal
PRNewswire - October 13, 2005
-- DHHS Panel Revises Approach for Treatment Experienced Patients -- NUTLEY, N.J., Oct. 13 /PRNewswire/ -- Newly updated HIV/AIDS treatment guidelines issued by the Department of Health and Human Services (DHHS) support the use of FUZEON(R) ( enfuvirtide ) with an active boosted protease inhibitor (PI) in patients w


Bay Area Latinos Unite to Promote AIDS Awareness in the Latino Community
PRNewswire - October 13, 2005
OAKLAND, Calif., Oct. 13 /PRNewswire/ -- HIV causes AIDS, Ignorance Kills, Protect Yourself is the slogan that the Bay Area National Latino AIDS Awareness Day (BANLAAD) coalition has adopted for this year s National AIDS Awareness Day on October 15, 2005. BANLAAD is a coalition formed by a diverse group of agencies, he


Latino Town Hall Meeting in Los Angeles To Discuss Future of Ryan White AIDS Funding
PRNewswire - October 13, 2005
-- Representatives Hilda Solis and Grace Napolitano Speak on Behalf of the Congressional Hispanic Caucus in Recognition of Latino AIDS Awareness Day WASHINGTON, Oct. 13 /PRNewswire/ -- The Ryan White ACTION Campaign joins Bienestar Human Services on October 14 from 12:00 pm - 2:00 pm (PDT) in hosting a Latino Town Hall


Bureaucrats to Fund County Rent Hike With $1.6 Million Cut to AIDS Services
PRNewswire - October 12, 2005
-- AIDS Healthcare Foundation Denounces Perverse Funding Priorities LOS ANGELES, Oct. 12 /PRNewswire/ -- Los Angeles County bureaucrats charged with distributing federal emergency AIDS funds sent a letter to community clinics and service providers on Friday informing them of $1.6 million in funding reductions to offset


Koronis Pharmaceuticals Begins Phase 1b Clinical Trial of Novel Anti-Viral HIV/AIDS Therapeutic in HIV-Positive Patients
PRNewswire - October 12, 2005
SEATTLE, Oct. 12 /PRNewswire/ -- Koronis Pharmaceuticals, Inc. today announced the initiation of a Phase 1b clinical trial of KP-1461, its novel anti-viral therapeutic, in HIV-positive patients. The objectives of the trial are to evaluate the safety, toxicity, pharmacokinetic profile and initial clinical activity of KP


Arizona Health Leaders Gather in Tucson to Discuss New Methods for Protecting Women from HIV
PRNewswire - October 12, 2005
TUCSON, Ariz., Oct. 12 /PRNewswire/ -- HIV/AIDS service providers, scientists, medical experts, health activists and policy makers from across Arizona met today with one of the world s leading HIV/AIDS researchers to discuss new strategies to halt the growing AIDS epidemic in women. Women account for nearly half the 40


AHF to Offer Free HIV Testing for National Latino AIDS Awareness Day (NLAAD)
PRNewswire - October 12, 2005
-- US Largest AIDS Organization Will Participate in Activities at Several California & Florida Sites Throughout This Week Leading Up to NLAAD, Saturday, October 15th LOS ANGELES, Oct. 12 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), which offers free HIV/AIDS treatment at its 14 clinics in California and Florid


Primagen and Roche Molecular Systems Initiate Discussions to Develop Dry Filter Spot Technology for HIV-1 Viral Load Testing in the Developing World
PRNewswire - October 11, 2005
AMSTERDAM, October 11 /PRNewswire/ -- Primagen Holding BV, The Netherlands and Roche Molecular Systems, Inc. (RMS), Pleasanton, California today announced the initiation of discussions about a development program to enable Primagen s Dry Filter Spot (DFS) technology to be used with RMS COBAS TaqMan Tests and AMPLICOR(


VIRxSYS Completes $30 Million Financing: Funds Will Support Phase II Trial for HIV/AIDS Therapy
PRNewswire - October 11, 2005
GAITHERSBURG, Md., Oct. 11 /PRNewswire/ -- VIRxSYS Corporation, a privately held company developing genetic therapies for HIV and cancer, announced the final closing of their latest financing round. The Series F Preferred Stock financing totaled approximately $31 million. Earlier closings of this round were used to com


Vical DNA Vaccine Technology Enters Phase 2 Clinical Trial for HIV
PRNewswire - October 11, 2005
SAN DIEGO, Oct. 11 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaq: VICL) announced today the initiation of a National Institutes of Health (NIH) sponsored Phase 2 clinical trial of a prime-boost vaccine approach against HIV. The trial involves priming an immune response with multiple doses of a plasmid DNA vaccin


Global Attention Turns to Hospice and Palliative Care on October 8
PRNewswire - October 6, 2005
-- An important global event. - Archbishop Tutu ALEXANDRIA, Va., Oct. 6 /PRNewswire/ -- October 8, 2005 marks the first World Hospice and Palliative Care Day -- a unified day of action to raise awareness for the expansion of hospice and palliative care services around the world. Every year, millions of people around th


Nationwide Strengthening of Hospital System in Tanzania Marks New Era in Fight Against AIDS in Africa
PRNewswire - October 6, 2005
-- The Abbott Fund and the Government of Tanzania Dedicate New Hospital Facilities to Meet Long-Term Needs of Patients with HIV/AIDS and Other Diseases DAR ES SALAAM, Tanzania, Oct. 6 /PRNewswire/ -- In a ceremony today, Abbott CEO Miles White joined Tanzanian President Benjamin William Mkapa in dedicating a new state-


Clinical Care Options and the American Academy of HIV Medicine Announce Collaboration to Create Leading-Edge Educational Programs
PRNewswire - October 6, 2005
-- Agreement Aims to Help HIV Doctors Provide Optimal Patient Care - RESTON, Va., Oct. 6 /PRNewswire/ -- Clinical Care Options (CCO), a leader in the development of innovative interactive medical education for healthcare professionals, and the American Academy of HIV Medicine (AAHIVM), the premier professional associat


National Latino AIDS Awareness Day Will Go Ahead in Louisiana!
PRNewswire - October 5, 2005
NEW YORK, Oct. 5 /PRNewswire/ -- In spite of the devastation caused by Hurricane Katrina to Louisiana and the rest of the gulf coasts, the National Latino AIDS Awareness Day will continue as planned on Saturday, October 15, 2005 in Baton Rouge and in hundreds of other locations across the United States . The Nationa


Development of Starpharma's VivaGel(TM) Accelerated with $US20m Funding from NIH
PRNewswire - October 3, 2005
MELBOURNE, Australia , Oct. 3 /PRNewswire-FirstCall/ -- * Development of VivaGel(TM) significantly accelerated * Development costs externally funded through to the start of large-scale efficacy trials * No loss of product ownership or dilution of equity for Starpharma * Significant commercial opportunity exists for


Strengthening of Health Care Services and Infrastructure Critical but Neglected Factor in Access to Care for Millions of Africans
PRNewswire - October 3, 2005
-- Findings on Back Office Services Reported in the British Medical Journal PARIS, Oct. 3 /PRNewswire/ -- An article published today in the British Medical Journal highlights the need for more attention to broad-based and balanced strengthening of health care facilities in Africa. The importance of coordinated investme


One Week Remains Until The DIVA Foundation's Sheryl Lee Ralph Presents the 15th Annual 'DIVAS Simply Singing!' AIDS Benefit Saturday October 8th Wilshire Ebell Theatre
PRNewswire - September 30, 2005
-- Musical Gala Benefits AIDS Healthcare Foundation & The Black AIDS Institute LOS ANGELES, Sept. 30 /PRNewswire/ -- Sheryl Lee Ralph is at it again! Her 15th installment of DIVAS Simply Singing! to benefit AIDS Healthcare Foundation (AHF), the largest AIDS organization in the US which operates free AIDS treatment


His Excellency Yoweri Museveni, Uganda's President, to Dedicate New, Free AIDS Clinic in Masaka on October 6th, Notes AHF
PRNewswire - September 30, 2005
-- Expanded AIDS Facility, Which Provides Free Care and Anti-retroviral Treatment (ART), Plans to Scale Up Treatment to 4,000 Ugandans. Facility is an Innovative Partnership of the Ministry of Health, Republic of Uganda; AIDS Healthcare Foundation, and Uganda Cares. More Than 1,000 Uganda Cares Clients on Treatment Are


Female Health Company Announces International Availability of Second- Generation Female Condom at Significantly Lower Price
PRNewswire - September 30, 2005
-- New Study Shows Expanded Use of FC2 Could Prevent Thousands of HIV Infections and Save Millions of Dollars in Health Care Costs Annually in South Africa and Brazil Alone BALTIMORE, Sept. 30 /PRNewswire/ -- Mary Ann Leeper, Ph.D., President and COO of the Chicago-based Female Health Company (FHC), announced today tha


HIV-1 Virulence Attenuating - 75% of Viruses Less 'Fit' Than Those of 15 Years Ago
PRNewswire - September 29, 2005
LONDON, September 29 /PRNewswire/ -- 75% of samples taken from 2002-2003 were found to be weaker than those from 1986-1989, both in terms of spread within individuals and transmission to others, reports a recent AIDS journal article, published by Lippincott Williams & Wilkins - Replicative fitness of historical and


RESOURCE's Recovery Resource Center Receives Federal Funding for a Ground- Breaking Substance-Abuse, HIV/AIDS, and Hepatitis Prevention Program
PRNewswire - September 29, 2005
MINNEAPOLIS, Sept. 29 /PRNewswire/ -- RESOURCE s Recovery Resource Center (RRC) has just received a $1.7 million, five-year contract from the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) to reduce the incidence of substance-abuse, HIV/AIDS, and hepatitis among communities of color and individ


M.A.C Cosmetics Receives the Global Business Coalition (GBC) on HIV/AIDS 2005 Award for Business Excellence at the Awards Gala Headlined by Secretary Condoleeza Rice, Senator Hilary Rodham Clinton and Academy Award Winner Angelina Jolie
PRNewswire - September 28, 2005
WASHINGTON, Sept. 28 /PRNewswire/ -- M.A.C Cosmetics is awarded the Global Business Coalition (GBC) 2005 Award for Business Excellence using Core Competency at the John F. Kennedy Center for the Performing Arts. This award will be presented on Wednesday September 28th at the GBC Annual Awards Gala emcee Academy Award W


Thousands With HIV/AIDS to Ride in Caravans to Washington, D.C. for Four Days of Protest and Prayer November 5-8
PRNewswire - September 28, 2005
-- Caravan Organizers to Assist People With HIV Displaced by Katrina WASHINGTON, Sept. 28 /PRNewswire/ -- Thousands of people living with HIV/AIDS are preparing to travel across the U.S. in ten activist caravans this October, stopping in more than 150 cities across the country to tell local and national leaders: We hav


De Beers Wins International HIV/AIDS Award: Global Business Coalition on HIV/AIDS Honors Companies' Efforts to Fight the Epidemic at Kennedy Center Gala
PRNewswire - September 28, 2005
WASHINGTON, Sept. 28 /PRNewswire/ -- Today De Beers is being honored for its workplace response to HIV/AIDS counseling and testing by the Global Business Coalition on HIV/AIDS (GBC) at its Annual Awards for Business Excellence Gala at the John F. Kennedy Center for the Performing Arts. UNHCR Goodwill Ambassador and act


Global Business Coalition on HIV/AIDS (GBC) Announces 2005 GBC Awards for Business Excellence Winners at Gala Headlined by Secretary Condoleezza Rice, Senator Hillary Rodham Clinton and Angelina Jolie
PRNewswire - September 27, 2005
-- Senators and CEOs to Discuss Improving Public-Private Collaboration to Combat the Global AIDS Pandemic at Hill Briefing -- Through Global AIDS Simulation, International AIDS Experts Demonstrate the Potential of Multisectoral Involvement in Stopping the Global AIDS Pandemic WASHINGTON, Sept. 27 /PRNewswire/ -- Global


Bristol-Myers Squibb Invites Others to Join in Expansion of Pediatric AIDS Corps in Africa
PRNewswire - September 27, 2005
PRINCETON, N.J., Sept. 27 /PRNewswire-FirstCall/ -- At an awards dinner in Washington D.C. tomorrow night, Bristol-Myers Squibb Company (NYSE: BMY) Chief Executive Officer Peter R. Dolan will invite other members of the Global Business Coalition on HIV/AIDS (GBC) to join Bristol-Myers Squibb and Baylor College of Medic


Lambs Farm Sued for Excluding Man Because of HIV-Positive Status
PRNewswire - September 27, 2005
-- Equip for Equality Seeks Damages and Injunction for Man Who Had Lived and Worked at Lambs Farm for Many Years CHICAGO, Sept. 27 /PRNewswire/ -- Equip for Equality today filed suit in federal court against The Lambs Farm, Inc. of Libertyville, Illinois, on behalf of a 54-year old man with a developmental disability w


Under the President's Emergency Plan for AIDS Relief, USAID Announces Contract to Swiftly Deliver Lifesaving Medicines and Supplies to Developing Countries
PRNewswire - September 27, 2005
-- Consortium of 15 Institutions to Implement Award WASHINGTON, Sept. 27 /PRNewswire/ -- Today, the President s Emergency Plan for AIDS Relief, through the U.S. Agency for International Development, announced a contract to strengthen the lifeline of essential drugs and supplies for people living with or affected by HIV


Medical Services to Begin Shipping VScan Tuberculosis (TB) Rapid Test Kits to Africa
PRNewswire - September 27, 2005
EDMONTON, Alberta, Sept. 27 /PRNewswire-FirstCall/ -- Medical Services International Inc. (OTC: MSITF) wishes to announce that it has begun to ship its VScan (TB) rapid test kits to Africa. The World Health Organization (WHO) has declared a tuberculosis (TB) emergency for Africa. This epidemic kills more than 500,000 A


KNOW HIV/AIDS Seeks to Normalize HIV Testing With Its Latest Message 'The KNOW Is Spreading'
PRNewswire - September 27, 2005
-- Viacom and Kaiser Family Foundation s Initiative, Featuring Grammy Award-Winning Hip-Hop Artist Common, Launches New Campaign Wave Across Multiple Platforms NEW YORK, Sept. 27 /PRNewswire/ -- As part of their Emmy and Peabody Award-winning public education initiative KNOW HIV/AIDS, Viacom Inc. and the Kaiser Family


Feds Approve AIDS Healthcare Foundation's Innovative Managed Care Plan as a 'Medicare Advantage' Plan (MA)
PRNewswire - September 26, 2005
-- In Response to the Medicare Modernization Act (MMA), AHF, Operator of One of the Nation s First Medicaid Managed Care Plans for People With AIDS, Sought Medicare Advantage Status for its Positive Healthcare Partners to Ensure Continuity of Life-saving Care and Services for Its Eligible Clients. AHF s Program is the


Schwarzenegger Bows to Drug Industry Cash, Says AIDS Healthcare Foundation
PRNewswire - September 23, 2005
-- CA Gov. Endorses Proposition #78, Pharma s Toothless, Voluntary Drug Discount Measure on November Ballot; Comes Out Against Proposition #79, Measure Backed by Health, Labor and Senior Groups -- While Drug Industry Has Pooled a Record-breaking $80 Million for California Measures, Schwarzenegger Remains Second Only to


IFPMA Improves Biomedical Data Transparency With Launch of First Worldwide Clinical Trials Portal
PRNewswire - September 21, 2005
GENEVA, Switzerland , September 21 /PRNewswire/ -- The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) today announced the launch of its new IFPMA Clinical Trials Portal. Developed in conjunction with information technology leader IBM, it is the first internet search engine construct


New Documentary Underscores That Successful Treatment of HIV-Infected Children Is Possible in Resource-Limited Settings
PRNewswire - September 21, 2005
-- Program Highlights the Botswana /Baylor Children s Center of Excellence, the World s Largest Pediatric AIDS Treatment Center HOUSTON, Sept. 21 /PRNewswire/ -- Baylor College of Medicine announced today that the U.S.-based Discovery Health Channel will turn its lens on the smallest and often most overlooked victims o


Botswana's Available Safe Blood Supply Increases 100% With Safe Blood for Africa Foundation's Program
PRNewswire - September 21, 2005
-- A Major Success For Botswana s Ministry of Health through President Bush s PEPFAR, ACHAP and Safe Blood for Africa Foundation Programs in The Fight to Prevent HIV/AIDS GABORONE, Botswana, Sept. 21 /PRNewswire/ -- According to the most recent assessment of the blood supply in Botswana, there has been an effective 100


Project HOPE's Director, HIV/AIDS Programs Receives International Honor
PRNewswire - September 20, 2005
MILLWOOD, Va., Sept. 20 /PRNewswire/ -- Project HOPE congratulates Dr. Renslow Sherer, Director, HIV/AIDS/Sexually Transmitted Infections Programs, on a remarkable recognition by his peers. On the occasion of its 10th anniversary, the International Association of Physicians in AIDS Care (IAPAC) has selected, from its m


Ranbaxy Receives Approval to Market Zidovudine Tablets
PRNewswire - September 20, 2005
PRINCETON, N.J., Sept. 20 /PRNewswire/ -- Ranbaxy Laboratories Limited (RLL) announced today that it has received approval from the U.S. Food and Drug Administration to manufacture and market Zidovudine Tablets USP, 300 mg. The Office of Generic Drugs, U.S. Food and Drug Administration, has determined the Ranbaxy formu


WHO Regional Director Highlights the Rise in New Emerging Diseases
PRNewswire - September 19, 2005
NOUMEA, New Caledonia , Sept. 19 /Xinhua-PRNewswire/ -- Dr Shigeru Omi, WHO Regional Director for the Western Pacific, today called for an all-out war on avian influenza and warned of the threat of new emerging diseases. While we still have a window of opportunity, we must do everything we can to avert an influenza pan


Glaxo's Patent Protection on First AIDS Drug, AZT, ends; AHF Blasts Glaxo's & Drug Industry's Greed
PRNewswire - September 17, 2005
-- US Largest AIDS Group Vows to Continue Its AZT Patent Piracy Lawsuit Against British Drug Giant, Says Glaxo s Action and Position on Patents for Life-saving AIDS Drugs, Too Little, Too Late LOS ANGELES, Sept. 17 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the largest AIDS organization in the US which operates


Former President Clinton Opens the Clinton Global Initiative
PRNewswire - September 15, 2005
-- King Abdullah II, Prime Minister Blair and Secretary of State Rice Take Part in the CGI s Inaugural Opening Session Featuring the Unveiling of 4 Major Commitments Worth Over $200 Million NEW YORK, Sept. 15 /PRNewswire/ -- Today, Former President William J. Clinton opened the Clinton Global Initiative, discussing the


African First Ladies Unveil New Campaign to Fight AIDS
PRNewswire - September 15, 2005
-- Adults Responsible for Protecting Children From Infection NEW YORK, Sept. 15 /PRNewswire/ -- With more than half of the world s HIV/AIDS cases located in Africa and up to one in three adults living with HIV in some communities, the pandemic in this region has claimed millions of lives and put the lives of millions m


Calypte's Aware(TM) HIV-1/2 BSP Test Receives Zimbabwe Approval
PRNewswire - September 15, 2005
-- Regulatory Trials Of Aware(TM) BSP Generate 100% Accuracy LAKE OSWEGO, Ore., Sept. 15 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (Amex: HIV) today announced that the Medical Laboratory & Clinical Scientists Council of Zimbabwe has issued notification that the Calypte Aware(TM) HIV-1/2 BSP rapid (bl


Prop 79 Supporters Kick-Off Campaign to Counter $75 Million Drug Industry Ad-Blitz
PRNewswire - September 14, 2005
-- Consumer, Health & Senior Advocates Kick-Off Yes on Prop 79 Campaign in Sacramento Today; Will Launch So Cal Grassroots Campaign With Opening of LA Field Office Tomorrow, September 15th WHAT: Yes on Proposition 79, So Cal Grassroots Campaign Kick-Off & LA Field Office Opening, featuring supporters from consu


Daytime Unites for Africa: Soap Operas Call Attention on Air to Aids Crisis
PRNewswire - September 14, 2005
NEW YORK, Sept. 14 /PRNewswire/ -- In an unprecedented display of unity in commitment, all nine daytime dramas on ABC, CBS and NBC have agreed to join together, over a ten-week period this fall, to call attention in their programming to the AIDS crisis in Africa. The Daytime Unites for Africa campaign was created by So


Remarks by President Bush at United Nations High-Level Plenary Meeting
PRNewswire - September 14, 2005
WASHINGTON, Sept. 14 /PRNewswire/ -- The following is a transcript of remarks by President Bush at a United Nations High-Level plenary meeting: United Nations Headquarters New York, New York -- 9:48 A.M. EDT THE PRESIDENT: Mr. Secretary General, Mr. President, distinguished guests, ladies and gentlemen: Thank you for t


Addressing AIDS a Key Topic at Clinton Global Initiative Meeting
PRNewswire - September 14, 2005
-- World Vision s President focuses on micro-loans for women and community care coalitions of volunteers for orphans NEW YORK, Sept. 14 /PRNewswire/ -- The AIDS pandemic and ways to address its impact on women and orphans will be explored this week by leaders in government, business and the non-profit sectors at the in


Data Safety Monitoring Board Recommends Continuation of Tanox's Phase 2 Clinical Trial of TNX-355 for Treatment of HIV
PRNewswire - September 13, 2005
-- No Safety Issues Cited During Planned Interim Review HOUSTON, Sept. 13 /PRNewswire-FirstCall/ -- An independent Data Safety Monitoring Board (DSMB) has reviewed a planned interim safety analysis of Tanox, Inc. s (Nasdaq: TNOX) Phase 2 clinical trial of TNX-355 for treatment of the human immunodeficiency virus (HIV)


AHF Continues to Provide Health Care Services to HIV-Positive Hurricane Evacuees
PRNewswire - September 12, 2005
-- US Largest AIDS Organization Treating Displaced HIV/AIDS Patients at Its Clinics in California & Florida LOS ANGELES, Sept. 12 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the largest AIDS organization in the U.S. which offers free AIDS treatment services at its 14 clinics in the U.S., today announced it is


AMCOL International (NYSE: ACO) Presents at European Medical Conference: Introduces Nano Bentonite With Antiviral Properties
PRNewswire - September 12, 2005
ARLINGTON HEIGHTS, IlL., Sept. 12 /PRNewswire-FirstCall/ -- AMCOL International Corporation (NYSE: ACO) announced today that test results of recently discovered anti-viral properties of nano bentonites will be jointly presented with Retroscreen Virology Ltd., a London-based research and testing facility. In this study,


Vical and NIH to Evaluate Enhanced-Delivery HIV Vaccine
PRNewswire - September 12, 2005
SAN DIEGO, Sept. 12 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaq: VICL) today announced plans to develop and evaluate electroporation-enhanced delivery of therapeutic and preventive DNA vaccines against HIV under a Cooperative Research and Development Agreement (CRADA) with the Vaccine Research Center (VRC), Na


YouthAIDS Brings Celebrities and Dignitaries to DC to Raise Funds and Awareness
PRNewswire - September 12, 2005
WASHINGTON, Sept. 12 /PRNewswire/ -- The following is being issued by YouthAIDS: WHY: AIDS affects young people at a greater rate than any other group: Every 15 seconds, a young person between the ages of 15-24 becomes infected with HIV; 12 million young people aged 15 to 24 are now living with HIV/AIDS; HIV is the lea


Detroit Artists Unite in the Fight Against AIDS at Tenth Annual 'ART WORKS FOR LIFE' Sept. 24
PRNewswire - September 9, 2005
FERNDALE, Mich., Sept. 9 /PRNewswire/ -- Over 300 of Detroit s most prominent artists will donate original pieces of art to be auctioned at the tenth annual ART WORKS FOR LIFE. This exciting event will begin at 6:30 p.m. on Saturday, September 24, 2005 at Detroit s historic Masonic Temple to benefit the Midwest AIDS Pr


AIDS Activists Target Charlize Theron & PeTA
PRNewswire - September 8, 2005
-- ACT UP!, AIDS Healthcare Foundation, More Than 20 AIDS Activists Unveil Campaign Targeting Hypocrisy of Hollywood Stars: You Cannot Wear an AIDS ribbon and Call Yourself a PeTA Supporter LOS ANGELES, Sept. 8 /PRNewswire/ -- Two days before People For the Ethical Treatment of Animals (PeTA) holds its 25th anniversary


Calypte Biomedical's Rockville, Maryland Facility Approved for the Manufacture of its HIV-1 Urine EIA Screening Test
PRNewswire - September 8, 2005
LAKE OSWEGO, Ore., Sept. 8 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (Amex: HIV) today announced that the United States Food and Drug Administration ( FDA ) has approved the Company s Rockville facility as the manufacturing site for its HIV-1 Urine EIA screening test. In 1996, Calypte s HIV-1 Urine E


Global Business Coalition on HIV/AIDS Announces Condoleezza Rice, Hillary Rodham Clinton and Angelina Jolie as Headliners at the 2005 GBC Awards for Business Excellence Gala
PRNewswire - September 8, 2005
-- Awards Given to Global Companies Leading the Business Community s Fight Against AIDS NEW YORK, Sept. 8 /PRNewswire-FirstCall/ -- Secretary of State Condoleezza Rice, Senator Hillary Rodham Clinton and Academy-Award winning actress Angelina Jolie will headline the 2005 Global Business Coalition on HIV/AIDS (GBC) Awar


The Founder of The AIDS Memorial Quilt Settles Legal Battle After Court Finds The NAMES Project Foundation Had Good Cause to Terminate Employment
PRNewswire - September 7, 2005
ATLANTA, Sept. 7 /PRNewswire/ -- The NAMES Project Foundation, the organization that cares for The AIDS Memorial Quilt, announced today that the legal dispute brought by Quilt founder, Cleve Jones, has been resolved. Jones agreed to withdraw his lawsuit only after the California Superior Court ruled in May and August 2


Panacos and Leading HIV Clinicians to Discuss PA-457 Clinical Trial Results: Analyst Briefing to be Held in New York on September 22, 2005
PRNewswire - September 7, 2005
WATERTOWN, Mass., Sept. 7 /PRNewswire-FirstCall/ -- Panacos Pharmaceuticals, Inc. (Nasdaq: PANC) ( Panacos or the Company ) today announced that it will hold a meeting for invited analysts and investment professionals on Thursday, September 22, 2005 from 8:00 am to 10:00 am at the St. Regis Hotel, Two East 55th Street,


IDM Announces Final Results of Phase 1 Therapeutic Aids Vaccine Study at Aids Vaccine 2005 International Conference
PRNewswire - September 7, 2005
SAN DIEGO, Sept. 7 /PRNewswire-FirstCall/ -- IDM Pharma, Inc. (IDM) (Nasdaq: IDMI), formerly Epimmune Inc., today announced the final results of the Phase 1 clinical trial of its EP HIV-1090 DNA vaccine in 40 HIV-1-infected individuals with full suppression of HIV-1 replication on stable anti-retroviral therapy. Result


PA Early Stage Partners Forms Azidex Pharmaceuticals, Inc. with Seed Investment: Pittsburgh-Based Company's Compounds Attack Drug Resistant HIV
PRNewswire - September 7, 2005
PITTSBURGH, Sept. 7 /PRNewswire/ -- PA Early Stage Partners, a family of venture funds that makes investments in early stage life sciences and information technology companies, announced today that it has made a seed investment in Azidex Pharmaceuticals, Inc., a company focused on the development of new therapeutic com


Favorable Clinical Results Reported by CytRx for HIV Vaccine
PRNewswire - September 7, 2005
-- DNA/Protein Vaccine Candidate DP6-001 Demonstrates Ability to Produce Neutralizing Antibody Responses to Multiple AIDS Virus Strains LOS ANGELES, Sept. 7 /PRNewswire-FirstCall/ -- CytRx Corporation (Nasdaq: CYTR) today announced interim results from a Phase 1 clinical trial indicating that a novel HIV DNA + protein


President Bush Risks Breaking G8 Promise to Africa
PRNewswire - September 6, 2005
-- Global Civil Society Coalition Says the Global Fund s Funding Gap for HIV, TB and Malaria Will Cost the Lives of Millions LONDON, Sept. 6 /PRNewswire/ -- Final pledges of money to the replenishment of the Global Fund for HIV, TB and Malaria fell drastically short of what was needed to scale up the fight against thes


Wealthy and Educated Women Are the Most Vulnerable to HIV Infection in Cameroon: For 100 HIV Infected Men, There Are 170 Infected Women
PRNewswire - September 6, 2005
CALVERTON, Md., Sept. 6 /PRNewswire/ -- Seven percent of women in Cameroon are infected with HIV, compared with 4% among men, according to the latest Demographic and Health Survey (CDHS), conducted from February to August of 2004, the third DHS of its kind in this country. HIV-infected women are more likely to be educa


CA Headed for Last Place in HIV Reporting, Says AHF
PRNewswire - September 1, 2005
-- As Philadelphia Adopts Names-Based Reporting, California at Risk for Losing Tens of Millions; Nation s Largest AIDS Group Urges Swift Action by Legislature to Prevent Significant Loss of Federal HIV/AIDS Funding LOS ANGELES, Sept. 1 /PRNewswire/ -- Amid news that the City of Philadelphia has become the latest govern


Aug. 31st Press Briefing by Conference Call with Jeffrey Sachs - Upcoming Millennium + 5 World Summit, the Millennium Development Goals and Controversial U.S.-Proposed Revisions to Summit Document
PRNewswire - August 30, 2005
-- Is the U.S. backing off on commitments to health, education and poverty reduction and endangering/undermining global progress? WASHINGTON and NEW YORK, Aug. 30 /PRNewswire/ -- WHAT: A press briefing by conference call with economist Jeffrey Sachs on the upcoming September 2005 World Summit of 170 heads of state and


Interim HIV Vaccine Trial Results to be Presented at AIDS Vaccine 2005 International Conference
PRNewswire - August 30, 2005
LOS ANGELES, Aug. 30 /PRNewswire-FirstCall/ -- CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical company engaged in the development and commercialization of human therapeutics primarily in the area of small molecules and ribonucleic acid interference (RNAi or gene silencing), today announced that preliminary interi


AIDS Healthcare Foundation to Donate 1 Million Condoms to Ugandan AIDS Fight
PRNewswire - August 29, 2005
-- US Largest AIDS Group Currently Operates 10 Free Uganda Cares AIDS Treatment Clinics Throughout Uganda; Clinics Are Operated in Partnership With Ugandan Ministry of Health LOS ANGELES, Aug. 29 /PRNewswire/ -- Based upon the revelation of a severe shortage of condoms in Uganda, long considered a worldwide model for A


Upward Spiral in AIDS Drug Prices Endangers Access, Says AHF
PRNewswire - August 29, 2005
-- $13K Per Year for Boehringer-Ingelheim s newest AIDS Drug Aptivus Reveals An Industry Out of Control ... and Totally Incapable of Self-Regulation Notes US Largest AIDS Group -- AHF Urges Californians to Demand Deeper Drug Discounts by Voting Yes on Prop. 79 in November LOS ANGELES, Aug. 29 /PRNewswire/ -- AIDS Healt


Arthur Ashe Stamp Dedicated at US Open
PRNewswire - August 27, 2005
NEW YORK, Aug. 27 /PRNewswire/ -- Humanitarian and world-class tennis player Arthur Ashe was immortalized on a postage stamp today when the U.S. Postal Service conducted a first-day-of-issue stamp dedication ceremony under the shadows of the stadium bearing his name. The ceremony took place as part of Arthur Ashe Kids


WHO Declares TB an Emergency in Africa: Call for 'Urgent and Extraordinary Actions' to Halt Worsening Epidemic
PRNewswire - August 26, 2005
MAPUTO, Mozambique , Aug. 26 /PRNewswire/ -- The World Health Organization (WHO) Regional Committee for Africa comprising health ministers from 46 Member States has declared tuberculosis an emergency in the African region -- a response to an epidemic that has more than quadrupled the annual number of new TB cases in mo


Living Well With HIV: A Long-Term Survivor Perspective
PRNewswire - August 25, 2005
HOUSTON, Aug. 25 /PRNewswire/ -- Nelson Vergel, a 22-year HIV survivor, international speaker and co-author of Built To Survive is visiting several US cities with Living Well With HIV, a comprehensive and free seminar on HIV treatments and side effect management for improved survival and quality of life. This seminar p


Building Stronger Health Systems Key to Reaching the Health Millennium Development Goals
PRNewswire - August 23, 2005
MANILA, Philippines , Aug. 23 /Xinhua-PRNewswire/ -- Building up and strengthening health systems is vital if more progress is to be made towards the Millennium Development Goals (MDGs), the World Health Organization (WHO) said in a new report. Unless urgent investments are made in health systems, current rates of prog


BET, Black AIDS Institute, Kaiser Family Foundation and YWCA Announce Winners of 2nd Annual Rap-It-Up/Black AIDS Short Subject Film Competition
PRNewswire - August 22, 2005
WASHINGTON, Aug. 22 /PRNewswire/ -- Concluding an extensive national call for submissions and thorough review process, BET, the Black AIDS Institute, Kaiser Family Foundation and YWCA proudly announce today that Let s Talk and Multitude of Mercies are the two winning screenplays of the 2nd Annual Rap- It-Up/Black AIDS


Panacos Drug Candidate PA-457 Shows Potent Antiviral Activity in HIV-infected Patients: Viral Load Reduction Meets Primary Endpoint of Phase 2a Study
PRNewswire - August 22, 2005
WATERTOWN, Mass., Aug. 22 /PRNewswire-FirstCall/ -- Panacos Pharmaceuticals, Inc. (Nasdaq: PANC) ( Panacos or the Company ), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced the successful completion of a Phase 2a clinical study of its lead HIV drug


It's All Shiny And New VH1 Premieres/Encores For The Week Of August 19-August 25 2005
PRNewswire - August 19, 2005
NEW YORK, Aug. 19 /PRNewswire/ -- Check out all of the brand new premieres headed to VH1 and VH1 Classic this week. INDIA.ARIE AND ASHLEY JUDD EXPLORE THE WORLDWIDE STRUGGLE AGAINST HIV/AIDS VH1 NEWS PRESENTS: TRACKING THE MONSTER: ASHLEY JUDD AND INDIA.ARIE CONFRONT AIDS IN AFRICA A Special Highlighting VH1 s Partners


Popular AIDS Fundraising Thrift Store to Open New Bay Area Site at Folsom & 9th: Items from HBO's 'Six Feet Under' to Find New Life via Benefit Sale at AHF's Latest 'Out of the Closet' Store in San Francisco
PRNewswire - August 18, 2005
Donated Props & Set Pieces From the Nearly (and Dearly) Departed Cult TV Favorite Six Feet Under to Be Sold at Grand Opening, Saturday August 20th What: Ribbon Cutting/Grand Opening Sale at Out of the Closet s Newest Store Benefiting AIDS Healthcare Foundation When: Saturday August 20th 10:00am (store open 10-7pm)


Cure to HIV Doldrums Found at Sea
PRNewswire - August 18, 2005
MIAMI, Aug. 18 /PRNewswire/ -- Upon being diagnosed with HIV, many people experience a prolonged period of inaction, emotional paralysis and even depression. It doesn t have to be that way, says author Nelson Vergel, who knows first-hand that there is life beyond an HIV-positive diagnosis. With the right regimen of nut


India.Arie and Ashley Judd Explore The Worldwide Struggle Against HIV/AIDS 'VH1 News Presents: Tracking The Monster: Ashley Judd and India.Arie Confront AIDS in Africa'
PRNewswire - August 18, 2005
A Special Highlighting VH1 s Partnership With The Global Fund To Fight AIDS, Tuberculosis and Malaria Premiering Tuesday, August 23 at 8PM* NEW YORK, Aug. 19 /PRNewswire/ -- AIDS: this health crisis has already taken the lives of over 20 million. Approximately 40 million people are living with HIV today. As part of its


Video Industry Event to Benefit the UCLA AIDS Institute
PRNewswire - August 17, 2005
-- Event for World s Leading HIV/AIDS Research Organization Sponsored by the PacifiCare Foundation LOS ANGELES, Aug. 17 /PRNewswire-FirstCall/ -- The Sideways Wine Tour, the Video Industry AIDS Action Committee s (VIAAC) third annual fund raiser benefiting the UCLA AIDS Institute, is being held this evening at 6:30 p.m


Hear No Evil? See No Evil? Speak No Evil?: KraftWorks Creates Celebrity Campaign for ALDO to Benefit YouthAIDS
PRNewswire - August 16, 2005
-- A-List Music and Hollywood Stars to Appear in Print and Outdoor Ads NEW YORK, Aug. 16 /PRNewswire/ -- ALDO, a global fashion footwear and accessories brand and retailer, and YouthAIDS, an HIV/AIDS education and prevention initiative, have partnered to create an international fundraising and awareness campaign to edu


MedMira Increases Product Registrations Internationally
PRNewswire - August 16, 2005
-- Rapid HIV and Hepatitis C Test Evaluations Underway in 24 Countries HALIFAX, Aug. 16 /PRNewswire-FirstCall/ - MedMira Inc., ( MedMira ) (TSX Venture: MIR, NASDAQ: MMIRF) the global market leader in rapid flow through diagnostic technology, announced today that it is registering its rapid HIV and combination HIV/hepa


ThinkQuest International 2006 Challenges Students to Build the Best Educational Web Site
PRNewswire - August 15, 2005
-- New Competition Now Open to Students and Teachers Worldwide REDWOOD SHORES, Calif., Aug. 15 /PRNewswire-FirstCall/ -- The Oracle Education Foundation today announced the opening of a new ThinkQuest competition, ThinkQuest International 2006, inviting students and teachers from around the world to take part in this u


MTV Announces New Documentary Special on The Poverty Crisis in Africa: 'The Diary of Angelina Jolie & Dr. Jeffrey Sachs in Africa'
PRNewswire - August 15, 2005
-- Academy Award-Winning Actress/Social Activist Jolie and Renowned Economist Sachs Travel to Kenya To Explore Poverty - And To Inspire Young People To Take Action -- Timed to Coincide with U.N. Summit, Special Premieres on September 14 at 7 p.m., As Part of MTV s New Pro-Social Initiative think MTV NEW YORK, Aug.


Feds Say Half of Gay Men Who Have HIV Don't Know It, Notes AHF
PRNewswire - August 11, 2005
-- JAMA Article Reports on CDC Study That Showed 48% of Men Infected With HIV Were Unaware of Their Infection. AHF Says US HIV Testing System is Broken; Calls for Routine HIV Testing in Healthcare Settings, More Access to HIV Testing Overall LOS ANGELES, Aug. 11 /PRNewswire/ -- A recent Centers for Disease Control and


Malawi Facing Serious Food Crisis: More Than 4.2 Million People in Need of Assistance
PRNewswire - August 11, 2005
WASHINGTON and ROME, Aug. 11 /PRNewswire/ -- Malawi is facing its worst food crisis in more than a decade, the result of a combination of factors, including drought, floods, consecutive poor harvests, endemic poverty and the effects of the HIV/AIDS pandemic, FAO said today. More than 4.2 million people, or over 34 perc


AHF Awarded National ACCME Accreditation for Continuing Medical Education
PRNewswire - August 9, 2005
-- Honor Conferred by Prestigious Organization Enables the Nation s Largest AIDS Organization to Issue Continuing Medical Education Credits to HIV/AIDS Providers Nationwide LOS ANGELES, Aug. 9 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the largest AIDS organization in the US which operates free AIDS treatment cl


Philanthropist Mouli Cohen Funds Indiana University Program to Provide Food to Kenya's HIV Sufferers
PRNewswire - August 2, 2005
SAN FRANCISCO and INDIANAPOLIS, Aug. 2 /PRNewswire/ -- World-renowned philanthropist Mouli Cohen announced today a partnership with Indiana University s HAART and Harvest program, designed to provide food to HIV/AIDS patients in Kenya , Africa. Today the overwhelming number of HIV/AIDS cases in and around Kenya has cau


HIV Drug Resistance Test More Descriptive Than Ever - Virco Launches New HIV Resistance Report - The virco(R)TYPE HIV-1 Analysis Provides What Doctors Need to Assess New Options for Treatment-Experienced Patients
PRNewswire - August 1, 2005
RARITAN, N.J., Aug. 1 /PRNewswire/ -- Addressing the need for a more complete assessment upon which to base HIV treatment decisions, Virco BVBA, a leader in drug-resistance testing, is rolling out the virco(R)TYPE HIV-1 resistance analysis with clinical cutoffs. Described as a report card that includes a grade point av


Simple Screening Prevents Disease, Improves the Health of Young Women and Unborn ChildrenSimple Screening Prevents Disease, Improves the Health of Young Women and Unborn Children
PRNewswire - July 29, 2005
ROCKVILLE, Md., July 29 /PRNewswire/ -- Simple steps by health care institutions can increase the number of women tested for and diagnosed with chlamydia according to a study conducted by Kaiser Permanente, in partnership with the Centers for Disease Control (CDC) of Atlanta, Georgia. The analysis, which evaluated almo


Italian Jewelry Designer Roberto Coin Introduces 'Charm Bracelet' in Support of YouthAIDS
PRNewswire - July 29, 2005
NEW YORK, July 29 /PRNewswire/ -- Italian jewelry designer Roberto Coin has joined forces with YouthAIDS in their global incentive of raising funds and spreading the message of HIV/AIDS awareness to the world s youth population. Implemented through events and promotions, Roberto Coin has specially-designed a diamond ch


The Foundation for Innovative New Diagnostics (FIND) and Eiken Chemical Co. LTD. Announce Collaboration to Develop Rapid Diagnostic Test for Tuberculosis
PRNewswire - July 29, 2005
SEATTLE, July 29 /PRNewswire/ -- The Foundation for Innovative New Diagnostics (FIND), a Geneva-based non-profit funded by the Bill & Melinda Gates Foundation, and Eiken Chemical Co. Ltd., a Japan-based manufacturer of clinical diagnostics, today announced a collaboration to develop a rapid and simple test for the


AIDS Healthcare Foundation: HHS' Ryan White Reauthorization Plan Offers 'Vast Improvement in AIDS Care'
PRNewswire - July 28, 2005
-- Nation s Largest AIDS Group Supports HHS Plan to Streamline Ryan White CARE Act. Government Redesign Calls for Increased Funding Levels for Life-Saving Medical Care, Particularly Among Underserved and Minority Populations, Reduction in Bureaucracy and Administrative Overhead. What: Press Conference & Teleconfere


AHF Calls CAFTA Win 'Devastating Loss' for Central Americans With HIV/AIDS
PRNewswire - July 28, 2005
-- Trade Agreement With Anti-Generic Drug Provisions Approved by House of Representatives Today in 217 to 215 Vote; Nation s Largest AIDS Organization Denounces Action and Calls on Global Community to Recognize HIV/AIDS as International Public Health Emergency WASHINGTON D.C., July 28 /PRNewswire/ -- AIDS advocates fro


Feds Signal Cutoff of AIDS Funds Over Faulty HIV Reporting System, According to AIDS Healthcare Foundation
PRNewswire - July 27, 2005
-- AHF Says California Could Lose Up to $50M Annually Unless It Scraps Current Code System. As Part of HHS Plan to Streamline Ryan White CARE Act, Officials Signal Intention to Require Reporting of HIV Cases by Individuals Names Rather Than Via Code-based system Beginning in Fiscal Year 2007. LOS ANGELES, July 27 /PRN


Current and Future Infectious Disease Threats: Developments in the Fight Against Infectious Diseases
PRNewswire - July 27, 2005
WASHINGTON, July 27 /PRNewswire/ -- Infectious diseases pose a serious threat to the nation s public health. Today, experts addressed key developments to the current and future outlook of infectious diseases, highlighting adolescent immunizations, outbreaks and epidemics of infectious diseases, antimicrobial resistance


HHS Outlines President's Principles for Reauthorization of Ryan White CARE Act
PRNewswire - July 27, 2005
Comprehensive Approach Will Help Extend and Improve the Lives of Those Living With HIV/AIDS and Increase Prevention Efforts WASHINGTON, July 27 /PRNewswire/ -- At a meeting today with members of the President s Advisory Committee on HIV/AIDS, the CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment and a


Patient Satisfaction With Once-Daily Dosing Of HIV Fixed-Dose Combination Tablet EPZICOM
PRNewswire - July 27, 2005
At a Glance -- Patients taking an HIV regimen containing the fixed dose combination EPZICOM (abacavir and lamivudine) dosed once daily (QD) tended to be more satisfied with the convenience of their HIV regimens than those taking ZIAGEN (abacavir sulfate) + EPIVIR (lamivudine) separately twice daily. -- Several aspects


AHF Lauds Proposed White House Revamp of Nation's AIDS Program
PRNewswire - July 27, 2005
Nation s Largest AIDS Group Supports HHS Plan to Streamline Ryan White CARE Act. Government Redesign Calls for Increased Funding Levels for Life-Saving Medical Care, Particularly Among Underserved and Minority Populations, Reduction in Bureaucracy and Administrative Overhead. NOTE - MEDIA AVAILABILITY: Michael Weinstei


Nationwide Walk to Benefit Children With AIDS
PRNewswire - July 27, 2005
Local MannaWalk Events to Provide Nutritional Programs for Orphans With Epidemic Disease WHAT: On August 6, in big cities and small towns across the United States, people will unite and walk together to show their support for fighting HIV/AIDS in children across the globe. The new nationwide event, called MannaWalk, wi


Epimmune's Recombinant Protein HIV Vaccine Candidate to be Tested in Clinical Trials by the NIH Sponsored HIV Vaccine Trials Network
PRNewswire - July 26, 2005
SAN DIEGO, July 26 /PRNewswire-FirstCall/ -- Epimmune Inc. (Nasdaq: EPMN) today announced that the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH), holds an active Investigational New Drug application (IND) from the FDA to test Epimmune s multi-epitope re


V.I. Technologies Presents Further Analysis of PA-457's Antiviral Activity Following a Single Oral Dose in HIV-infected Patients, at 3rd International AIDS Society Conference
PRNewswire - July 26, 2005
WATERTOWN, Mass., July 26 /PRNewswire-FirstCall/ -- V.I. Technologies ( Vitex ) and collaborators at the University at Buffalo s School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, today presented a detailed analysis of the Phase I/II clinical trial of its HIV drug candidate PA-457 at the 3rd International AID


Epimmune's Recombinant Protein HIV Vaccine Candidate to be Tested in Clinical Trials by the NIH Sponsored HIV Vaccine Trials Network
PRNewswire - July 26, 2005
SAN DIEGO, July 26 /PRNewswire-FirstCall/ -- Epimmune Inc. (Nasdaq: EPMN) today announced that the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH), holds an active Investigational New Drug application (IND) from the FDA to test Epimmune s multi-epitope re


Long-Term Safety Data Of LEXIVA/R In HIV Patients Co-Infected With Hepatitis
PRNewswire - July 26, 2005
AT a GLANCE 120-week data from APV30002/APV30005 study of ART regimens containing LEXIVA/r: -- Median serum levels of ALT and AST, enzyme markers for liver disease, remained stable in 35 patients co-infected with hepatitis C or B. -- There were few new treatment-emergent Grade 3-4 ALT or AST toxicities observed betwe


Epidemiology Study Reports New Information on Hypersensitivity Reactions to Abacavir
PRNewswire - July 26, 2005
At a Glance -- Data from 11,586 patients who took an abacavir-containing product were obtained from four databases in this Epidemiology Study. -- Rechallenge with an abacavir-containing product in patients with a history of HSR or HSR-like events occurred in 18 of 11,586 (0.2%) patients in this study. -- Hospitaliz


Study Results Presented on Pharmacokinetics of Once-Daily HIV Combination Therapy -- Combination of LEXIVA/r and Truvada Evaluated
PRNewswire - July 26, 2005
RIO DE JANEIRO, Brazil , July 26 /PRNewswire/ -- An open label, single-arm study conducted among 15 HIV-positive patients evaluated the pharmacokinetic parameters of a once-daily combination of LEXIVA(R) ( fosamprenavir calcium), ritonavir and


AIDS Activists Cry Foul as Drug Companies Push Prices to Record Levels
PRNewswire - July 25, 2005
NEW YORK, July 25 /PRNewswire/ -- The following was released today by AIDS Treatment Activists Coalition: A steady onslaught of unreasonable, unacceptable, and unjustified increases in the price of therapies to treat HIV has caused activists in the US to accuse drugmakers of artificially inflating the market at the exp


Data on New Options to Improve FUZEON Self-Injection Presented at International AIDS Conference
PRNewswire - July 25, 2005
RIO DE JANEIRO, Brazil , July 25 /PRNewswire/ -- Researchers are evaluating two new methods for self-injecting FUZEON(R) (enfuvirtide) in an effort to identify viable alternatives for patients who may wish to administer the drug without the standard needle and syringe. At the International AIDS Society (IAS) conference


AHF Says California Must Act Now to Scrap Broken HIV Reporting System: Press Conference - 11am Hollywood
PRNewswire - July 25, 2005
-- LA Times Article Today Blasts California s Current HIV Reporting System as Too Cumbersome. Most AIDS Advocates and Officials Statewide Now Seek to Move to a More Accurate Names-Based Reporting System - the Norm in 37 States. Under Current Alphanumeric System, California Stands to Lose Up to $50M Annually in Federal


New Study Results Find That Patients Treated With Boosted INVIRASE, A Potent Anti-HIV Treatment, Showed No Significant Resistance to Protease Inhibitors
PRNewswire - July 25, 2005
RIO DE JANEIRO, Brazil , July 25 /PRNewswire/ -- Patients starting HIV treatment with Roche s protease inhibitor INVIRASE(R) (saquinavir mesylate) boosted with a small dose of ritonavir show no significant resistance to protease inhibitors , according to a study presented today at the 3rd International AIDS Society


'HIV Medic' Program Trains Africans as Health Workers in Fight Against AIDS
PRNewswire - July 22, 2005
-- US Largest AIDS Group to Expand Innovative Program Which Trains Africans to Work With Health Care Providers Treating People With HIV/AIDS on Hard-Hit Continent. To Date, AHF Global Immunity Has Trained 75 HIV Medics in Uganda , Zambia and Rwanda . -- NOTE: Next AHF-GI HIV Medics


Abbott and Celera Diagnostics Announce CE Marking for HCV Real-Time PCR
PRNewswire - July 22, 2005
-- Highly Sensitive Molecular Test Provides Valuable Tool for Measuring HCV in Serum and Plasma, Helping Physicians to Effectively Manage Patient Therapy DELKENHEIM, Germany , July 22 /PRNewswire-FirstCall/ -- Abbott and Celera Diagnostics, a joint venture between the Applied Biosystems Group and Celera Genomics Group


Members of Congress, Public Health Experts and Community Leaders Convene in Chicago to Discuss Racial and Ethnic Health Disparities
PRNewswire - July 22, 2005
-- Tobacco, Obesity, Stem Cells, HIV/AIDS, Immigrant Health and Environmental Health to be Addressed CHICAGO, July 22 /PRNewswire/ -- Members of Congress, public health experts, community leaders and citizens of Chicago will convene tomorrow, Saturday, July 23, to address racial and ethnic health disparities in the are


AIDS Experts Oppose CAFTA Agreement: Treaty Will Block Access to Affordable Medicine
PRNewswire - July 21, 2005
WASHINGTON, July 21 /PRNewswire/ -- Republican House leaders have tentatively scheduled a vote on the DR-CAFTA free trade agreement for Wednesday, July 27. Today at 1pm ET Global AIDS Alliance will co-sponsor a press conference by telephone to explain why many health advocates are opposing the treaty. Dr. Paul Zeitz, E


FDA Grants Fast Track Status for the Investigational HIV Protease Inhibitor 640385 (VX-385)
PRNewswire - July 19, 2005
-- GlaxoSmithKline to Initiate Phase IIb Clinical Trial in HIV-infected Patients CAMBRIDGE, Mass., July 19 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that its collaborator, GlaxoSmithKline (GSK), has received fast track designation for the HIV protease inhibitor (PI) 64


Uganda's First Lady Joins AHF President to Dedicate AIDS Clinic in Kampala's Busiest Marketplace
PRNewswire - July 19, 2005
-- The UGANDA CARES - St Balikuddembe Market Clinic, an Innovative Partnership of the Kampala City Council, United Market Vendors Association (UMVA), Development Initiatives International, Marie Stopes Uganda and AIDS Healthcare Foundation Global Immunity (AHF-GI), Will Target Vendors in the Largest Marketplace in East


Roche and Trimeris Announce FDA Filing of FUZEON(R) sNDA for Administration with a Needle-Free Injection Device
PRNewswire - July 18, 2005
-- New Study of FUZEON with Biojector 2000 to Begin in August 2005 NUTLEY, N.J. and MORRISVILLE, N.C., July 18 /PRNewswire/ -- Roche and Trimeris (Nasdaq: TRMS) today announced that the U.S. Food and Drug Administration ( FDA ) has accepted the filing of their sNDA to consider inclusion of information about the Bioject


Gender-Based Violence Correlates with HIV/AIDS Among Women: amfAR calls for greater attention to sexual violence at international AIDS conference
PRNewswire - July 18, 2005
NEW YORK, July 18 /PRNewswire/ -- amfAR has released an issue brief demonstrating a close connection between gender-based violence and HIV infection. The New York-based AIDS research foundation is calling for resources to develop, test, and implement behavioral, biomedical, and social interventions to address violence


Cultural Stigma and AIDS: Avoiding Discussion on Sexuality and Drug Use Causes AIDS Epidemic to Rage On
PRNewswire - July 18, 2005
-- Erik Estrada to Deliver Urgent Address to Healthcare Professionals and Policy Makers on Behalf of the Latino Community CHICAGO, July 18 /PRNewswire/ -- Healthcare professionals, policy makers and other thought leaders will convene at the Holiday Inn Chicago-Mart Plaza on July 25th and 26th for the 2005 National Conf


India.Arie and Ashley Judd Explore the Worldwide Struggle Against HIV/AIDS in 'VH1 News Presents: Tracking the Monster: Ashley Judd and India.Arie Confront Aids in Africa'
PRNewswire - July 14, 2005
-- A Special Highlighting VH1 s Partnership With The Global Fund To Fight Aids, Tuberculosis And Malaria BEVERLY HILLS, Calif., July 14 /PRNewswire/ -- AIDS: this health crisis has already taken the lives of over 20 million. Approximately 38 million people are living with HIV today. As part of its continuing public aff


7TH ON SALE Goes Online: Historic Fashion Industry HIV/AIDS Fundraising Event Returns
PRNewswire - July 14, 2005
NEW YORK, July 14 /PRNewswire/ -- After 10 years, 7TH ON SALE returns and is available online for the first time. The unprecedented new format is sure to make fashion and fundraising history once again. The Council of Fashion Designers of America (CFDA) Foundation has teamed with Vogue magazine, eBay, Kenneth Cole, and


Ranbaxy Receives Tentative Approval for Zidovudine Tablets as Part of the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) Initiative
PRNewswire - July 14, 2005
PRINCETON, N.J., July 14 /PRNewswire/ -- Ranbaxy Laboratories Limited (RLL) announced today that it has received tentative approval from the U.S. Food and Drug Administration (USFDA) to manufacture and market Zidovudine Tablets USP, 300 mg. This is the first approval granted by the USFDA for generic Zidovudine. This is


USA for Innovation: Brazil Succeeds in Industrial Blackmail - Abbott Bows to Drug Price Reductions
PRNewswire - July 13, 2005
-- Abbott Laboratories Avoid Patent Break After Agreeing to Price Reduction WASHINGTON, July 13 /PRNewswire/ -- USA for Innovation today expressed its disappointment with the Government of Brazil s decision to use industrial blackmail to achieve a price reduction on Abbott Labs AIDS drugs under the threat of a patent


Nelson Mandela Calls on Private Sector to Respond to AIDS
PRNewswire - July 12, 2005
JOHANNESBURG, South Africa , July 12 /PRNewswire/ -- The following is a statement from Former South African President Nelson Mandela: I am pleased that Ambassador Holbrooke and the Global Business Coalition on HIV/AIDS (GBC) have opened a South African office and are embarking on an effort to engage more African busine


Remarks By First Lady Laura Bush to Centre for the Book
PRNewswire - July 12, 2005
WASHINGTON, July 12 /PRNewswire/ -- The following is a transcript of remarks by First Lady Laura Bush to Centre for the Book: Centre for the Book - Cape Town, South Africa 2:57 P.M. (Local) MRS. BUSH: Thank you all very much. Thank you, Ambassador. Thanks each and every one of you for your warm welcome. I m so glad we


Key Club International Is 'Kicking' HIV/AIDS Out of Kenya: Key Clubbers Trick-or-Treat for UNICEF to Support HIV/AIDS Prevention Program
PRNewswire - July 11, 2005
NEW YORK, July 11 /PRNewswire/ -- The U.S. Fund for UNICEF proudly announced that as part of Key Club International s fall Season of Service the youth service organization will tackle the spread of HIV/AIDS through the education and enrichment of young girls in Kenya . Money raised by Key Club members for this year s T


Abbott Statement on Agreement With Brazilian Government for Kaletra(R) (Lopinavir/Ritonavir)
PRNewswire - July 9, 2005
SAO PAULO, Brazil , July 9 /PRNewswire/ -- Abbott announced today that it achieved its goals in negotiating an agreement with the government of Brazil regarding Kaletra (R) ( lopinavir / ritonavir ), th


Multimedia News Release - National HIV Testing Day 2005 Marks 20 Years of Testing
PRNewswire - July 8, 2005
-- Community Groups Across the Country Organize Testing, Counseling Events to Encourage Everyone to Know Their HIV Status WASHINGTON, July 8 /PRNewswire/ -- In 1985, when concern and uncertainty surrounding the AIDS epidemic was at an all time high, a diagnostic test for HIV was made commercially available, enabling pe


Global Health Leaders React to G8's First-Ever Call for More Investment in Microbicides to Protect Women from HIV
PRNewswire - July 8, 2005
GLENEAGLES, Scotland, July 8 /PRNewswire/ -- Joint Statement From: Zeda Rosenberg, CEO, International Partnership for Microbicides (IPM) Polly Harrison, Director, Alliance for Microbicide Development (AMD) Lori Heise, Director, Global Campaign for Microbicides (GCM) Manju Chatani, Coordinator, African Microbicides Advo


Napo Adds Glenmark of India to Global Team to Develop and Commercialize a Novel Treatment for Diarrhea
PRNewswire - July 7, 2005
-- Glenmark Deal Added to Agreements in China and the West; Glenmark to Manufacture Crofelemer for Global Market and Provide Equity Investment SOUTH SAN FRANCISCO, Calif., July 7 /PRNewswire/ -- Napo Pharmaceuticals, Inc. announced today a collaboration agreement with Glenmark Pharmaceuticals Ltd. of Mumbai,


Fired LA AIDS Director Leaves County AIDS Program a $5.4M Deficit, says AHF
PRNewswire - July 7, 2005
-- Chuck Henry, Former Head of LA County s Office of AIDS Programs & Policy, Committed More Federal Ryan White Title I Funding to Grantees Than Was Allocated. Grants Included Two Contested No Bid Contracts for $1.9M and $1.5M -- LA AIDS Program Faces Impending Financial Crisis - Like Many Eligible Metropolitan Area


Medical Services to Supply Law Enforcement Agencies With HIV Test Kits
PRNewswire - July 7, 2005
EDMONTON, Alberta, July 7 /PRNewswire-FirstCall/ -- Medical Services International Inc.(Pinksheets: MSITF) is pleased to announce that it has received a Letter of Commitment from the Shanghai Police Department that it will be using the VScan HIV test kit. The test kits will be deployed as part of their regular equipmen


Par Pharmaceutical Announces FDA Approval of Megace(R) ES for Anorexia, Cachexia, or an Unexplained, Significant Weight Loss in Patients With a Diagnosis of AIDS
PRNewswire - July 6, 2005
WOODCLIFF LAKE, N.J., July 6 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that the U.S. Food and Drug Administration ( FDA ) has approved Megace(R) ES (megestrol acetate), a concentrated oral suspension for the treatment of anorexia, cachexia, or an unexplained, significant w


ViroLogic Announces Multi-Year Service Agreement With Schering-Plough to Support New HIV Drug Discovery and Development Efforts
PRNewswire - July 6, 2005
SOUTH SAN FRANCISCO, Calif., July 6 /PRNewswire-FirstCall/ -- ViroLogic, Inc., (Nasdaq: VLGC) announced today that the Company has signed a multi-year, $4.8 million service agreement with Schering-Plough Research Institute, the research arm of Schering-Plough Corporation (NYSE: SGP), to use ViroLogic s novel HIV resist


U.S. Adults Have Mixed Views about Providing Foreign Aid to Poorer Countries for Public Health Initiatives and HIV/AIDS Treatment and Prevention
PRNewswire - July 6, 2005
ROCHESTER, N.Y., July 6 /PRNewswire/ -- The American public overall does not appear to be a strong proponent for increased foreign aid to poorer countries for public health initiatives and to help with the prevention of disease including HIV/AIDS. While one-in-five (21%) U.S. adults believes the U.S. government spends


Calypte Announces Distribution Agreements in Eight African Countries: Regulatory Trials to Begin in Three Additional African Countries
PRNewswire - July 5, 2005
PLEASANTON, Calif., July 5 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (Amex: HIV ) today announced that it has executed distribution agreements with two distributors for the marketing and sale of its Aware(TM) rapid HIV antibody tests in eight countries in Sub-Saharan Africa.


MedMira Expands Market Presence in Latin America: Product Registrations Completed in Argentina, Peru and Panama
PRNewswire - July 5, 2005
HALIFAX, July 5 /PRNewswire-FirstCall/ - MedMira Inc., ( MedMira ) (TSX Venture: MIR, NASDAQ: MMIRF) the global market leader in rapid flow-through diagnostic tests, announced today that it has expanded its market presence in Latin America with the completion of product registrations in Argentina ,


Theratechnologies launches Phase III clinical trial for TH9507 (ThGRF) treating HIV-associated lipodystrophy
PRNewswire - July 5, 2005
MONTREAL, July 5 /PRNewswire-FirstCall/ - Theratechnologies (TSX: TH) announced today that on June 30 a patient in Atlanta, Georgia, became the first to begin treatment in the Phase III clinical trial testing Theratechnologies TH9507 (ThGRF) compound in HIV associated lipodystrophy, a condition that affects many patien


Live 8 Celebrities, Grassroots Activists and One Million Americans Join ONE: The Campaign To Make Poverty History
PRNewswire - July 2, 2005
-- Deliver 300,000 Letters Calling For Historic Deal at G8, Call For End to Global AIDS and Poverty PHILADELPHIA, July 2 /PRNewswire/ -- Today, ONE volunteers from across America joined community leaders, activists and Live 8 artists and celebrities to kick-off the Philadelphia Live 8 Concert by delivering 300,000 lett


AHF Commends Botswana Officials for Challenging US' PEPFAR Numbers
PRNewswire - July 1, 2005
-- US Largest AIDS Group Has Long Challenged Administration Claims Over Ambitious Global AIDS Program. Bush Officials Claim at Least 20,000 in Botswana on AIDS Drugs Via PEPFAR; Botswana Government States Number Via US Help is Actually Zero. LOS ANGELES, July 1 /PRNewswire/ -- AIDS Healthcare Foundation (AHF) the large


Virgin Megastores Unite With ONE: The Campaign to Make Poverty History
PRNewswire - June 28, 2005
-- Virgin Megastore Chain Partner with International Organizations for One Day Event to Help Fight Global AIDS and Extreme Poverty ** UPDATED INFORMATION ON EVENT PERFORMANCES** LOS ANGELES, June 28 /PRNewswire/ -- More than one billion people live on less than $1 a day with few opportunities to earn more. Each day ove


College Students Crawl 32 Miles into Record Book for Pediatric AIDS
PRNewswire - June 28, 2005
-- Leo Chau and Sean Duffy crawled 32.26 miles (45 hours straight) through hail, lightning, and freezing temperatures into the Guinness Book of World Records to raise nearly $20,000 for the Elizabeth Glaser Pediatric AIDS Foundation. COLORADO SPRINGS, Colo., June 28 /PRNewswire/ -- In Colorado Springs, Colorado, on Jun


Grand Challenges in Global Health Initiative Selects 43 Groundbreaking Research Projects for More Than $436 Million in Funding
PRNewswire - June 27, 2005
-- Scientists Around the World to Discover New Ways to Fight Disease in Poorest Countries SEATTLE, June 27 /PRNewswire/ -- The Grand Challenges in Global Health initiative, a major effort to achieve scientific breakthroughs against diseases that kill millions of people each year in the world s poorest countries, today


Trinity Biotech Announces Donation of $1,000,000 of HIV Rapid Tests on National HIV Testing Day
PRNewswire - June 27, 2005
DUBLIN, Ireland , June 27 /PRNewswire-FirstCall/ -- In recognition of National HIV Testing Day, Trinity Biotech plc (NASDAQ: TRIBD, ISE: TRIB.I) announced today that it will make a donation to the value of US$1m of their Uni-Gold(TM) Recombigen(R) HIV Rapid tests to community based organizations (CBO s) and public heal


Statement by Mike Leavitt, Secretary of Health and Human Services, Regarding National HIV Testing Day, June 27, 2005
PRNewswire - June 27, 2005
WASHINGTON, June 27 /PRNewswire/ -- The following is a statement by Mike Leavitt, Secretary of Health and Human Services, regarding National HIV Testing Day, June 27, 2005: Today marks the 11th annual observance of National HIV Testing Day (NHTD), which reminds all Americans that HIV testing is an important step in the


Bristol-Myers Squibb, Baylor College of Medicine to Establish Pediatric AIDS Corps for Africa
PRNewswire - June 27, 2005
-- Company to Build Additional Clinical Centers; Cuts Price of Pediatric HIV Formulations HOUSTON and NEW YORK, June 27 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company, New York (NYSE: BMY) and Baylor College of Medicine, Houston, today announced a groundbreaking multi-part program to provide medical care for Af


CAEAR Coalition Commends Senate Subcommittee for Jumpstarting the 2005 Ryan White CARE Act Reauthorization Process
PRNewswire - June 24, 2005
-- Hearing Highlights Important Issues Addressed in Coalition s Reauthorization Recommendations WASHINGTON, June 24 /PRNewswire/ -- CAEAR Coalition supports the bipartisan spirit of the hearing on the Ryan White CARE Act reauthorization conducted on June 23, 2005, by the Senate Subcommittee on Federal Financial Managem


National STD/AIDS Program: The Government declares anti-retroviral Kaletra to be of public interest and will produce it in Brazil
PRNewswire - June 24, 2005
BRASILIA, Brazil , June 24 /PRNewswire/ -- The Ministry of Health of Brazil has declared the anti-retroviral drug Kaletra (Lopinavir/ ritonavir ), manufactured by Abbott Laboratories , to be of public interest.


Broadway Star Bruce Vilanch, Comedic Actor Wayne Brady and Sports Legend Billie Jean King Join Elton John For HIV/AIDS Awareness Concert and Fundraiser Philadelphia Freedom Concert & Ball
PRNewswire - June 24, 2005
PHILADELPHIA, June 24 /PRNewswire/ -- With only days to go before the landmark HIV/AIDS awareness event and fundraiser, the PHILADELPHIA FREEDOM CONCERT AND BALL, headlined by Sir Elton John on July 4 in Philadelphia, organizers today announced the addition of Broadway star Bruce Vilanch and comedic actor Wayne Brady a


PacifiCare Provides $19,000 to Help California Churches Provide Free HIV Education and Testing in Observance of National HIV Testing Day
PRNewswire - June 24, 2005
* 1 Million Americans are HIV-Positive, the Highest Level Ever, According to CDC * Nearly Half of These Cases Are Among African Americans CYPRESS, Calif., June 24 /PRNewswire-FirstCall/ -- Seeking to help stop the nationwide spread of HIV and AIDS among African Americans, PacifiCare Health Systems Inc. (NYSE: PHS) is p


Patient Care Threatened Under Guise of Evidence-Based Medicine
PRNewswire - June 23, 2005
-- New Poll Shows EBM Does Not Address Voters Healthcare Concerns, Majority of New Yorkers Oppose Concept ALBANY, N.Y., June 23 /PRNewswire/ -- The Latino Commission on AIDS, appearing in Albany Tuesday with New York s chapter of the National Alliance for the Mentally Ill, The Epilepsy Foundation of New York City, and


IAVI President and CEO Testifies on AIDS Vaccines Before U.S. Senate Committee on Foreign Relations
PRNewswire - June 23, 2005
WASHINGTON, June 23 /PRNewswire/ -- The International AIDS Vaccine Initiative (IAVI) was one of three leading organizations in the AIDS vaccine field to testify today at the U.S. Senate Foreign Relations Committee hearing on AIDS vaccines. The hearing, led by Chairman Richard Lugar (R-IN), discussed the AIDS pandemic a


Double-Digit Growth Rates Peak for $16 Billion Antiviral Market
PRNewswire - June 23, 2005
NEW YORK, June 23 /PRNewswire/ -- The excellent annual growth rates recently enjoyed by the world market for prescription antiviral medications will peak in the 2005-2006 period at nearly 17% before falling to more modest levels by the end of the decade, according to a newly released report from Kalorama Information. N


Gov't Report Confirms Need to Revamp Nation's AIDS Program, Says AHF
PRNewswire - June 23, 2005
-- Government Accountability Office (GAO) Report on The Ryan White CARE Act Bolsters AIDS Healthcare Foundation s Call to Streamline Crucial AIDS Funding Program. AHF s Proposal Would Reduce Bureaucracy, Increase Reach & Effectiveness of Program WASHINGTON, June 23 /PRNewswire/ -- The Government Accountability Offi


Pamela Anderson, M.A.C VIVA GLAM V Spokesperson, Urges the World to Get Tested for HIV in a Radio Public Service Announcement Premiering June 27 - National HIV Testing Day
PRNewswire - June 23, 2005
-- 40 Million People are Infected with HIV/AIDS Worldwide and 95% of Those Infected Don t Know It -- Anderson States in the Public Service Announcement More People Tested Means Less People Infected, and Know Your Status to Help Stop the Spread of HIV/AIDS NEW YORK, June 23 /PRNewswire/ -- M.A.C AIDS Fund (MAF), the cha


U.S. FDA Approves New Anti-HIV Drug Aptivus for Use in Combination Therapy
PRNewswire - June 23, 2005
RIDGEFIELD, Conn., June 23 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration ( FDA ) has granted accelerated approval of Aptivus(R) (tipranavir) capsules. Accelerated approval is a regulatory process that expedites the approval of therapies for serious


Pfizer Announces Fourth Round of Global Health Fellows, Continues to Infuse Developing Countries with Needed Human Capital
PRNewswire - June 23, 2005
-- Company Volunteers Take on International Assignments to Fight Devastating Diseases NEW YORK, June 23 /PRNewswire/ -- Pfizer Inc today announced the fourth class of Global Health Fellows, a group of nineteen Pfizer colleagues from North America, Europe and Australia who will be paired wit


Peregrine Pharmaceuticals Presents Data Supporting Broad Spectrum Anti-Viral Potential of Tarvacin(TM) at BIO 2005
PRNewswire - June 22, 2005
-- Data Presented Shows That Tarvacin(TM) Binds to Viruses Belonging to Six Different Virus Families; Inhibits Replication of Multiple Virus Types; and Protects Against Lethal Viral Infections in Pre-Clinical Animal Models of Two Different Viruses TUSTIN, Calif., June 22 /PRNewswire-FirstCall/ -- Peregrine Pharmaceutic


Generically Creative: Drug Companies Balance Patents and Patients
PRNewswire - June 22, 2005
RESEARCH TRIANGLE PARK, N.C., June 22 /PRNewswire/ -- A generics balancing act offers a compelling peek at how the drug industry can both protect its patents and deliver drugs to needy patients. On Monday, the United States Food and Drug Administration announced its tentative decision to approve limited generic version


Ranbaxy Receives Tentative Approval for Nevirapine Tablets as Part of the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) Initiative
PRNewswire - June 22, 2005
PRINCETON, N.J., June 22 /PRNewswire/ -- Ranbaxy Laboratories Limited (RLL) announced today that it has received tentative approval from the U.S. Food and Drug Administration to manufacture and market Nevirapine Tablets, 200 mg. This is RLL s second tentative approval under the expedited review process of the U.S. Pres


Fast Track Development of Breakthrough TB Diagnostic Test Launched at BIO 2005F
PRNewswire - June 21, 2005
-- PROTEOME SYSTEMS (an Australian Public Company) and FIND [Funded by The Bill & Melinda Gates Foundation] back rapid diagnostic test for TB -- New test cuts diagnosis waiting time to 3 minutes from 24 hours PHILADELPHIA, June 21 /PRNewswire/ -- Geneva-based Foundation for Innovative New Diagnostics [FIND], which


GSK Biologicals and IAVI Partner to Develop AIDS Vaccine
PRNewswire - June 21, 2005
-- Agreement to Develop Prophylactic Vaccine Against AIDS for Use in Developing Countries is First-Ever Product Development Collaboration Between International AIDS Vaccine Initiative and a Major Vaccine Maker LONDON, June 21 /PRNewswire-FirstCall/ -- GlaxoSmithKline Biologicals (GSK Biologicals) and the International


BET Premieres HIV/AIDS Testing Special Featuring Hip Hop Diva Ciara and Comedienne Mo'Nique
PRNewswire - June 20, 2005
WASHINGTON, June 20 /PRNewswire/ -- On Sunday, June 26 at 3:00 pm ET/PT, BET will premiere OPEN MIC: MY THING, an hour-long special program produced as part of Rap-It-Up, the network s award-winning HIV/AIDS public education partnership with the Kaiser Family Foundation. Co-hosted by Mad Linx of BET s RAP CITY and hip


MTV and Kaiser Family Foundation Reach Out to Young People to Highlight National HIV Testing Day (June 27th)
PRNewswire - June 20, 2005
-- Efforts Will Reside on Air, Online, and in Communities Nationwide NEW YORK, June 20 /PRNewswire/ -- MTV: Music Television and the Kaiser Family Foundation today announced a series of complementary on-air, online and on the ground efforts as part of the network s think: Sexual Health campaign. The activities will enc


Weak Health Services Block Progress in Asia And the Pacific
PRNewswire - June 20, 2005
TOKYO, June 20 /Xinhua-PRNewswire/ -- The World Health Organization (WHO) said today that weak and inequitable health systems are preventing many Asia- Pacific nations from meeting international goals set on health and poverty. The health care systems of many countries are failing to deliver services of adequate qualit


AIDS Healthcare Foundation Proposes Redesign of Nation's AIDS Program
PRNewswire - June 20, 2005
-- Nation s Largest AIDS Group to Propose Streamlining Ryan White CARE Act to Reduce Bureaucracy, Increase Funding for Much-Needed & Life-Saving Medical Care, Services What: Press Conference & Teleconference Call for Overhaul of Ryan White CARE Act for Funding of HIV/AIDS Care & Services When: Monday June


Abbott and Celera Diagnostics Announce CE Marking for HIV-1 Real-Time PCR Viral Load Test
PRNewswire - June 16, 2005
-- Test Provides Highly Accurate Tool for Measuring Levels of HIV-1 and Its Subtypes in the Blood, Allowing Physicians to Better Manage Patient Therapy DELKENHEIM, Germany , June 16 /PRNewswire-FirstCall/ -- Abbott and Celera Diagnostics, a joint venture between the Applied Biosystems Group (NYSE: ABI) and Celera Genom


Vical Receives $12 Million HIV Vaccine Production Order to Support NIH Phase 2 Trials
PRNewswire - June 16, 2005
SAN DIEGO, June 16 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaq: VICL) announced today the receipt of approximately $12.1 million in production orders for multiple clinical lots of DNA vaccines against HIV for the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases of the


PEPFAR Must Add 765,000 People to AIDS Treatment Rosters by September '05 to Meet Congress' Goals, Says AHF
PRNewswire - June 14, 2005
-- Despite Bush s and Administration Officials Claims of Success With Ambitious Program, AHF Says the 235,000 People Now on $15B Global AIDS Treatment Represent a Mere 25% of Congressionally Mandated Goal of One Million on Life-saving Treatment by September 2005 LOS ANGELES, June 14 /PRNewswire/ -- AIDS Healthcare Foun


AHF Praises Bristol-Myers Squibb for Halting New Drug Ads
PRNewswire - June 14, 2005
-- Company Pledges Not to Run Direct-to-Consumer Drug Ads for Any New Drugs for at Least One Year -- Pharmaceutical Industry Has Come Under Greater Public Scrutiny Since Vioxx, Other Scandals LOS ANGELES, June 14 /PRNewswire/ -- AIDS Healthcare Foundation, the nation s largest AIDS group which operates free AIDS treatm


President Bush's Cut to AIDS Prevention in Africa Would Be 'Devastating,' Says Global AIDS Alliance: This Week Congress Considers Bush Proposal
PRNewswire - June 14, 2005
WASHINGTON, June 14 /PRNewswire/ -- President Bush claims to have tripled US aid to Africa, yet he has set the Global Fund on a course to disaster. While promising to back the Fund, the cut he has proposed to the US contribution to the Fund could lead to a massive reduction in HIV/AIDS prevention and care for orphans.


AHF Calls PhRMA's CAFTA Drug Access Claims, 'Self-Serving and Dangerous'
PRNewswire - June 14, 2005
-- US Largest AIDS Organization Disputes Claim That NAFTA Improved Health Outcomes in Mexico : Calls on Congress to Prevent Central American HIV/AIDS Patients From Paying With Their Lives LOS ANGELES, June 14 /PRNewswire/ -- As the House Ways and Means Committee prepares its mark-up of CAFTA on Wednesday, AIDS Healthca


Mixed Messages From Washington, Drug Industry Fuel Rising HIV Rates, Says AHF
PRNewswire - June 14, 2005
-- Government Now Reports 1 Million Cases Nationwide; AHF Says Mixed Messages From Washington on Unsafe Sex and Irresponsible Drug Industry Ads Contribute to Crisis LOS ANGELES, June 14 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the nation s largest AIDS organization with clinics in the US, Africa, Asia and Cent


AHF to Launch Rapid HIV Testing Targeting San Francisco's Transgender Community
PRNewswire - June 14, 2005
What: Open House to Kick-Off AHF s Newest Rapid HIV Testing Location Targeting SF s Transgender Community For B-roll and audio consideration, the event will feature a performance by the Ark of Refuge Choir Where: Ark of Refuge and AIDS Healthcare Foundation s Magic Johnson Clinic/San Francisco 1025 Howar


14 June: World Blood Donor Day - Anyone Can Save A Life: Eight out of Ten People in the World Do Not Have Access to Safe Blood
PRNewswire - June 14, 2005
GENEVA, June 14 /Xinhua-PRNewswire/ -- Thanks to the millions of people who give blood safely and anonymously, thousands of lives are saved every day. But the chances of receiving a safe transfusion -- or any transfusion at all -- vary enormously from country to country. Some 60% of global blood supplies goes to 18% of


TMC114 Expanded Access Program for People Living with HIV/AIDS to Begin Enrollment in Autumn of 2005
PRNewswire - June 14, 2005
-- Tibotec to File for Accelerated Approval for TMC114 YARDLEY, Pennsylvania, June 14 /PRNewswire/ -- Tibotec, Inc. announced today it plans to initiate an expanded access program (EAP) for its investigational protease inhibitor, TMC114, in the autumn of this year for people with HIV/AIDS who need the compound to const


NOVA Research Company Breaks Language Barriers: NOVA's QDS-HAPI(TM) for Pocket PC used for Multilingual POSIT Supplement in South African Schools, Introduces New Adolescent HIV/STD Risk-Scale
PRNewswire - June 14, 2005
BETHESDA, Md., June 14 /PRNewswire/ -- The National Institute on Drug Abuse (NIDA) has supplemented a 5-year research grant to NOVA Research Company, a provider of innovative technology, consulting, and research support services for the global health and research communities, to conduct an Adolescent HIV/STD Risk-of-Ex


First Tuberculosis Drug Developed by a Non-profit Begins Clinical Trials: Trial is First in TB Alliance's Growing Pipeline of Drugs; Provides Model for Future Drug Development
PRNewswire - June 14, 2005
NEW YORK, June 14 /PRNewswire/ -- The Global Alliance for TB Drug Development (TB Alliance), a non-profit public-private partnership developing affordable, new drug regimens for tuberculosis, today announced the start of Phase I clinical trials for the lead TB drug in its pipeline, PA-824. The trials begin this month.


AHF Calls for $34M in Unspent Ryan White Funding to Be Shifted to ADAP
PRNewswire - June 13, 2005
-- CARE Act Requires Unspent Funds be Returned to Feds; Nation s Largest AIDS Group Supports Call to Shift Unspent Millions to Needy AIDS Drug Assistance Programs (ADAP) -- Ten States Currently Have Waiting Lists for Access to Lifesaving AIDS Drug Programs LOS ANGELES, June 13 /PRNewswire/ -- As a new government report


Esperanza USA Confronts HIV/AIDS with the Hispanic Faith Community
PRNewswire - June 13, 2005
-- Results of New Study Shows Barriers Hispanic Faith Leaders Confront Regarding the HIV/AIDS Epidemic in the Hispanic Community WASHINGTON, June 13 /PRNewswire/ -- Esperanza USA, a leading voice for Hispanic Americans in the nation, today released the results of a new, in- depth study on how Hispanic churches and thei


Remarks by President Bush in Statement on the African Growth and Opportunity Act
PRNewswire - June 13, 2005
WASHINGTON, June 13 /PRNewswire/ -- The following are remarks by President Bush in statement on the African Growth and Opportunity Act: Room 450 - Dwight D. Eisenhower Executive Office Building 11:11 A.M. EDT THE PRESIDENT: Thank you all for coming. Welcome to the White House. I want to thank the five Presidents who ar


Trade Agreements 'Bad Medicine' for AIDS, Says AHF
PRNewswire - June 9, 2005
AIDS Healthcare Foundation Hails Waxman Report Faulting Trade Agreements Like -- NAFTA and CAFTA for Reducing Access to Life-saving HIV/AIDS Medications LOS ANGELES, June 9 /PRNewswire/ -- AIDS advocates from AIDS Healthcare Foundation (AHF), the nation s largest provider of HIV/AIDS medical care serving thousands of p


Harbinger Research Issues Bird's Eye Report for Amazon Biotech, Inc.
PRNewswire - June 9, 2005
NEW YORK, June 9 /PRNewswire-FirstCall/ -- Harbinger Research LLC, http://www.harbingerresearch.com, an independent equity research firm, announced today that it has issued a Bird s Eye Report for Amazon Biotech, Inc. (OTC Bulletin Board: AMZB), http://www.amazonbiotech.com , a development stage pharmaceutical/biotech


Osel Receives NIH Award Under Partnerships for Topical Microbicides
PRNewswire - June 9, 2005
SANTA CLARA, Calif., June 9 /PRNewswire/-- Osel, Inc., the Bacterio-Therapeutics company, announced award of a multiple-year grant from the NIAID, NIH towards development of an encapsulated MucoCept Lactobacillus strain for therapeutic prevention of bacterial vaginosis (BV) and HIV infection under support of the Partne


454 Life Sciences Presents Detection Breakthrough at XIV International HIV Drug Resistance Workshop: 454's ultra-deep sequencing able to detect low levels of drug resistant HIV
PRNewswire - June 9, 2005
BRANFORD, Conn., June 9 /PRNewswire-FirstCall/ -- 454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation (Nasdaq: CRGN), reported today that scientists from the Company presented a poster detailing a potentially new application for the Company s technology -- ultra-deep sequencing of the HIV virus. The p


'Blair Should Reject Bush's Excuses on Aid to Africa,' Says Global AIDS Alliance
PRNewswire - June 7, 2005
WASHINGTON, June 7 /PRNewswire/ -- British Prime Minister Tony Blair will face difficult challenges when he visits the White House today to discuss aid to Africa. Negotiations on debt cancellation have reached an impasse, and Blair s appeal to double aid to Africa has been rebuffed. The stakes for Africa at this meetin


Sangamo BioSciences Highlights Data From the 8th Annual Meeting of the American Society of Gene Therapy
PRNewswire - June 7, 2005
-- Data Presented from ZFP-mediated Gene Regulation and Gene Modification Programs RICHMOND, Calif., June 7 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today highlights of data presented at the 8th Annual Meeting of the American Society of Gene Therapy (ASGT) held in St. Louis, June 1-5


Paris and Nicky Hilton, Kimora Lee Simmons, Christina Aguilera, Rebecca Romijn, Elle Macpherson, Heidi Klum Among 44 Celebrities To Bare All For New Book To Benefit The Elton John AIDS Foundation
PRNewswire - June 6, 2005
NEW YORK, June 6 /PRNewswire/ -- Paris and Nicky Hilton, Kimora Lee, Christina Aguilera, Rebecca Romijn, Elle Macpherson and Heidi Klum are among 44 women who are using their star power to raise funds and awareness for the Elton John AIDS Foundation. The well known women have bared all, donning nothing but Cartier jewe


KNOW HIV/AIDS Encourages Americans to Get Tested For HIV
PRNewswire - June 6, 2005
-- Viacom and Kaiser s Initiative Features New PSAs, Special Programming and Community Outreach NEW YORK, June 6 /PRNewswire/ -- Viacom Inc. and the Kaiser Family Foundation announced today, as part of their Emmy and Peabody Award-winning public education campaign, KNOW HIV/AIDS, a new series of public service announce


Verity TeleForm Plays Key Role at Kenyan AIDS Clinic
PRNewswire - June 6, 2005
-- Content Capture Software Used to Speed Creation of Patient Treatment Database -- Part of Presidential Initiative to Treat AIDS in Resource-Poor Countries SUNNYVALE, Calif., June 6 /PRNewswire-FirstCall/ -- Verity Inc. (Nasdaq: VRTY), a leading provider of enterprise software that enables organizations to maximize th


It's Stars, Stripes and Big-Name Stars in Philadelphia for Fourth of July; Elton John, Patti LaBelle, Dave Matthews, Will Smith, Sarah McLachlan and Stevie Wonder Are Among Those Performing in America's Birthplace Over the Weekend
PRNewswire - June 2, 2005
PHILADELPHIA, June 2 /PRNewswire/ -- Philadelphia s 229th Fourth of July celebration promises to be one of the most momentous in history, with long-established patriotic remembrances, large-scale music events and fireworks taking place over the long four-day holiday. It s stars, stripes and big-name stars in America s


AHF Hails California Assembly for Passing Condoms in Prisons Bill
PRNewswire - June 2, 2005
-- AB 1677, (Koretz, D-West Hollywood), Clears Assembly in 41 to 34 Vote; Bill, Sponsored by Southern California HIV/AIDS Coalition (SCHAC), AIDS Healthcare Foundation (AHF) and AIDS Project Los Angeles (APLA), Seeks to Reduce Spread of HIV and Other STDs Among California Inmates SACRAMENTO, Calif., June 2 /PRNewswire/


US & Latin American AIDS Advocates Blast CAFTA's Anti-Generic Drug Provisions: Patients Will 'Pay With Their Lives' Experts Warn
PRNewswire - June 2, 2005
LOS ANGELES, June 2 /PRNewswire/ -- AIDS advocates with expertise on the HIV crisis among Latin Americans today called on Congress to protect access to low-cost generic HIV medications now available in Central America but threatened by the proposed Central American Free Trade Agreement (CAFTA). Poor Central Americans w


Call for World Leaders to Redouble Efforts to Develop Vaccines and Microbicides to Prevent HIV
PRNewswire - June 2, 2005
NEW YORK, June 2 /PRNewswire/ -- Thursday, June 2, 2005 - Researchers and international leaders at the United Nations General Assembly High-Level Meeting on HIV/AIDS today called on governments around the world to complement their existing efforts with a focus on developing new technologies, such as microbicides and va


AHF Lauds Senator Coburn's (R-OK) Move to Nix US-Backed AIDS Vaccine Trial in Thailand
PRNewswire - June 1, 2005
-- Letter From Maverick Oklahoma Physician/Senator Urges HHS Secretary Mike Leavitt to Reconsider $119M NIH HIV Vaccine Trial in Thailand After Leading HIV Researchers Cite Questionable Project s ... Lack of Scientific Merit. LOS ANGELES, June 1 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the largest AIDS organiz


MedMira Wins Exclusive Right to Sell Rapid HIV Tests in China's Guizhou Province
PRNewswire - June 1, 2005
-- Represents Upwards of 1.5 Million Tests per Year for Province s Blood Banks HALIFAX, June 1 /PRNewswire-FirstCall/ - MedMira Inc., ( MedMira ) (TSX Venture: MIR, NASDAQ: MMIRF) the global market leader in rapid flow-through diagnostic technology, announced today that it has won a government tender to supply rapid HI


Sangamo BioSciences to Present Data From Its ZFP Therapeutic(TM) Programs at the 8th Annual Meeting of the American Society of Gene Therapy
PRNewswire - June 1, 2005
-- Nine Presentations From ZFP-Mediated Gene Regulation and Gene Modification Programs ST. LOUIS, June 1 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced presentations of data from several of the Company s zinc finger DNA binding protein (ZFP) Therapeutic(TM) programs at the 8th Annual


New Trojan(R) Condoms Campaign Aims to Make a Difference and Strike Down Complacency About Unprotected Sex
PRNewswire - May 31, 2005
-- Advertising Aims To Reach Primetime TV Viewers With Safer Sex Messages; Personalize Devastating Effects of Unprotected Sex PRINCETON, N.J., May 31 /PRNewswire/ -- The sobering fact that millions of people may be taking unnecessary health risks is the catalyst for a new advertising campaign from the makers of Trojan(


Medical Services Begins Testing With Mexican Military
PRNewswire - May 27, 2005
EDMONTON, Alberta, May 27 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pinksheets: MSITF) is pleased to announce that the military in Mexico has begun testing the VScan HIV 1&2 rapid test kit. The process to get the military in Mexico to test a product is a very long and difficult process. The Com


Ranbaxy HIV Update
PRNewswire - May 27, 2005
PRINCETON, N.J., May 27 /PRNewswire/ -- Ranbaxy Laboratories Limited (Ranbaxy) announced today that the Company has made further three filings of its Anti-Retroviral (ARVs) formulations, to the World Health Organization (WHO) for its approval under the latter s pre-qualification project for HIV/AIDS drugs.


Ranbaxy Receives Tentative Approval for Lamivudine Tablets as Part of the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) Initiative
PRNewswire - May 27, 2005
PRINCETON, N.J., May 27 /PRNewswire/ -- Ranbaxy Laboratories Limited (RLL) announced today that it has received tentative approval from the U.S. Food and Drug Administration to manufacture and market Lamivudine Tablets, 150 mg. This is the first product reviewed under the expedited review provisions of the U.


Human Genome Sciences Reports on Progress Toward Commercialization
PRNewswire - May 26, 2005
- New Division to Identify Early Stage Pipeline Opportunities and Monetize Intellectual Property and Technology Assets ROCKVILLE, Md., May 26 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today will report on the company s continuing progress toward commercialization at a meeting of financial ana


Arthur J. Ammann, M.D., Joins Board of Directors of Viral Genetics, Inc.: Honored Physician an Expert in HIV/AIDS Transmission and Treatment
PRNewswire - May 25, 2005
AZUSA, Calif., May 25 /PRNewswire-FirstCall/ -- Arthur J. Ammann, M.D., President of Global Strategies for HIV Prevention, has been named to the Board of Directors of Viral Genetics, Inc., (OTC Bulletin Board: VRAL). Viral Genetics is a drug development company developing VGV-1, a biological therapy for the treatment o


V.I. Technologies and Collaborators Present Three Studies on the Molecular Target of PA-457, First-in-Class HIV Maturation Inhibitor, at the Cold Spring Harbor Retrovirus Conference
PRNewswire - May 24, 2005
WATERTOWN, Mass., May 24 /PRNewswire-FirstCall/ -- V.I. Technologies, Inc. (Nasdaq: VITX) ( Vitex or the Company ), a biotechnology company dedicated to developing the next generation of anti-infective products, today announced that Vitex scientists and their collaborators are presenting three reports describing their


Therapies from Gilead and Bristol-Myers Squibb Will Expand the HIV Market
PRNewswire - May 24, 2005
-- New Antiretroviral Products and Novel Classes Will Expand the Treatment Options for Patients Resistant to Current ARVs, According to a New Study from Decision Resources WALTHAM, Mass., May 24 /PRNewswire/ -- Decision Resources, Inc., one of the world s leading research and advisory firms focusing on pharmaceutical a


Disease Directory Provides Contacts Nationwide
PRNewswire - May 23, 2005
LONGMONT, Colo., May 23 /PRNewswire/ -- The National Infectious Disease Directory (http://www.guides4living.com) is now shipping. This valuable resource for health care providers nationwide was formerly HIV/AIDS Resources. The name of the directory has been changed this year to The National Infectious Disease Directory


Armed Conflicts Leading Cause of World Hunger Emergencies - FAO Report: Conflicts, HIV/AIDS, Climate Change Main Causes of Hunger
PRNewswire - May 23, 2005
WASHINGTON and ROME, May 23 /PRNewswire/ -- Armed conflicts are now the leading cause of world hunger with the effects of HIV/AIDS and climate change not far behind, according to an FAO report presented today at a meeting of the Committee on World Food Security (CFS). The Committee is holding its 31st Session 23-26 May


High-Level Briefing on the Desperate Situation of Orphans and Vulnerable Children Sponsored by Representative Barbara Lee (D-Ca) To Take Place May 24, 2005, Capitol Building, Room HC-8, 10 am - 11:30 am
PRNewswire - May 23, 2005
--Experts in the Field To Comment on Progress Made on UN Mandate on HIV/AIDS and Recent Analysis of Four African Nations WASHINGTON, May 23 /PRNewswire/ -- Representative Barbara Lee (D-CA) is sponsoring a high-level briefing on the situation of the tens of millions of orphans and vulnerable children in developing coun


AHF Steps Up Efforts to Rein in AIDS Drug Ads
PRNewswire - May 23, 2005
-- In Letters to HIV/AIDS Drug Manufacturers, US Largest Aids Group Calls for Halt to Companies Irresponsible Direct to Consumer Drug Advertising for HIV/AIDS Treatment LOS ANGELES, May 23 /PRNewswire/ -- AIDS Healthcare Foundation, (AHF) the nation s largest AIDS group and a direct provider of HIV/AIDS medical care to


Research and Markets: South Africa Pharmaceutical Market Largest in Africa, Estimated at US$1,687 Million in 2005
PRNewswire - May 20, 2005
DUBLIN, Ireland , May 20 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/reports/c17760 ) has announced the addition of South Africa Pharmaceutical Market Intelligence Report to their offering. The Republic of South Africa represents one of the most diverse medical markets in the


FDA Antiviral Drugs Advisory Committee Recommends Accelerated Approval for Investigational Anti-HIV Drug Tipranavir
PRNewswire - May 19, 2005
GAITHERSBURG, Md., May 19 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration s ( FDA ) Antiviral Drugs Advisory Committee recommended the approval of the investigational anti-HIV drug tipranavir (11-3).


BET, Cox Communications of New Orleans and Hot 104.5 FM Bring Award-Winning Rap-It-Up Campaign to New Orleans on May 29
PRNewswire - May 19, 2005
-- KNOU Rap-It-Up Block Party Features Free Concert and On-site HIV Testing WASHINGTON, May 19 /PRNewswire/ -- BET s Rap-It-Up brings its award- winning national HIV/AIDS public awareness initiative to New Orleans to sponsor the Annual KNOU Block Party on Sunday, May 29 from 2 - 7 p.m. CT at Marconi Meadows City Park.


A Clear Call for Comprehensive Sex Education in Schools: 2005 Trojan(R) Sexual Health Monitor Reveals High Awareness of Health Risks of Unsafe Sex But Only Four Percent Use Condoms During Oral Sex
PRNewswire - May 19, 2005
PRINCETON, N.J., May 19 /PRNewswire/ -- A comprehensive sex education curriculum that includes messages about both safer sex and abstinence provides a solid foundation of crucial information about sex in everyday life and should continue to be taught in school, say a majority of men and women aged 18 to 24 nationwide (


Showtime Presents Provocative Programming Slate for Gay Pride Month in June
PRNewswire - May 18, 2005
-- Line-up Includes SAME SEX AMERICA, WE ARE DAD, JACK, DAMAGED GOODS, SHOOK and New Episodes of QUEER AS FOLK LOS ANGELES, May 18 /PRNewswire/ -- In June, Showtime Networks will honor Gay Pride Month with provocative programming featuring the network s celebrated new documentary SAME SEX AMERICA, which takes a hard lo


UN Annan Report Hails AIDS Healthcare Foundation Global Treatment Initiatives
PRNewswire - May 18, 2005
-- Combating AIDS in the Developing World, Millennium Project Report Commissioned by Kofi Annan, Cites US Largest AIDS Organization s Global Treatment Projects in South Africa and Uganda AMSTERDAM, May 18 /PRNewswire/ -- The UN Millennium Project, an independent advisory body commissioned by UN Secretary-General Kofi A


World Health Organization and International Federation of Red Cross Collaborate With Safe Blood For Africa in Voluntary Blood Donor Recruitment Program
PRNewswire - May 18, 2005
ABUJA, Nigeria , May 18 /PRNewswire/ -- In an effort to increase voluntary blood donations and create best practices for safe blood collection and screening of donors, the World Health Organization (WHO) and International Federation of Red Cross Red Crescent Societies collaborated with Safe Blood For Africa Foundation


26 Companies of the Global Business Coalition on HIV/AIDS (GBC) Announce Immediate Commitments to Fight AIDS in China
PRNewswire - May 17, 2005
BEIJING, May 17 /PRNewswire/ -- In response to Chinese Vice Premier Madame Wu Yi s call on Chinese and international companies to take action to stem the growing HIV/AIDS epidemic, the Global Business Coalition on HIV/AIDS (GBC) announces definite commitments by 26 companies to tackle HIV/AIDS in their workplaces and t


Mandela's White House Meeting to Discuss AIDS Policy
PRNewswire - May 17, 2005
-- Mandela and Bush May Find Common Ground on Basic Education in Africa, But They May Disagree on Global Fund and Debt Cancellation WASHINGTON, May 17 /PRNewswire/ -- During his visit to the White House today, Nelson Mandela is expected to raise critical issues regarding the US approach to helping Africa. Yesterday, in


TRIZIVIR, First Tablet to Combine Three Medications for HIV, Receives Traditional Approval Status From FDA
PRNewswire - May 16, 2005
RESEARCH TRIANGLE PARK, N.C., May 16 /PRNewswire/ -- GlaxoSmithKline (GSK) today announced that the U.S. Food and Drug Administration ( FDA ) has granted traditional approval status to TRIZIVIR(R) (abacavir sulfate, lamivudine, and zidovudine) for the treatment of HIV infection. TRIZIVIR is a fixed-dose- combination ta


Evaluation by the Uganda Virus Research Institute Qualifies Calypte Rapid HIV Assays for Sale in the Republic of Uganda
PRNewswire - May 16, 2005
PLEASANTON, Calif., May 16 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (Amex: HIV) today announced that the Republic of Uganda HIV/AIDS Reference and Quality Assurance Laboratory (HRL), Uganda Virus Research Institute, in Entebbe has issued a recommendation that the Uganda National Drug Authority grant app


Pegasys(R) Findings Suggest New Approaches to Maximize Hepatitis C Therapy: Starting treatment earlier and staying on treatment longer may increase treatment response rates for certain hepatitis C patients
PRNewswire - May 16, 2005
CHICAGO, May 16 /PRNewswire/ -- Starting hepatitis C treatment before liver disease progresses and identifying the correlation between early response and sustained virological response, are two potential approaches that may optimize treatment outcomes in certain patients according to data from two Pegasys(R) (peginterf


GSK Promotes Trizivir in Naive Patients, Despite Negative Findings, Says AHF
PRNewswire - May 16, 2005
-- GSK Announces FDA Traditional Approval Status of Trizivir ; US Largest AIDS Organization Decries Drug Giant s Aggressive Marketing of All-in-One AIDS Regimen Despite Failed NIH Trial LOS ANGELES, May 16 /PRNewswire/ -- In reaction to an announcement today by GlaxoSmithKline (


Asian & Pacific Islander HIV/AIDS Anti-Stigma Public Service Announcements Break New Ground in Creative and Dramatic Content
PRNewswire - May 16, 2005
SAN FRANCISCO, May 16 /PRNewswire/ -- The national launch of The Banyan Tree Project included the production of two groundbreaking 30-second public service announcements (PSAs) which revolve around the tagline message, Rooted in Acceptance and the call for a more compassionate, understanding attitude towards Asian


Research and Markets: Pipeline Insight: HIV - Hold Your Horses
PRNewswire - May 16, 2005
DUBLIN, Ireland , May 16 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/reports/c17483 ) has announced the addition of Pipeline Insight: HIV - Hold Your Horses to their offering. In the current antiretroviral landscape, resistance in all three of the established classes is proving to be problem


FDA Approves Pegasys(R) as the First and Only Pegylated Interferon for the Treatment of Chronic Hepatitis B
PRNewswire - May 13, 2005
-- Pegasys -- Most Prescribed Hepatitis C Medication -- Now Approved for 1.25 Million Americans with Chronic Hepatitis B NUTLEY, N.J., May 13 /PRNewswire/ -- Roche announced today that the U.S. Food and Drug Administration ( FDA ) has approved Pegasys(R) (peginterferon alfa-2a), the most prescribed hepatitis C medicati


Research and Markets: Keep Abreast of Company and Industry Developments in the HIV Industry
PRNewswire - May 13, 2005
DUBLIN, Ireland , May 13 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/reports/c17473 ) has announced the addition of HIV - Industry Background and Company News Updates to their offering. This Industry and Company News Updates is designed to provide a comprehensive list of all companies with a


Statement by Dr. Kenneth Moritsugu, Deputy Surgeon General U.S. Department of Health and Human Services Regarding National Asian and Pacific Islander HIV/AIDS Awareness Day, May 19, 2005
PRNewswire - May 13, 2005
WASHINGTON, May 13 /PRNewswire/ -- The following is a statement by Dr. Kenneth Moritsugu, Deputy Surgeon General U.S. Department of Health and Human Services: The Department of Health and Human Services (HHS) is pleased to support the first annual National Asian and Pacific Islander (API) HIV/AIDS Awareness Day, which


The First National Asian & Pacific Islander HIV/AIDS Awareness Day Takes Root in San Francisco
PRNewswire - May 12, 2005
-- A&PI Wellness Center Launches National Initiative to Foster Acceptance and Reduce Stigma in Asian & Pacific Islander Communities SAN FRANCISCO, May 12 /PRNewswire/ -- Asian & Pacific Islander Wellness Center (A&PI Wellness Center) has claimed May 19, 2005, as the first annual, National Asian & Pa


Ranbaxy HIV Update - May 2005
PRNewswire - May 12, 2005
PRINCETON, N.J., May 12 /PRNewswire/ -- Ranbaxy Laboratories Limited (Ranbaxy) announced today that the Company has made three further fresh filings of its Anti-Retroviral (ARVs) formulations, to the World Health Organisation (WHO) for its approval, taking the total number of filings submitted with the WHO, to eight. T


President Obasanjo Donates His Blood in Cooperation With Safe Blood For Africa(TM) Foundation to Open Nigeria's First National Blood Transfusion Center
PRNewswire - May 12, 2005
-- Officials From the US Embassy, USAID and Federal Ministry of Health Join Ribbon Cutting Ceremony for New Center Critically Needed to Prevent Spread of HIV/AIDS Through Infected Blood ABUJA, Nigeria , May 12 /PRNewswire/ -- In a critically needed step in the fight against the spread of HIV/AIDS in Nigeria, His Excell


Samaritan's Lead Oral Entry Inhibitor HIV Drug SP01A Initiates PII HIV Monotherapy Trial
PRNewswire - May 11, 2005
- A Previous Phase II Study plus Multiple Preclinical Studies Suggest SP01A as Preventing HIV From Entering the Human Cell - HIV is Notorious in its Ability to Change or Mutate Which in Itself can Keep the Current HIV Drugs from Working, Making Drug Resistance the Most Common Cause of Treatment Failure - With Encourag


AHF Blasts Pharma Over Ad Guidelines, Says Industry Incapable of Self-Regulation
PRNewswire - May 10, 2005
-- AIDS Healthcare Foundation Calls on FDA to Rein in Out-of-Control Drug Industry Advertising; Recent JAMA Study Shows Influence Direct to Consumer Advertising Has on Doctors Prescribing Decisions LOS ANGELES, May 10 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the largest AIDS organization in the US which operat


MedMira Receives FDA Approval for Enhancements to Rapid HIV Test: New Features Improve Cost Effectiveness and Provide More Flexibility
PRNewswire - May 10, 2005
HALIFAX, May 10 /PRNewswire-FirstCall/ - MedMira Inc., ( MedMira ) (TSX Venture: MIR, NASDAQ: MMIRF) the global market leader in rapid flow-through diagnostic technology, announced today that it has received approval from the United States Food and Drug Administration ( FDA ) to provide new features in


Training HIV/AIDS Orphans in Sub-Saharan Africa: Field Schools Fight Hunger and Poverty With Farming Know-How and Life Skills
PRNewswire - May 9, 2005
WASHINGTON and ROME, May 9 /PRNewswire/ -- AIDS orphans in Africa are being helped to improve their often desperate living conditions by learning agricultural techniques in specially designed schools, FAO said today. To date, FAO has set up 34 Junior Farmer Field and Life Schools for orphaned children in


South Africa Orphans and Los Angeles Youth Lead International Exchange on AIDS/HIV Orphans Day
PRNewswire - May 9, 2005
LOS ANGELES, May 9 /PRNewswire/ -- On Saturday, May 7, GlobalTribe Network (http://www.GlobalTribeNet.org), a Los Angeles based non-profit organization, produced an international video-conference to mark World AIDS/HIV Orphans Day. An estimated 1000 young people participated from four continents, including a group from


New York Steps up Support for 20th Year of World's Largest AIDS Fundraiser: Record Crowd and Host of Stars Expected at AIDS Walk New York
PRNewswire - May 9, 2005
NEW YORK, May 9 /PRNewswire/ -- More than 45,000 New Yorkers are expected to take to the streets on Sunday, May 15, 2005 for the 20th annual AIDS Walk New York. With increased outreach and a new advertising campaign that is creating quite a buzz, Gay Men s Health Crisis (GMHC) Executive Director Ana Oliveira is encoura


Global Business Coalition on HIV/AIDS (GBC) and World Vision Launch impact! HIV/AIDS Campaign
PRNewswire - May 5, 2005
-- Both Groups Call on Financial Sector to Take Action Against the Spread of AIDS BERMUDA, May 5 /PRNewswire/ -- The Global Business Coalition on HIV/AIDS (GBC), the pre-eminent organization leading the business response to AIDS and World Vision, an international humanitarian relief organization, are calling on the glo


BD and CMMB Join Forces to Address the Challenge of HIV/AIDS Pandemic in Zambia
PRNewswire - May 5, 2005
-- Ten BD Associates Head to Africa as Part of Unique Volunteer Project FRANKLIN LAKES, N.J., and NEW YORK, May 5 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a global medical technology company, and the Catholic Medical Mission Board (CMMB) today announced an innovative collaboration to hel


AIDS Drug Assistance Programs: Americans in Crisis
PRNewswire - May 5, 2005
-- Panel Presentation Today by Frontline Providers and Patients WASHINGTON, May 5 /PRNewswire/ -- In order to provide AIDS therapies to all Americans who need them, a minimum of $303 million in additional federal funding is urgently needed for the AIDS Drug Assistance Program (ADAP) for the Fiscal Year 2006. That is th


AHF Expresses 'Profound Disappointment' With Senate Judiciary Committee for Failure to Move SB 945 (Soto, D-Ontario), California's HIV Reporting Bill, Forward
PRNewswire - May 4, 2005
-- Nation s Largest AIDS Group Now Calls on Senator Kuehl and Members of the Gay & Lesbian Caucus to Immediately Work to Backfill Significant Loss in Federal HIV/AIDS Funding Over Past Three Years as a Result of Undercounting HIV Cases Due to Serious Flaws in State s Code-based Reporting System SACRAMENTO, May 4 /P


War on AIDS Needs Food, Aid Agencies Say
PRNewswire - May 4, 2005
KANSAS CITY, Mo., May 4 /PRNewswire/ -- The five billion dollars earmarked by U.S. President George W. Bush to fight HIV/AIDS could be wasted if his administration does not increase food aid resources, asserted the head of a leading development organization. Speaking at the Export Food Aid conference in Kansas City, ru


ICF Consulting Awarded $1.4 Million Health and Human Services Contract to Support HIV/AIDS Policy
PRNewswire - May 3, 2005
-- ICF Consulting to Provide Social Marketing, Technical Assistance for The Leadership Campaign on AIDS FAIRFAX, Va., May 3 /PRNewswire/ -- ICF Consulting was awarded a $1.4 million contract with the U.S. Department of Health and Human Services (HHS) to support The Leadership Campaign on AIDS (TLCA) for the Office of H


Abbott Submits Application to U.S. FDA for a New, More Convenient Formulation of Kaletra(R) (Lopinavir/Ritonavir)
PRNewswire - May 3, 2005
ABBOTT PARK, Ill., May 3 /PRNewswire-FirstCall/ -- Abbott announced today that it submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration ( FDA ) for the approval of a new, more convenient tablet formulation of its protease inhibitor (PI)


SB 945 (Soto, D-Ontario), California HIV Reporting Bill, Up in Senate Judiciary Committee Today; Bill Cleared Senate Health April 20th in 6 to 4 Vote, Say Supporters of SB 945
PRNewswire - May 3, 2005
-- California HIV Reporting Bill Would Increase Understanding of HIV/AIDS; Lead to Improved Allocation of Federal Ryan White Funding -- Growing Statewide Coalition of Government, Health, HIV/AIDS, Consumer and Community Organizations Supports Measure Sponsored by Los Angeles County, AIDS Healthcare Foundation and the H


To Date 135 Mayors and Municipalities Across the Globe Have Joined in Solidarity to Highlight the Plight of AIDS Orphans and Children Living With HIV/AIDS by Declaring May 7, 2005 World AIDS Orphans Day
PRNewswire - May 3, 2005
NEW YORK, May 3 /PRNewswire/ -- The theme of this year s Day is to mobilize support for the elimination of school fees for the poorest children. At the onset of the 21st century, hundreds of millions of the world s poorest children continue to pay fees in order to attend school. While always a tragedy, this situation b


Abbott Receives FDA Approval for a Once-Daily Kaletra(R)-Based (lopinavir/ritonavir) Treatment Regimen: New Dosing Option Provides Flexibility to People New to HIV Therapy
PRNewswire - May 2, 2005
ABBOTT PARK, Ill., May 2 /PRNewswire-FirstCall/ -- Abbott announced today that it received U.S. Food and Drug Administration ( FDA ) approval to market a once-daily dosing regimen for Kaletra (R) ( lopinavir /


VIRxSYS Announces Completion of Phase I Study of VRX496, Novel HIV Gene Therapy, and Plans to Initiate Phase II Study
PRNewswire - May 2, 2005
GAITHERSBURG, Md., May 2 /PRNewswire/ -- VIRxSYS Corporation, a private biotechnology company focused on the development of gene therapy treatments for diseases such as HIV/AIDS, today reported completion of the initial protocol-mandated observations in a Phase I clinical trial evaluating the safety and tolerability of


Achillion Announces Receipt of SBIR Grant from National Institutes of Health for New Area of HIV Research: Company to Optimize Novel Capsid Assembly Inhibitor
PRNewswire - May 2, 2005
NEW HAVEN, Conn., May 2 /PRNewswire/ -- Achillion Pharmaceuticals Inc., today announced that the Company has received a Phase 1 Small Business Innovation Research Grant (SBIR) from the National Institute of Allergy and Infectious Disease (NIAID) branch of the National Institutes of Health (NIH). The grant covers Human


New Pharmacokinetic Data On Taking Lexiva Simultaneously With Nexium
PRNewswire - April 29, 2005
QUEBEC CITY, Quebec, April 29 /PRNewswire/ -- Today GlaxoSmithKline (GSK) presented new pharmacokinetic (PK) data on taking the HIV protease inhibitor LEXIVA(R) ( fosamprenavir calcium, FPV) Tablets with the proton pump inhibitor (PPI), Nexium(R) (esomeprazole magnesium, ESO) 20mg Delayed-Release Capsules.


Independent Women's Forum Expresses Concern in Open Letter to Secretary Leavitt: Proposed UN Infant Formula Policy Anti-Woman, Anti-Mother & Anti-Development
PRNewswire - April 29, 2005
WASHINGTON, April 29 /PRNewswire/ -- The Independent Women s Forum today announces that it has sent a letter to Health and Human Services Secretary Mike Leavitt expressing serious concerns about United Nations policies that could ultimately lead to a ban on infant formula throughout much of the world, setting women s d


TheBody.com Website Names Dr. Charles Farthing, AIDS Healthcare Foundation's Chief of Medicine, One of Its 'Outstanding Physicians' in 2005 HIV Leadership Awards
PRNewswire - April 29, 2005
-- Chief of Medicine for US Largest AIDS Group is One of 10 Physicians Nationwide to be Honored With Outstanding Physician Leadership Award by Respected Online HIV/AIDS Information Resource LOS ANGELES, April 29 /PRNewswire/ -- AIDS Healthcare Foundation, (AHF) the largest AIDS organization in the US which operates fre


Pernessa C. Seele, Founder and CEO of The Balm In Gilead, Inc.(TM) Named as One of Thirty-Five Most Beautiful Women by Essence Magazine
PRNewswire - April 28, 2005
NEW YORK, April 28 /PRNewswire/ -- During the celebration of its 35th anniversary, Essence Magazine, the premiere magazine for African American women, named 35 of their most beautiful women in the world. The May issue -- on newsstands now-features such women as Iman, Halle Berry, Angela Bassett, Alicia Keys and Queen L


Responding to New Pope's Hard-Line Ban on Condoms, Condomania(R) Donates 30,000 'Madonna' Condoms
PRNewswire - April 27, 2005
-- Los Angeles Gay and Lesbian Center and New York s Gay Men s Health Crisis to Provide Free Madonna Condoms With Each HIV Test LOS ANGELES, April 27 /PRNewswire/ -- Condomania (http://www.condomania.com), America s first condom store, will provide 30,000 Madonna condoms to Los Angeles Gay and Lesbian Center (LAGLC) an


AHF Applauds Efforts to Hold Serono Accountable in Bribery Scandal Involving AIDS Wasting Drug, Serostim
PRNewswire - April 25, 2005
-- As Drug Company Announces the Allocation of $725 Million to Settle Federal Charges, US Largest AIDS Group Commends Authorities Vigorous Efforts to Hold Serono Executives Accountable LOS ANGELES, April 25 /PRNewswire/ -- As the Swiss biotechnology company, Serono, announced the allocation of $725 million to settle a


US' Largest AIDS Group Calls on Congress to Ensure CAFTA Allows Continued Access to Life-saving AIDS Drugs in Central America
PRNewswire - April 22, 2005
-- Congress to Act on CAFTA in Late May; AIDS Healthcare Foundation, Operator of Three Free AIDS Treatment Clinics in Honduras , Urges Reconsideration of New Restrictions on Patent Laws That Severely Restrict Access to Generic Anti-Retroviral AIDS Drugs LOS ANGELES, April 22 /PRNewswire/ -- As the


NanoLogix Announces Study Confirms Identikits Detect Common AIDS Infection Known as Mycobacterium Avium Complex
PRNewswire - April 21, 2005
SHARON, Pa., April 21 /PRNewswire-FirstCall/ -- NanoLogix, Inc., (Pink Sheets: IFEC), a Nanobiotechnology company engaged in the research, development and commercialization of technologies for the production of bacteria and disease testing kits, alternative sources of fuel, cancer therapy and remediation of toxic mater


Waiting Lists and Limited Access to AIDS Drug Assistance Programs Persist Despite Increased Federal and State Funding
PRNewswire - April 20, 2005
-- Wide Variation in Access to HIV Medications Across States WASHINGTON, April 20 /PRNewswire/ -- Twenty-one State AIDS Drug Assistance Programs (ADAPs) report limiting access to their programs in some way, including 11 with waiting lists, despite an increase in the national ADAP budget, according to the ninth annual N


Insmed Initiates Phase II HIV-Associated Lipodystrophy Trial With Somatokine(R)
PRNewswire - April 20, 2005
RICHMOND, Va., April 20 /PRNewswire-FirstCall/ -- Insmed Incorporated (Nasdaq: INSM) today announced that it has initiated a Phase II clinical trial examining the therapeutic benefit of treating HIV-Associated Lipodystrophy with SomatoKine(R), the Company s proprietary once daily IGF-I therapy. The Phase II clinical tr


Medical Device Manufacturer Pleads Guilty to Conspiring to Disseminate Adulterated Computer Software Device, Reports U.S. Attorney
PRNewswire - April 19, 2005
BOSTON, April 19 /PRNewswire/ -- A Michigan medical device manufacturer and its President pleaded guilty today in federal court to conspiring with others to disseminate adulterated computer software devices for use in interpreting test results in order to promote diagnoses of AIDS wasting and to increase sales of an AI


California HIV Reporting Bill SB 945 (Soto, D-Ontario) Up in Senate Health Committee Wednesday, April 20th
PRNewswire - April 19, 2005
-- Bill Would Increase Understanding of HIV/AIDS; Lead to Improved Allocation of Federal Ryan White Funding -- Growing Statewide Coalition of Government, Health, HIV/AIDS, Consumer and Community Organizations Supports Measure Sponsored by Los Angeles County, AIDS Healthcare Foundation and the Health Officers Associatio


California HIV Reporting Bill Would Increase Understanding of HIV/AIDS; Lead to Improved Allocation of Federal Ryan White Funding
PRNewswire - April 19, 2005
-- SB 945 (Soto, D-Ontario) Up in Senate Health Committee Wednesday, April 20th -- Growing Statewide Coalition of Government, Health, HIV/AIDS, Consumer and Community Organizations Supports Measure Sponsored by Los Angeles County, AIDS Healthcare Foundation and the Health Officers Association of California SACRAMENTO,


College Students Lead Efforts to Fight STDs and AIDS on Historically Black College and University Campuses
PRNewswire - April 18, 2005
-- St. Augustine Falcons to Wear Got AIDS? T-Shirts on Campus -- Effort is in Conjunction With National STD Awareness Month LOS ANGELES, April 18 /PRNewswire/ -- April is National STD Awareness month in the U.S. In response to the growing number of new sexually transmitted disease (STD) infections among Black college s


AHF Says Serono Must be Held Accountable Over Bribery Scandal Involving AIDS Wasting Drug, Serostim
PRNewswire - April 18, 2005
-- As Justice Department Indicts Four Former Executives of Swiss Biotech Company, US Largest AIDS Group Says Company Itself Must Also be Held Accountable LOS ANGELES, April 18 /PRNewswire/ -- As four former executives for the Swiss biotechnology company, Serono, were indicted by the United States Department of Just


Congress Members Ron Dellums (Ret.) and Diane Watson (D-CA) Join Entertainer Sheryl Lee Ralph and 'Divas Simply Singing' in 'Celebrating Carl Bean House!'
PRNewswire - April 15, 2005
-- As Funding Cuts Threaten AHF s West Adams AIDS Care Center, Community Gathers to Celebrate State-of-the-Art Health Facility Offering South L.A. Residents Improved Access to Quality Care, Services What: Community reception at West Adams AIDS center Celebrating Carl Bean House! When: Saturday, April 16, 1:00pm to 4:00


Research and Markets: View This In-Depth Overview and Case Record of the Main Approaches to HIV Vaccine Research and Development
PRNewswire - April 15, 2005
DUBLIN, Ireland , April 15 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/reports/c15870 ) has announced the addition of Stakeholder Opinions: HIV Vaccines - The Emperor Has No Clothes to their offering. In December 2004, 35.9 - 44.3 million individuals were currently living with HIV/AIDS.


Results From Phase I HIV Vaccine Study Reported at Keystone Symposium
PRNewswire - April 15, 2005
GAITHERSBURG, Md., April 15 /PRNewswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC) announced that safety and immune response data were presented from the first of several ongoing Phase I clinical trials involving an HIV vaccine candidate developed jointly by GenVec and the Vaccine Research Center (VRC) of the National I


New Data on Most Prescribed Hepatitis C Therapy Pegasys(R) Presented at European Association for the Study of the Liver (EASL) Conference
PRNewswire - April 15, 2005
-- Roche continues pioneering research to enhance treatment for hepatitis C patients PARIS, April 15 /PRNewswire/ -- New Pegasys(R) (peginterferon alfa-2a) data, including exploration of factors associated with treatment response in hepatitis C patients, were revealed in 33 oral and poster presentations at the 40th Ann


Former Executives for Serono, Inc. Charged with Conspiracy and Offering Kickbacks to Doctors
PRNewswire - April 14, 2005
BOSTON, April 14 /PRNewswire/ -- Four former top executives in sales and marketing for Serono Laboratories, Inc. were indicted today by a federal grand jury in connection with a conspiracy to offer and pay kickbacks to doctors in the form of an all expenses paid trip for the doctors and their guests to attend a medical


AIDS Action Committee's 20th Annual AIDS Pledge Walk, 'From All Walks of Life,' Revives Theme and Former Route
PRNewswire - April 14, 2005
-- New Post-Walk Health Fair to be Added to Sun., June 5 Festivities BOSTON, April 14 /PRNewswire/ -- The need to raise awareness and funds to stop the spread of HIV/AIDS and support those living with the disease is as paramount today as it was 20 years ago, when AIDS Action Committee (AAC) held its first AIDS Walk in


Bush Administration Must Fight Brazil on Theft of Drug Patents: ACU Finds Brazil Spent 60% More on Aerospace Subsidies Last Year Than on Its Own AIDS Program
PRNewswire - April 14, 2005
ALEXANDRIA, Va., April 14 /PRNewswire/ -- The American Conservative Union, the nation s oldest and largest grassroots conservative organization, is calling upon the Bush administration to take action and prevent Brazil from stealing patents from three American pharmaceutical companies on the grounds of a national emer


Abbott Fund and Baylor College of Medicine Partner to Create the First International Network of Centers Treating Children With HIV
PRNewswire - April 14, 2005
HOUSTON and ABBOTT PARK, Ill., April 14 /PRNewswire-FirstCall/ -- To address the growing need for care and treatment of children with HIV/AIDS in the developing world, Baylor College of Medicine announced today that it has received a grant from the Abbott Fund s Step Forward program to link Baylor s individual pediatri


News Conference to Announce Musical Artists Joining Elton John for July 4 Philadelphia Freedom Concert & Ball
PRNewswire - April 14, 2005
PHILADELPHIA, April 14 /PRNewswire/ -- Who will be joining headliner Sir Elton John on July 4 for the Philadelphia Freedom Concert and Ball? Momentum is building and stars are lining up to join this historic effort -- shaping up to be the largest outdoor HIV/AIDS awareness event ever -- to raise two million dollars for


23 Sub-Saharan African Countries Need Food Assistance: HIV/AIDS Pandemic Contributes to Food Insecurity
PRNewswire - April 13, 2005
WASHINGTON and ROME, April 13 /PRNewswire/ -- Some 23 countries* in sub- Saharan Africa will need food assistance in the coming months, according to the Africa Report, which FAO released today. The causes range from civil strife and war to adverse weather and economic disruption. The Africa Report is a regional and cou


Ugandan Minister, Advisor to Ugandan 1st Lady Testifies Before Congress: USAID is Undermining Lifesaving Efforts in His Country
PRNewswire - April 13, 2005
WASHINGTON, April 13 /PRNewswire/ -- The following is being issued by Gerard Health Foundation: Rev. Martin Ssempa, director of the Makerere Youth Ministry in Uganda and Special Representative to the First Lady of Uganda s Task Force on AIDS, today told Congress that USAID and CDC are failing to support the indigenous


Children's AIDS Fund Commends Progress, Urges Faster Implementation of President's AIDS Initiative as House Holds Hearings
PRNewswire - April 13, 2005
WASHINGTON, April 13 /PRNewswire/ -- The President s Emergency Plan for AIDS Relief (PEPFAR) -- is making a real difference in the lives of Africans. We see more progress every time we travel to Africa. We hope that the important hearings being held today by the House International Relations Committee will spur even fu


Report: Seven Percent of Tanzanians Infected with HIV; Rate Reaches as High as 13 Percent in Some Urban Areas
PRNewswire - April 13, 2005
DAR ES SALAAM, Tanzania , April 13 /PRNewswire/ -- Tanzania continues to battle high HIV infection rates with 7 percent of adult men and women now infected, according to the new Tanzania HIV/AIDS Indicator Survey (THIS). Prevalence is as high as 13 percent in some urban areas. The 2003-2004 Tanzania HIV/AIDS Indicator


People's Republic of China Signs an Historic Pact With Safe Blood International(TM) Foundation to Fight Against Spread Of HIV/AIDS
PRNewswire - April 12, 2005
-- Framework Agreement Creates Safe Blood for China (TM) Foundation to Help Establish a Safe Blood Supply in China BEIJING, April 12 /PRNewswire/ -- In an important step to help combat the spread of HIV/AIDS in China, The People s Republic of China s Ministry of Health signed a groundbreaking framework agreement with W


Lipid Sciences, Inc. Presents Latest Viral Immunotherapy Data at Keystone Symposium
PRNewswire - April 12, 2005
PLEASANTON, Calif., April 12 /PRNewswire-FirstCall/ -- Lipid Sciences, Inc. (Nasdaq: LIPD), announced that the latest results of both in vivo and in vitro studies supporting the Company s Viral Immunotherapy Platform have been presented at the Keystone Symposium, HIV Vaccines: Current Challenges and Future Prospects.


HIV Treatment-Experienced Patients Set High Standards for Therapy Success: New amfAR Survey Results Underscore Importance of Patient-Doctor Discussions on Treatment Goals and Available Options
PRNewswire - April 11, 2005
OAKLAND, Calif., April 11 /PRNewswire/ -- Patients who have previously failed at least two anti-HIV regimens continue to have high standards for their treatment success, according to a survey commissioned by the American Foundation for AIDS Research (amfAR). The survey results emphasize the need for patients to discuss


Medical Services Awarded Additional $25 Million Contract for its VScan HIV Test Kits
PRNewswire - April 10, 2005
EDMONTON, Alberta, April 10 /PRNewswire-FirstCall/ -- Medical Services International Inc. announced today that it has been awarded a US$25 million contract from the Federal Government of Nigeria for its VScan HIV 1&2 Test Kits. The Government of Nigeria recently issued a tender notice for eligible companies to subm


ABC to Re-Broadcast 'Extreme Makeover: Home Edition' Episode Showing How KB Home Built Dream Home for Deserving Broadbent Family
PRNewswire - April 7, 2005
-- Network to Also Air Behind-the-Scenes Footage in How d They Do That? LOS ANGELES, April 7 /PRNewswire-FirstCall/ -- Fans of ABC s hit show Extreme Makeover: Home Edition will have another chance to see how KB Home (NYSE: KBH), one of America s largest homebuilders, rebuilt a home for a deserving Las Vegas family in


Bristol-Myers Squibb Joins RDI in Combating HIV Drug Resistance
PRNewswire - April 7, 2005
LONDON, April 7 /PRNewswire/ -- The HIV Resistance Response Database Initiative (RDI) announced today that Bristol-Myers Squibb , a leading research-based pharmaceutical company in the HIV/AIDS field, has joined its Corporate Sponsorship program for 2005. Under the terms of the agreement Bristol-Myers Squibb is a Corpo


Expanded Initiative to Prevent Mother-to-Child Transmission of HIV Expects to Reach 200,000 Women in Seven Nations
PRNewswire - April 7, 2005
-- Elizabeth Glaser Pediatric AIDS Foundation and Johnson & Johnson Partner to Make Every Child Count on World Health Organization s World Health Day 2005 WASHINGTON, April 7 /PRNewswire/ -- The Elizabeth Glaser Pediatric AIDS Foundation today announced a $1.25 million partnership with Johnson & Johnson to init


AIDS in Africa - Integrating HIV Prevention and Care in Africa: Existing Challenges and Innovative Solutions
PRNewswire - April 6, 2005
LOS ANGELES, April 6 /PRNewswire/ -- On April 15, 2005 the UCLA AIDS Institute will host a full day symposium on AIDS in Africa entitled Integrating HIV Prevention and Care in Africa: Existing Challenges and Innovative Solutions. The Honorable Stephen Lewis, United Nations Special Envoy HIV/AIDS in Africa and Laurie Ga


Sangamo BioSciences Announces Publication in Nature Demonstrating the Use of Its Zinc Finger Technology to Correct Human Genes
PRNewswire - April 4, 2005
-- Paper Describes Approach for Genome Editing That May Lead to Potential Treatment for Monogenic Diseases and HIV/AIDS RICHMOND, Calif., April 4 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced publication of data that demonstrates the use of the Company s zinc finger DNA-binding prot


Federal Court Rules Glaxo's CEO Must Answer Questions in AIDS Drug Patent Piracy Case, Reports AHF
PRNewswire - April 4, 2005
-- Magistrate Judge Rules in Favor of AHF s Motion to Compel Glaxo CEO Jean- Pierre Garnier to Continue Deposition in AIDS Group s Action Against British Drug Giant Over AZT Patent LOS ANGELES, April 4 /PRNewswire/ -- A California federal court has ruled that GlaxoSmithKline s (GSK) Chief Executive Officer, Jean-Pierre


New Web Resource on HIV/AIDS, TB and Malaria: GlobalHealthReporting.org Helps Journalists and Others Stay Up-to-Date on the Latest News, Reports, and Data
PRNewswire - March 31, 2005
MENLO PARK, Calif., March 31 /PRNewswire/ -- Updated daily with the latest information on HIV/AIDS, tuberculosis (TB), and malaria, the new Web site GlobalHealthReporting.org offers an easy and efficient way to stay on top of breaking news, new reports and data, and events from around the world. This free site is opera


Pamela Anderson is the Next Spokesperson and Newest Face for the M.A.C AIDS Fund's VIVA GLAM V Lipstick Advertising Campaign
PRNewswire - March 31, 2005
-- Anderson Joins A-List Team of Spokespeople, Christina Aguilera, Missy Elliott, Linda Evangelista and Chloe Sevigny to raise awareness and funds for people living with HIV/AIDS -- The New VIVA GLAM Icon will advocate the M.A.C AIDS Fund call-to-action of Get Tested NEW YORK, March 31 /PRNewswire/ -- The M.A.C AIDS Fu


Green Light for ThGRF in Phase IIIGreen Light for ThGRF in Phase III
PRNewswire - March 31, 2005
MONTREAL, March 31 /PRNewswire-FirstCall/ - Theratechnologies (TSX: TH) reports on a positive meeting with the Food and Drug Administration ( FDA ) in the United States held on March 30, 2005. The purpose of the meeting was to discuss the Company s plans for late-stage development of ThGRF (TH9507) in HIV-associated li


Advanced Biological Laboratories SA (ABL, S.A) Licenses Stanford HIV Resistance Interpretation Algorithm - Adds to ViroScore Suite Genetic Sequence Database and Analysis Engine
PRNewswire - March 30, 2005
-- ABL to integrate the Stanford Algorithm with the 5 algorithms currently used in its global resistance interpretation report offered in the ViroScore Suite Diagnostic Product TOPSFIELD, Mass., March 30 /PRNewswire/ -- ABL, SA (A Luxembourg Company) with TherapyEdge Inc. (Durham, NC) today announced it had signed a l


Human Genome Sciences Begins Dosing of Patients in a Phase 1 Clinical Trial of CCR5 mAb in Patients Infected With HIV-1
PRNewswire - March 30, 2005
ROCKVILLE, Md., March 30 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) announced today that it has begun dosing patients in a Phase 1 clinical trial to evaluate the safety, tolerability and pharmacology of CCR5 mAb in patients who are infected with HIV-1, the retrovirus that causes acquired immun


Magic Johnson to Dedicate & Tour AHF's Jacksonville HIV Clinic Named in His Honor
PRNewswire - March 29, 2005
-- State-of-the-Art AIDS Healthcare Foundation Center Offers Northeast Florida Residents Improved Access to Quality Care, Services JACKSONVILLE, Fla., March 29 /PRNewswire/ -- What: Magic Johnson to dedicate & tour Jacksonville HIV clinic named in his honor When: Thursday, March 31st 11am Where: AHF s Magic


Chart-Topping Musicians Provide Beacon of Hope to African AIDS Crisis
PRNewswire - March 25, 2005
-- Jars of Clay, The Chuck Davis African American Dance Ensemble and others to perform fund-raising concert April 16 in downtown Durham, NC DURHAM, N.C., March 25 /PRNewswire/ -- A Saturday afternoon listening to chart-topping musicians and local artists in downtown Durham will provide a beacon of hope to women and orp


Sanofi-aventis Joins the Fight Against Tuberculosis in South Africa
PRNewswire - March 24, 2005
-- Partnership with the Nelson Mandela Foundation and the South African Department of Health -- THE TB FREE PROGRAM for the Treatment of Tuberculosis Sufferers JOHANNESBURG, South Africa, March 24 /PRNewswire-FirstCall/ -- In Johannesburg today, South African Health Minister Dr. Manto Tshabalala-Msimang and sanofi-aven


AIDS Treatment Numbers Claimed by PEPFAR Are Still Far Below Congress' Goals, Says AHF
PRNewswire - March 24, 2005
AHF Says President Bush s Ambitious $5B Global AIDS Program Placed 155,000 People on Treatment Support - Just 8% of Goal of Two Million on Life-saving Treatment. Report to Congress Shows 67,000 on ARVs Via US Funding - Barely 3% of Emergency Plan s Target. LOS ANGELES, March 24 /PRNewswire-FirstCall/ -- AIDS Healthcare


AHF Decries Passage of Bill by India's Upper House of Parliament Prohibiting Production of Generic Versions of Patented Drugs, Urges Ongoing Access to Cheaper ARVs for Africa and the Rest of the World
PRNewswire - March 24, 2005
LOS ANGELES, March 24 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the largest AIDS organization in the US which operates free AIDS treatment clinics in the US, Africa, Central America and Asia -- including one clinic in Mysore, India -- today decried the passage of a bill by India s upper house of parliament that


LA City Council Votes in Favor of Motion to Regulate Commercial Sex Venues in Los Angeles
PRNewswire - March 24, 2005
-- AIDS Healthcare Foundation Praises City Council Support of Ordinance to Increase Regulations at Los Angeles Bathhouses & Sex Clubs. Ordinance, Which Is Intended to Improve Testing & Prevention Services at Venues, Must Go Before Mayor for Approval Before Returning to LA County Officials. LOS ANGELES, March 24


US' Largest AIDS Group Seeks Improved Access to Life-Saving AIDS Drugs in Mexico
PRNewswire - March 23, 2005
-- As US & Mexican Presidents Conclude NAFTA Meeting in Texas Today, AIDS Healthcare Foundation Urges Reconsideration of Patent Laws That Severely Restrict Access to Anti-Retroviral AIDS Drugs. To Enter into NAFTA, Mexico Strengthened Its Patent Laws, and Now Few Can Access AIDS Drugs Due to High Costs and Limited


Ranbaxy HIV Update -- March 2005
PRNewswire - March 23, 2005
PRINCETON, N.J., March 23 /PRNewswire/ -- Ranbaxy Laboratories Limited (RLL) announced today that the Company has made two additional filings of its Anti-Retroviral (ARV) agents with the World Health Organization (WHO) for its approval, taking the total number of Ranbaxy ARV filings submitted with the WHO to five.


Research and Markets: View This Detailed Examination of the HIV Antiretrovirals Market Today
PRNewswire - March 23, 2005
DUBLIN, Ireland , March 23 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/reports/c14506) has announced the addition of HIV -- Benchmarking Rapid Antiretroviral Uptake to their offering. Historically, HIV antiretrovirals have differed markedly in their speed of market uptake.


Juvaris Announces Collaboration With the International AIDS Vaccine Initiative (IAVI)
PRNewswire - March 23, 2005
PLEASANTON, Calif., March 23 /PRNewswire/ -- Juvaris BioTherapeutics Inc., a private biotechnology company, today announced a research collaboration with the International AIDS Vaccine Initiative (IAVI) to use Juvaris immunostimulant technology in the screening of Human Immunodeficiency Virus (HIV) vaccine candidates.


Procyon Reports First Pharmacokinetic Results for its HIV Protease Inhibitor, PPL-100
PRNewswire - March 23, 2005
-- The Company to Present the Latest Cross-Resistance and Pharmacokinetic Profiling Data at the 6th International Workshop on Clinical Pharmacology of HIV Therapy TICKER: PBP (TSX) MONTREAL, March 23 /PRNewswire-FirstCall/ - Procyon Biopharma Inc. (TSX:PBP) reported today the first pharmacokinetics results with PPL-100


Promising Results Reported for HIV Patients Suffering From Facial Wasting
PRNewswire - March 22, 2005
-- Success of Radiesse(TM) Facial Wasting Treatment Trial Means Potential Physical and Psychological Benefits for Many Infected With HIV NEW YORK, March 22 /PRNewswire/ -- Physicians from leading plastic surgery and dermatology practices report positive results from HIV patients participating in a clinical trial of Rad


Bristol-Myers Squibb Extends Assistance to State AIDS Drug Assistance Programs: Two-Year Agreement Will Provide an Additional $60 Million to Assist Struggling Programs
PRNewswire - March 22, 2005
PRINCETON, N.J., March 22 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company (NYSE: BMY) today announced the company will extend its relief efforts for two more years to the state-administered AIDS Drug Assistance Programs (ADAPs) to help address the funding crisis the programs face. Bristol-Myers Squibb has provid


New Partnership to Address Unique and Growing Needs of Women and Families Affected by HIV/AIDS: National AIDS Fund and Johnson & Johnson grant awards to U.S. groups
PRNewswire - March 22, 2005
WASHINGTON, March 22 /PRNewswire/ -- In response to an alarming increase in rates of HIV/AIDS infection among women in the United States , the National AIDS Fund and Johnson & Johnson have formed a partnership to address the unique needs of women and families whose lives have been impacted by the physical, emotiona


U.S. Government Should Revoke Preferred Trade Status for Brazil: Recent Decision to Break Patents on AIDS Drugs Another Sign of Brazil's Contempt for Intellectual Property Rights
PRNewswire - March 21, 2005
WASHINGTON, March 21 /PRNewswire/ -- Defenders of Property Rights today announced plans to petition Acting U.S. Trade Representative, Peter Allgeier, to revoke Brazil s preferred trade status with the United States , otherwise known as the Generalized System of Preferences. The United States is reviewing Brazil s GSP s


TB Alliance and GlaxoSmithKline Launch Broad Discovery Portfolio to Develop New TB Therapies: Program Commits to Affordable Pricing
PRNewswire - March 21, 2005
NEW YORK and LONDON, March 21 /PRNewswire/ -- The Global Alliance for TB Drug Development (TB Alliance) and GlaxoSmithKline (FTSE/NYSE: GSK) announced today they will pursue a joint drug discovery program to improve the treatment of tuberculosis (TB). The program substantially enhances the worldwide TB drug pipeline by


ViroLogic's Phenosense Assay Shown Superior to Virco's Antivirogram: Study Published in JAIDS Finds PhenoSense HIV More Precise Than Antivirogram and Better at Detecting Resistance to Nucleoside Reverse Transcriptase Inhibitors
PRNewswire - March 21, 2005
SOUTH SAN FRANCISCO, Calif., March 21 /PRNewswire-FirstCall/ -- ViroLogic, Inc. (Nasdaq: VLGC) today announced the publication of results from an independent study that compared the precision and sensitivity of its widely used HIV drug resistance assay PhenoSense(TM) HIV with Antivirogram(R), developed by Virco BVBA. R


Roche Announces New Study to Evaluate Pegasys and Copegus to Treat Hepatitis C in Liver Transplant Patients
PRNewswire - March 21, 2005
-- Hepatitis C is the Leading Cause of Liver Transplantation in U.S. NUTLEY, N.J., March 21 /PRNewswire/ -- Roche has initiated a new study to evaluate treatment strategies to reduce post-transplant recurrence of hepatitis C infection with the most prescribed hepatitis C treatment combination in the U.S., Pegasys(R) (p


AIDS Advocates Score Major Victory in US Senate
PRNewswire - March 18, 2005
WASHINGTON, March 18 /PRNewswire/ -- Yesterday the US Senate approved an amendment to the Budget Resolution that increased funds available to the Global Fund from $300 million to $800 million for FY 2006. The amendment was sponsored by Senators Durbin (D-IL) and Santorum (R-PA). The Fund is a cost- effective, democracy


India Designated 16th Country in President Bush's Emergency Plan for HIV/AIDS Relief (PEPFAR) Funds
PRNewswire - March 18, 2005
WASHINGTON, March 18 /PRNewswire/ -- On March 17, 2005, separate House and Senate bills designated India as the 16th country to receive President Bush s Emergency Plan for HIV/AIDS Relief (PEPFAR) funds. The House bill was sponsored by Representatives Lee (D-TX), Leach (R-IA), Ackerman (D-NY), Ros-Lehtinen (R-FL), Fale


AIDS Action Committee to Open a New Drop In Center in the South End: Establishes multicultural, comprehensive wellness and HIV prevention center for gay/bi/same-gender-loving men in Boston
PRNewswire - March 16, 2005
BOSTON, Mar. 16 /PRNewswire/ -- In April, AIDS Action Committee of Massachusetts, Inc. (AAC) will open a new multicultural, comprehensive wellness and HIV prevention center for gay, bisexual and same gender-loving men in Boston called the MALE or Men s Action Life Empowerment Center at 571 Columbus Avenue in the South


AnorMED initiates enrollment into phase I/II study for new HIV entry inhibitor
PRNewswire - March 16, 2005
VANCOUVER, March 16 /PRNewswire-FirstCall/ - AnorMED Inc. (TSX:AOM) announced today initiation of enrollment into a Phase Ib/IIa trial to evaluate the potential of AMD070, an oral CXCR4 HIV entry inhibitor, in HIV-infected patients. The Company s clinical program for AMD070 is being conducted by leading investigators a


FDA Approves Roche's COBAS AmpliScreen Hepatitis C and HIV-1 Tests To Improve Safety of Organ and Tissue Donations
PRNewswire - March 16, 2005
-- FDA expands use beyond blood screening and source plasma - test for use in screening cadaveric donors INDIANAPOLIS, March 16 /PRNewswire/ -- Today, Roche Diagnostics announced that the United States Food and Drug Administration (FDA) approved its COBAS AmpliScreen HIV-1 and Hepatitis C (HCV) Tests to screen cadaveri


Viral Genetics, Inc. Completes Patient Enrollment for South African Phase III Trial of VGV-1 for the Treatment of HIV-1
PRNewswire - March 15, 2005
AZUSA, Calif., March 15 /PRNewswire-FirstCall/ -- Viral Genetics, Inc. (OTC Bulletin Board: VRAL), a drug development company developing a biological therapy for the treatment of HIV infection, announced today that it has completed patient enrollment in its South African Phase III trial of VGV-1 for the treatment of HI


New Study Reveals Little Risk in Insuring HIV Positive Patients in Holland
PRNewswire - March 15, 2005
-- Dutch Association of Insurers Member Companies Begin Offering Life Insurance Policies to Patients Receiving Highly Active Antiretroviral Therapy AMSTERDAM, The Netherlands , March 15 /PRNewswire/ -- The Dutch Association of Insurers has announced the results of a study revealing there is little risk in providing lif


TNX-355 Among Select HIV Viral Entry Inhibitors Featured at European Drug Discovery Conference: Drug Discovery Case History to Be Presented
PRNewswire - March 14, 2005
HOUSTON, March 14 /PRNewswire-FirstCall/ -- Tanox s (Nasdaq: TNOX) first- in-class CD4 antagonist, TNX-355, for the treatment of HIV/AIDS is among five human immunodeficiency viral entry inhibitors to be discussed at the Drug Discovery Technology Europe Conference in London, March 14-17, 2005. In a session titled Drug


Tanox Completes Enrollment of TNX-355 Phase 2 Clinical Trial for the Treatment of HIV
PRNewswire - March 9, 2005
HOUSTON, March 9 /PRNewswire-FirstCall/ -- Tanox, Inc. (Nasdaq: TNOX) has completed enrollment in its Phase 2 clinical trial of TNX-355 for the treatment of the human immunodeficiency virus (HIV). The study, which has enrolled the target of 80 patients, is being conducted at 30 sites in the United States ,


Abbott Fund, Baylor College of Medicine and the Government of Malawi to Build New Clinic for HIV-Infected children
PRNewswire - Wednesday March 9, 2005
LILONGWE, Malawi , March 9 /PRNewswire-FirstCall/ -- The Abbott Fund, Baylor College of Medicine and the Government of Malawi have announced they will partner in the establishment of Malawi s first center dedicated to providing care and treatment for children with HIV/AIDS. Construction of the new clinic on the Kamuzu


Global Coalition on Women and AIDS Hosts Congressional Briefing on International Women's Day
PRNewswire - March 8, 2005
-- Women and AIDS U.S. Tour: Empower Women, Save Lives takes part in Leadership Breakfast and Congressional Briefing with Senator Hillary Rodham Clinton, Senator Orrin Hatch and Ambassador Randall Tobias. WASHINGTON, March 8 /PRNewswire/ -- In response to the growing women and AIDS crisis, the UNAIDS-led Global Coaliti


South African Tribunal Asks for Damages Estimates in GSK AIDS Drug Case, Says AHF
PRNewswire - March 8, 2005
-- Competition Tribunal s Latest Action Allows Complaint Filed by South African AIDS Advocates & AIDS Healthcare Foundation to Proceed DURBAN, South Africa and LOS ANGELES, March 8 /PRNewswire/ -- A landmark South African legal complaint against British drug maker GlaxoSmithKline (GSK) over its AIDS drug pricing an


MedMira Wins Government Tender for Rapid HIV Test in China: MiraWell(R) Rapid HIV Test Selected Based on Quality and Performance
PRNewswire - March 7, 2005
HALIFAX, March 7 /PRNewswire-FirstCall/ - MedMira Inc., ( MedMira ) (TSX Venture: MIR, NASDAQ:MMIRF) the global market leader in rapid flow-through diagnostic technology, announced today that it has won the first rapid HIV test tender in the province of Jilin in the People s Republic of China. The tender is structured


Calypte Biomedical Issues Update on China Clinical Trial Program
PRNewswire - March 7, 2005
PLEASANTON, Calif., March 7 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (Amex: HIV) today announced a progress report on the Chinese clinical trial program of its rapid HIV-1/2 tests in The Peoples Republic of China (China). The ongoing trials are evaluating the sensitivity and specificity of the Company s


The Balm In Gilead, Inc.(TM) Mobilizes 16th Annual Black Church Week of Prayer for the Healing of AIDS March 6-12, 2005
PRNewswire - March 3, 2005
-- Congressman Mel Watt, National Medical Association s Dr. Winston Price, Journalist George Curry, Gospel Legend Bobby Jones and National Nurses Association Dr. Betty Lewis Lead Thousands of Churches in Nation s Largest AIDS Awareness Campaign Targeting African Americans NEW YORK, March 3 /PRNewswire/ -- Next week, th


Cellegy Announces 50% Enrollment in Phase 3 HIV Prevention Trial in Ghana
PRNewswire - March 3, 2005
SOUTH SAN FRANCISCO, Calif., March 3 /PRNewswire-FirstCall/ -- Cellegy Pharmaceuticals, Inc. (Nasdaq: CLGY) announced today that 50% enrollment has been achieved in the Savvy(R) (C31G vaginal gel) Phase 3 HIV prevention trial in Ghana based on current projected enrollment. This is a significant milestone reflecting the


College Media Gurus Garner Exceptional Placement Rate for HIV Awareness PSA
PRNewswire - March 3, 2005
-- Campus Media Group Delivers amfAR 14 Percent Hit Rate for Ads Targeting Fast Growing Group of HIV Victims: College-Age Women ST. PAUL, Minn., March 3 /PRNewswire/ -- In an annual effort to provide pro-bono services to one non-profit organization, Campus Media Group (CMG) has chosen the American Foundation for AIDS R


MedMira Presents World's First OTC Rapid HIV Test to International Conference
PRNewswire - March 2, 2005
-- MiraCare(TM) Rapid HIV Test Shows 100% Agreement in Independent Evaluation HALIFAX, March 2 /PRNewswire-FirstCall/ - MedMira Inc., ( MedMira ) (TSX Venture: MIR, NASDAQ:MMIRF) the global market leader in rapid flow-through diagnostic technology, announced today that it had presented its MiraCare(TM) rapid, over-the-


HHS Awards Almost $1.7 Billion for HIV/AIDS Care
PRNewswire - March 2, 2005
WASHINGTON, March 2 /PRNewswire/ -- HHS Secretary Mike Leavitt today announced 174 grants worth nearly $1.7 billion to help all 50 states, nine U.S. territories, 51 cities hit hard by HIV/AIDS, and 64 community-based organizations provide essential services to low-income residents living with HIV/AIDS. The Fiscal Year


LA County Threatens Closure of Only AIDS Hospice
PRNewswire - March 1, 2005
-- State-of-the-Art AIDS Healthcare Foundation Center Offers South LA and West Adams Residents Improved Access to Quality Care, Services What: Media Availability After the Board of Supervisors action on meeting agenda item #15 -- Possible $1.1M L.A. County Funding Cut Would Likely Force Closure of West Adams AIDS Hospi


New Data Presented at Major AIDS Meeting Show FUZEON Plus an Active Protease Inhibitor Provides Maximal HIV Suppression in Treatment Experienced Patients
PRNewswire - March 1, 2005
-- Large Trials of Investigational Drugs Support Powerful Treatment Strategy for Triple-Class Experienced Patients BOSTON, March 1 /PRNewswire-FirstCall/ -- Patients previously treated with three classes of antiretrovirals can achieve maximal viral suppression when starting a regimen of FUZEON(R) (


Sangamo BioSciences Announces presentation of Data from HIV Program at 12th Conference on Retroviruses and Opportunistic Infections
PRNewswire - March 1, 2005
RICHMOND, Calif., March 1 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced that data from their program to develop a treatment for HIV infection was presented at the 12th Conference on Retroviruses and Opportunistic Infections held in Boston last week. The data describe the use of Sang


Global Coalition on Women and AIDS Announces 5-City U.S. Tour: The Women and AIDS U.S. Tour: Empower Women, Save Lives - to Highlight AIDS Efforts that Work for Women and Girls
PRNewswire - March 1, 2005
-- UNAIDS , M.A.C AIDS Fund, United Nations Foundation, World Vision Sponsoring Unprecedented Tour -- Launches in NYC March 2. Stops in Nashville, Miami and Chicago. Ends on International Women s Day -- March 8 in Washington, D.C. NEW YORK, March 1 /PRNewswire/ -- In response to the growing women and AIDS crisis, the U


AIDS Action and AIDS Project Rhode Island Forge New Partnership
PRNewswire - March 1, 2005
-- AAC Hotlines Program adds RI calls today; Expansion Includes Volunteer Training, Crystal Meth Education and Outreach and Gay Men s Prevention Initiatives BOSTON, March 1 /PRNewswire/ -- AIDS Action Committee of Massachusetts, Inc.(AAC) and AIDS Project Rhode Island (APRI) created a new partnership effective immediat


Medical Services Goes Retail in Peru
PRNewswire - February 28, 2005
EDMONTON, Alberta, Feb. 28 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pinksheets: MSITF) is pleased to announce that through a major pharmaceutical company with significant retail capability in Peru , that the VScan HIV test kit will now be available on a retail basis in the pharmaceutical company s


Novel HIV Gene Therapy Yields Exciting Results in Phase I Clinical Trial
PRNewswire - February 28, 2005
GAITHERSBURG, Md., Feb. 28 /PRNewswire/ -- VIRxSYS Corporation, a private biotechnology company focused on the development of gene therapy treatments for diseases such as HIV/AIDS and cancer, reports unexpected and unprecedented findings in its ongoing Phase I clinical trial of its VRX496 therapy in patients with HIV.


Panacos Pharmaceuticals Presents Data at Retrovirus Conference Showing Potent Activity of Drug Candidate PA-457 Following a Single Oral Dose in HIV-infected Patients
PRNewswire - February 28, 2005
-- Company Makes Additional Presentations on PA-457 at Conference GAITHERSBURG, Md., Feb. 28 /PRNewswire/ -- Panacos Pharmaceuticals, Inc., today announced that it has provided detailed results from a positive Phase I/II clinical trial of its HIV drug candidate PA-457 at the 12th Conference on Retroviruses and Opportun


Studies Highlight Utility of Virologic Assays in HIV Management at 12th Conference on Retroviruses and Opportunistic Infections
PRNewswire - February 28, 2005
SOUTH SAN FRANCISCO, Calif., Feb. 28 /PRNewswire-FirstCall/ -- ViroLogic, Inc. (Nasdaq: VLGC) announced today that 20 presentations related to its sophisticated tests characterizing replication capacity (RC), viral tropism, and phenotypic and genotypic resistance to anti-HIV drugs were made at the 12th Conference on Re


Kidney Dysfunction in HIV Patients May Be Detected Earlier Using Estimated GFR Compared to Measures of Serum Creatinine Only
PRNewswire - February 28, 2005
RESEARCH TRIANGLE PARK, N.C. -- Tracking the subtle kidney damage that can lead to chronic kidney disease in HIV patients is increasingly important as people survive longer and may have an increased risk of renal dysfunction as a result of their disease, therapy-related damage, or co-morbid conditions such as diabetes


Data on Investigational HIV Compounds Presented at CROI: Protease Inhibitor Studied in Patients with Limited Treatment Options
PRNewswire - February 25, 2005
BOSTON, Feb. 25 /PRNewswire/ -- Scientists from Tibotec Pharmaceuticals Ltd. presented data on several new compounds for the treatment of HIV/AIDS at the 12th Conference on Retroviruses and Opportunistic Infections (CROI), held February 22-25 in Boston, MA, USA. Tibotec presented interim Phase IIB results on TMC114, a


FDA Approves Pegasys and Copegus as Only Hepatitis C Treatment for HIV Patients: Pegasys combination offers the only FDA-approved option against a leading cause of death in people with HIV
PRNewswire - February 25, 2005
NUTLEY, N.J., Feb. 25 /PRNewswire/ -- Roche announced today that the U.S. Food and Drug Administration ( FDA ) has approved Pegasys(R) (peginterferon alfa-2a) and Copegus(R) (ribavirin, USP) for the treatment of chronic hepatitis C in patients coinfected with hepatitis C and HIV. Pegasys


FDA Approves First Ever Treatment for Hepatitis C in Patients with HIV: Pegasys and Copegus Combination Therapy Offers New Hope Against a Leading Cause of Death in People with HIV
PRNewswire - February 25, 2005
NEW YORK, Feb. 25 /PRNewswire/ -- ADDITIONAL RESOURCES: Video, hard copy requests, contact information and more available at http://www.prnewswire.com/broadcast/21317/consumer.shtml STORY SUMMARY: Roche announced today that the U.S. Food and Drug Administration ( FDA ) has approved the first and only hepatitis C treatm


Sun Microsystems Teams With Bono to Fulfill His Wish for One Million Voices to Join the ONE Campaign
PRNewswire - February 25, 2005
SANTA CLARA, Calif., Feb. 25 /PRNewswire-FirstCall/ -- Sun Microsystems, Inc. (Nasdaq: SUNW), today announced it will join Bono to electronically enlist legions of Americans into the ONE Campaign, a non-profit initiative launched by the singer and social activist to raise the voices of citizens to combat AIDS and pover


FDA Utilizes Pharsight Consultants During Model Development: Pharsight Supports FDA Modeling Efforts for End of Phase IIa Meetings End of Phase IIa Meetings Created as Part of Critical Path Initiative
PRNewswire - February 25, 2005
MOUNTAIN VIEW, Calif., Feb. 25 /PRNewswire-FirstCall/ -- Pharsight Corporation (OTC Bulletin Board: PHST), a leading provider of software and strategic services designed to optimize clinical drug development, announced today that the U.S. Food and Drug Administration ( FDA ) has utilized Pharsight s scientific input in


IMVAMUNE(TM) Vaccine - Protection Against Smallpox in 3 Days: Bavarian Nordic CEO Peter Wulff Presents Latest Developments of IMVAMUNE(TM) Smallpox Vaccine at BIO Conference
PRNewswire - February 24, 2005
WASHINGTON and COPENHAGEN, Denmark , Feb. 24 /PRNewswire/ -- IMVAMUNE(TM), a third-generation Modified Virus Ankara (MVA) vaccine under development by Bavarian Nordic of Denmark, is expected to be effective against smallpox three days after one vaccination compared to traditional replicating vaccines (i.


Discovery Channel Global Education Partnership Launches Learning Center in Soweto
PRNewswire - February 23, 2005
-- The Project s 29th Learning Center in South Africa Demonstrates Sustainability After Eight Years SILVER SPRING, Md., Feb. 23 /PRNewswire/ -- The Discovery Channel Global Education Partnership, a non-profit organization that helps under-resourced schools and communities around the world have access to the universe of


Marketing Strategies of Pharmaceutical Multinationals Exposed in South Africa
PRNewswire - February 23, 2005
CAPE TOWN, South Africa , Feb. 23 /PRNewswire/ -- The following release is being issued by The Dr. Rath Health Foundation Africa: As its unscrupulous business practices are being revealed in the United States and in other industrialized countries, the pharmaceutical industry is turning to the developing world to make u


Microsoft Scientists Search for Breakthroughs in HIV Vaccine Design
PRNewswire - February 23, 2005
-- Microsoft Collaborates With Leading Doctors and Scientists, Using Advanced Machine-Learning Techniques to Optimize HIV Vaccines BOSTON, Feb. 23 /PRNewswire-FirstCall/ -- Microsoft Research has pioneered promising new ways to combat one of humankind s most deadly viruses with advanced software typically used to analy


Mymetics Announces Completion of Debt Restructuring Agreements with MFC Bancorp Ltd.
PRNewswire - February 23, 2005
NYON, Switzerland , Feb. 23 /PRNewswire-FirstCall/ -- Mymetics Corporation ( Mymetics or the Company OTC Bulletin Board: MYMX) announced today that it has executed financing agreements with MFC Merchant Bank S.A. and MFC Bancorp Ltd. (collectively MFC ) to restructure the outstanding debt owed by Mymetics to MFC. U


Sangamo BioSciences Announces Presentation by Clinical Collaborator of Data at Major HIV Medical Conference
PRNewswire - February 23, 2005
RICHMOND, Calif., Feb. 23 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced that data from their program to develop a treatment for HIV infection will be presented by a clinical collaborator at a major medical conference this week. The data show that Sangamo s zinc finger DNA binding pr


Press Conference: India Could Cut Off Access to Generic AIDS Medication
PRNewswire - February 23, 2005
WASHINGTON, Feb. 23 /PRNewswire/ -- The following is being issued by the Global AIDS Alliance: What: A press briefing calling on the government of India to show greater leadership on HIV/AIDS. Experts on AIDS and international trade law will explain how India s latest actions will undermine global access to af


Advanced Biological Laboratories SA (ABL, SA) Acquires Majority Control of TherapyEdge Inc.; Acquisition Adds Key Biotech Patent and Related Products
PRNewswire - February 22, 2005
-- ABL to Integrate TherapyEdge-HIV Product Functionality into Existing Product Line and License IP to Leading Diagnostic and Laboratory Companies DURHAM, N.C., Feb. 22 /PRNewswire/ -- ABL, SA (A Luxembourg Company) acquired majority control of TherapyEdge Inc.(Durham, NC) and its strategic intellectual property (IP),


Targeted Genetics Announces Preliminary Safety Data From Phase I HIV Vaccine Trial
PRNewswire - February 22, 2005
SEATTLE, Feb. 22 /PRNewswire-FirstCall/ -- Targeted Genetics Corporation (Nasdaq: TGEN) today reported preliminary results from a Phase I trial of tgAAC09, an investigational recombinant adeno-associated viral vector (rAAV)-based HIV/AIDS vaccine candidate, enrolling healthy volunteers who are not infected with HIV. Th


Innovative HIV/STD Prevention Program Targets Risky Brief 'Marriages' in Rural Guinean Gold Mining Camps
PRNewswire - February 22, 2005
KANKAN, Guinea , Feb. 22 /PRNewswire/ -- A common, yet risky practice among gold miners in rural Guinea to engage in short marriages with women working briefly at the mine is the target of an innovative health communication program that educates both women and miners about how to prevent HIV and other sexually transmit


Benitec Announces NIH Funded AIDS Collaboration
PRNewswire - February 22, 2005
MOUNTAIN VIEW, Calif., Feb. 22 /PRNewswire/ -- Benitec Ltd. (ASX: BLT) today announced a collaboration with City of Hope (based in Duarte California) to develop a novel T-cell based therapy for AIDS patients. This collaboration will be the second HIV-related collaboration between Benitec and City of Hope and will be fu


Africa Gets Its MTV Today With the Launch of MTV Base: Pan-African Channel Puts African Artists in the Spotlight
PRNewswire - February 22, 2005
JOHANNESBURG, LONDON and NEW YORK, Feb. 22 /PRNewswire/ -- MTV Networks, a division of Viacom Inc. (NYSE: VIA and VIA.B), will today launch MTV base, MTV s first pan-African music television channel. MTV base goes live at 20:00 hrs CAT (Central African Time)/18:00 hrs GMT, beaming to a launch audience of 1.3 million ho


Bavarian Nordic Announces Further Investment in Smallpox Vaccine Production and Product Development in the U.S. and Europe
PRNewswire - February 22, 2005
WASHINGTON, and COPENHAGEN, Denmark , Feb. 22 /PRNewswire/ -- Bavarian Nordic announced that it will embark on further significant investments to extend production for its IMVAMUNE(TM) smallpox vaccine program, as well as accelerate product development activities in its smallpox, HIV and cancer vaccine programs in the


US Patent Granted to Cyclacel for Novel Cyclin Dependent Kinase Inhibitor Series
PRNewswire - February 18, 2005
DUNDEE, Scotland, Feb. 18 /PRNewswire/ -- Cyclacel Group plc ( Cyclacel ), the cell cycle-based biopharmaceutical company, announced today that it received a U.S. Patent (US6,531,479) covering a novel series of pyrimidine small molecules shown to control the progress of cells through the cancer cell cycle. One group of


Leaders From Politics, Medicine and Religion Join The Balm In Gilead, Inc.(TM) as National Co-Chairs of the 16th Annual Black Church Week of Prayer for the Healing of AIDS March 6-12, 2005
PRNewswire - February 17, 2005
-- Congressman Mel Watt, National Medical Association s Dr. Winston Price, Journalist George Curry, Gospel Legend Bobby Jones and National Nurses Association Dr. Betty Lewis Lead Thousands of Churches in Nation s Largest AIDS Awareness Campaign NEW YORK, Feb. 17 /PRNewswire/ -- Pernessa Seele, founder and CEO of The Ba


MedMira Rapid HIV Test Makes Steady Progress in OTC Market: 2nd Shipment of MiraCare(TM) Rapid HIV Test to Retail Pharmacies Completed
PRNewswire - February 17, 2005
HALIFAX, Feb. 17 /PRNewswire-FirstCall/ - MedMira Inc., ( MedMira ) (TSX Venture: MIR, NASDAQ: MMIRF) the global market leader in rapid flow-through diagnostic technology, announced today that it has completed a second shipment of its Over-The-Counter (OTC) MiraCare(TM) Rapid HIV Test (MiraCare(TM)) against a standing


TheraQuest Receives Orphan Drug Status for its Abuse Deterrent, Once-Daily Tramadol
PRNewswire - February 17, 2005
BLUE BELL, Pa., Feb. 17 /PRNewswire/ -- TheraQuest Biosciences, a development stage pain management company today announced that the FDA Office of Orphan Products Development has granted Orphan Drug Designation for TQ- 1017, its abuse deterrent once-daily extended release tramadol for the treatment of painful HIV-assoc


AIDS Action Serves Up 10th Annual 'Taste of the South End': Features Creations from Area's Finest Chefs from 40 South End Restaurants
PRNewswire - February 16, 2005
-- March 15th 6-9 p.m. at BCA s Cyclorama; Unveils New Cookbook & Restaurant Guide BOSTON, Feb. 16 /PRNewswire/ -- Imagine sampling delectable culinary creations from some of Boston s most celebrated chefs representing nearly 40 South End award-winning restaurants -- in one evening, in one place, in casual attire.


Thailand to Host Miss Universe(R) 2005: Competition to Be Broadcast Live on NBC
PRNewswire - February 16, 2005
NEW YORK, Feb. 16 /PRNewswire/ -- Paula M. Shugart, President of the Miss Universe Organization announced today that Bangkok, Thailand will host the 2005 MISS UNIVERSE(R) Competition. The show will broadcast domestically on NBC and Telemundo on Monday, May 30, 2005 at 9PM ET (delayed PT) and will be distributed around


DuSable Museum to Present South Africa's Newest Sensation Soweto Gospel Choir March 8, 2005
PRNewswire - February 15, 2005
-- Chicago Appearance Made Possible by Gardner Rich & Company and Pamodzi Investment Holdings CHICAGO, Feb. 15 /PRNewswire/ -- SOWETO GOSPEL CHOIR, the most exciting vocal group to emerge from South Africa since Ladysmith Black Mambazo, will bring their magnetic energy, joyful spirits and beautiful harmonies, in ad


MedMira Rapid HIV Test is the Choice of Internationally Renowned Medical Institutes: Recent Study Indicates Need for Increased Rapid HIV Testing In America
PRNewswire - February 15, 2005
HALIFAX, Feb. 15 /PRNewswire-FirstCall/ - MedMira Inc., ( MedMira ) (TSX Venture: MIR, NASDAQ:MMIRF) the global market leader in rapid flow- through diagnostic technology, today announced that internationally renowned Stanford Medical University, Duke Medical University and Johns Hopkin s Medical Research University ar


Calypte Biomedical Initiates Africa Clinical Trials Program: First Trial Begins in Uganda
PRNewswire - February 15, 2005
PLEASANTON, Calif., Feb. 15 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (Amex: HIV) today announced that it has initiated a clinical trial program of its Aware(TM) rapid HIV-1/2 test platform in Africa. The first trials are being conducted in the Republic of Uganda HIV/AIDS Reference and Quality Assurance


MTV and Kaiser Family Foundation Extend Sexual Health Information Partnership for Young People: As Part of Fight For Your Rights: Protect Yourself Campaign, Partnership Is Renewed for 9th Year
PRNewswire - February 15, 2005
-- More Than One Million Viewers Have Called Campaign s Hotline; Nearly 100 Million Viewers Have Seen Sexual Health Programming NEW YORK, Feb. 15 /PRNewswire/ -- MTV: Music Television and the Kaiser Family Foundation today announced they have extended their partnership to promote sexual health among young people. This


Trends in HIV Treatment: Once-Daily Regimens
PRNewswire - February 15, 2005
NEW YORK, Feb. 15 /PRNewswire/ -- THIS IS A MULTIVU SPECIAL RADIO REPORT MANY HIV TREATMENTS REQUIRE PATIENTS TO TAKE SEVERAL PILLS AT DIFFERENT TIMES THROUGHOUT THE DAY. THIS CAN BE CONFUSING AND DIFFICULT TO REMEMBER; HOWEVER, FAILURE TO TAKE THE MEDICATIONS ON TIME, EVERY TIME, ALLOWS THE VIRUS TO CHANGE, WHICH MAY


'Love Safely' Is Public Health Message for Valentine's Day: The American Social Health Association Urges Condom Education and Use
PRNewswire - February 14, 2005
RESEARCH TRIANGLE PARK, N.C., Feb. 14 /PRNewswire/ -- The national nonprofit that chose Valentine s Day as National Condom Day is sticking by its message: Love safely-passion and prevention are both important. The American Social Health Association (ASHA), a 90-year-old nonprofit dedicated to sexually transmitted disea


Abbott and OraSure Technologies Enter Agreement for OraQuick(R) ADVANCE(TM) Rapid HIV-1/2 Test: Abbott Obtains Exclusive Distribution Rights for Hospitals and Non-Exclusive Rights to Physician Offices in the United States
PRNewswire - February 14, 2005
ABBOTT PARK, Ill., and BETHLEHEM, Pa., Feb. 14 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) and OraSure Technologies (Nasdaq: OSUR) today announced an agreement for the distribution of OraSure Technologies OraQuick(R) ADVANCE(TM) rapid antibody test for the detection of antibodies to the Human Immunodeficiency Virus Ty


ViroLogic Assays Used to Characterize and Identify Potential Treatments for Virulent Multi-Drug Resistant Strain of HIV
PRNewswire - February 14, 2005
-- Recent Identification of a New York City Patient Infected With Multi-Drug Resistant HIV Who Rapidly Progressed to AIDS Prompts Health Officials to Encourage Resistance Testing in Newly Infected Individuals - SOUTH SAN FRANCISCO, Calif., Feb. 14 /PRNewswire-FirstCall/ -- ViroLogic, Inc. (Nasdaq: VLGC) today announced


Statement from AIDS Action Committee of Massachusetts, Inc. Rebecca Haag, Executive Director: Regarding New Drug-Resistant HIV Strain Found in Gay, Crystal Meth-Using Man in New York City
PRNewswire - February 12, 2005
BOSTON, Feb. 12 /PRNewswire/ -- New York, Boston and Providence are so geographically close and people travel among them so frequently, that news from New York is news for Boston and Providence. Although this is the first reported case, and even if this case is isolated, it is prudent to track this and recognize it as


Remarks by President Bush at the Swearing-in Ceremony for Michael Leavitt, Secretary of Health and Human Services
PRNewswire - February 11, 2005
WASHINGTON, Feb. 11 /PRNewswire/ -- The following is a transcript of remarks by President Bush at the swearing-in ceremony for Michael Leavitt, Secretary of Health and Human Services: The Great Hall - U.S. Department of Health and Human Services - Washington, D.C. 10:45 A.M. EST THE PRESIDENT: Good morning. I m proud t


NYC's First Rapid HIV Drug-Resistant AIDS Case Prompts Call to Step Up HIV Prevention, Reports AIDS Healthcare Foundation
PRNewswire - February 11, 2005
-- New York s Public Health Dept. Issues Health Advisory After Reporting Case of Man Who Progressed From HIV Diagnosis to Highly Drug Resistant Case of AIDS in Just Three Months Late Last Year What: Media Availability - Response to New, Rapid & Drug Resistant Strain of HIV - AIDS Healthcare Foundation officials ava


Find HIV-Positive Love at POZ.com with New, Free Personals: Plus: POZ uncovers New York's thriving AIDS drug black-market
PRNewswire - February 11, 2005
NEW YORK, Feb. 11 /PRNewswire/ -- As a special Valentine to HIV-positive people everywhere, America s leading AIDS publication will launch POZ Personals, a free online dating-plus site for PWAs. Too many people with HIV suffer rejection when disclosing they are positive, said POZ founder Sean Strub. There s a huge indu


Magic Johnson to Dedicate & Tour AHF's West Adams AIDS Clinic Named in His Honor: State-of-the-Art AIDS Healthcare Foundation Center Offers South L.A. Residents Improved Access to Quality Care, Services
PRNewswire - February 11, 2005
What: Magic Johnson to dedicate & tour L.A. AIDS clinic named in his honor When: TUESDAY, FEB 15th 11am Where: AHF s Magic Johnson Healthcare Center/West Adams 2146 West Adams Blvd. (2 blocks west of Western Avenue) Los Angeles CA 90018 (323) 766-2170 Who: Magic Johnson, founder the Magic Johnson Foundation Mic


NIDA-Funded Studies Show Expanding HIV Screening Is Cost Effective
PRNewswire - February 9, 2005
WASHINGTON, Feb. 9 /PRNewswire/ -- Two multicenter research teams supported in part by the National Institute on Drug Abuse, National Institutes of Health, have independently determined through the development of computer models that routine screening for HIV in health care settings is as cost effective as screening fo


Sir Elton John to Headline Landmark HIV/AIDS Awareness Concert and Fundraiser in Philadelphia on July 4: Philadelphia Freedom Concert & Ball
PRNewswire - February 9, 2005
-- Event Slated to Raise Two Million Dollars For Elton John Aids Foundation And Philadelphia Region HIV/AIDS Provider Organizations PHILADELPHIA, Feb. 9 /PRNewswire/ -- The city that gave the world Live Aid, raising unparalleled global awareness and funds for the fight against hunger, is about to step into the spotligh


2005 Antibody World Summit Attracting Hundreds of Top Executives, Business Development, and Researchers from Around the World for July 25-27 Extravaganza in New Jersey
PRNewswire - February 9, 2005
JERSEY CITY, N.J., Feb. 9 /PRNewswire/ -- The 4th Annual Antibody World Summit, a three-day, multi-tracked annual conference extravaganza and networking event, is scheduled to kick off on July 25 in Philadelphia for what is turning out to be one of the largest gathering of monoclonal antibody experts of the year. The m


GMP Companies, Inc. Announces Results of Preliminary In Vitro Testing of Novel Topical Anti-Infective Technology
PRNewswire - February 8, 2005
FORT LAUDERDALE, Fla., Feb. 8 /PRNewswire-FirstCall/ -- GMP Companies, Inc., a biotechnology and medical technology health care company, announced today that its GMP Anti-Infective Solutions, Inc. subsidiary completed preliminary in vitro testing of Microbisol(TM), a new, non-alcohol based topical agent designed to pre


Peregrine Pharmaceuticals Adds Two Prominent Virologists to Its Scientific Resource Board
PRNewswire - February 8, 2005
TUSTIN, Calif., Feb. 8 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a biopharmaceutical company with a broad portfolio of products under development, announced today the addition of Preston. A. Marx, Ph.D., a leading researcher in the cause and spread of HIV and other viral diseases and Ste


Tanox to Present at BIO CEO Conference; Expert Panel to Address the Battle Against Resistance in HIV
PRNewswire - February 8, 2005
HOUSTON, Feb. 8 /PRNewswire-FirstCall/ -- Tanox, Inc. (Nasdaq: TNOX) will participate in a panel discussion titled HIV: The War Against Resistance at the BIO CEO & Investor Conference to be held Feb. 23-24, 2005 in New York City. Tanox Medical Director Stanley Lewis, M.D. was selected to appear on the panel slated


India Begins Its First Preventive AIDS Vaccine Trial
PRNewswire - February 7, 2005
DELHI, India , Feb. 7 /PRNewswire/ -- Today began India s first-ever human clinical trial of an investigational vaccine candidate designed to prevent HIV/AIDS. The trial is being conducted by a partnership between the Government of India -- through the Indian Council of Medical Research (ICMR) and the National AIDS Con


Targeted Genetics, IAVI and Collaborators Expand Phase I Clinical Trial Program of HIV/AIDS Vaccine Program to India
PRNewswire - February 7, 2005
SEATTLE, Feb. 7 /PRNewswire-FirstCall/ -- Targeted Genetics Corp. (Nasdaq: TGEN), the not-for-profit International AIDS Vaccine Initiative (IAVI), the Indian Council of Medical Research (ICMR) and National AIDS Control Organization (NACO), and researchers at Columbus Children s Research Institute (CCRI) and The Childre


PA Health Secretary Celebrates National Black HIV/AIDS Awareness and Information Day: Statewide Incidence Rate for African-Americans is 18 Times Higher Than White Population
PRNewswire - February 7, 2005
HARRISBURG, Pa., Feb. 7 /PRNewswire/ -- In celebration of National Black HIV/AIDS Awareness and Information Day, Health Secretary Dr. Calvin B. Johnson encourages African-Americans to learn how to prevent HIV/AIDS infection and about the devastating effect the disease can have on Pennsylvania s communities. In Pennsylv


New AIDS Organization Aimed at Black College Students: L.I.F.E. AIDS: Leaders in the Fight to Eradicate AIDS
PRNewswire - February 4, 2005
LOS ANGELES, Feb. 4 /PRNewswire/ -- In response to growing numbers of new HIV infections among Black college students, the Black AIDS Institute (The Institute) and the Magic Johnson Foundation have announced today the formation of L.I.F.E. AIDS, (Leaders in the Fight to Eradicate AIDS), an effort aimed at educating and


Bioject and Chronimed/StatScript Announce Supply Agreement: Novel Needle-Free Injection System to Be Available for HIV Therapy
PRNewswire - February 4, 2005
BEDMINSTER, N.J., Feb. 4 /PRNewswire-FirstCall/ -- Bioject Medical Technologies, Inc. (Nasdaq: BJCT), a leading developer of needle-free drug delivery systems, announced today that it has entered into a supply agreement with Chronimed Inc. (Nasdaq: CHMD), a specialty pharmacy which distributes pharmaceuticals and provi


Black AIDS Institute Releases 'State of AIDS in Black America' Report
PRNewswire - February 4, 2005
-- Report Arms African Americans With the Information They Need to Get Involved and Move From Awareness to Action LOS ANGELES, Feb. 4 /PRNewswire/ -- The Black AIDS Institute (The Institute), a national Black policy organization based in Los Angeles, released a national report on the state of AIDS in Black America, tit


BET, Black AIDS Institute, Kaiser Family Foundation and YWCA Announce Return of Rap-It-Up/Black AIDS Short Subject Film Competition
PRNewswire - February 3, 2005
WASHINGTON, Feb. 3 /PRNewswire/ -- BET, the Black AIDS Institute, and the Kaiser Family Foundation announce plans to launch their 2nd Annual Rap-It- Up/Black AIDS Short Subject (RIU/BASS) Film Competition on February 7, 2005. The YWCA USA, the nation s oldest and largest multicultural women s organization in the world,


ViroLogic Announces Three-Year Service Agreement With GlaxoSmithKline to Support New HIV Drug Discovery and Development Efforts
PRNewswire - February 3, 2005
SOUTH SAN FRANCISCO, Calif., Feb. 3 /PRNewswire-FirstCall/ -- ViroLogic, Inc., (Nasdaq: VLGC) announced today that the Company has signed a three-year, $7.5 million service agreement with GlaxoSmithKline (NYSE: GSK) to use ViroLogic s novel HIV resistance testing technology to support GSK s drug discovery and developme


SHOWTIME Tackles Serious Issues for AFRICAN-AMERICAN AIDS AWARENESS DAY With 'Shouting Silent' on February 7
PRNewswire - February 3, 2005
LOS ANGELES, Feb. 3 /PRNewswire/ -- On February 7th, AFRICAN-AMERICAN AIDS AWARENESS DAY, SHOWTIME will recognize the urgency of the HIV/AIDS issue in the African-American community by airing Shouting Silent. This film, which explores the South African HIV/AIDS epidemic through the eyes of an adult orphan who lost her


CAEAR Coalition Urges Congress to Heed President's Call for Ryan White CARE Act Reauthorization in State of the Union
PRNewswire - February 3, 2005
-- Calls on President and Congress to Reverse Years of Flat Funding and Increase CARE Act Appropriations WASHINGTON, Feb. 3 /PRNewswire/ -- The following is a statement of Patricia Bass, Chair CAEAR Coalition: The reauthorization of the Ryan White CARE Act is crucial to the health and well-being of people living with H


BET, General Motors Celebrate Black History Month by Honoring Today's History Makers in The Making
PRNewswire - February 2, 2005
-- 2005 Honorees Include NFL Star, Police Chief, Best-Selling Authors, AIDS Activist and Philanthropist WASHINGTON, Feb. 2 /PRNewswire/ -- BET, along with General Motors (GM), will celebrate Black History Month throughout February by recognizing and honoring History Makers in The Making; contemporary African-American l


Rapid HIV Testing Campaign Targets African American and Latina Women
PRNewswire - February 2, 2005
TRENTON, N.J., Feb. 2 /PRNewswire/ -- A free, Rapid HIV test that allows people to get results in 20 minutes rather than two weeks is the focus of a year-long, $2 million advertising and public awareness campaign designed to encourage more people to get tested. The television, radio and bus advertising campaign builds


Infectech Registers Identikit Test Kits With FDA and Can Begin Selling Line of TB and Non-TB Bacteria Testing Products
PRNewswire - February 1, 2005
SHARON, Pa., Feb. 1 /PRNewswire-FirstCall/ -- Infectech, Inc. (Pink Sheets: IFEC), a biotechnology company engaged in research, development and commercialization of technologies for the production of bacteria and disease testing kits, alternative sources of fuel and remediation of toxic materials, today announced that


Medical Services to Begin Supplying Blood Banks in China
PRNewswire - February 1, 2005
EDMONTON, Alberta, Feb. 1 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pinksheets: MSITF) is pleased to announce that it will begin supplying the VScan HIV rapid test kit to blood banks in the People s Republic of China . The kits will be used by the blood banks to test the blood that is donated for t


BET and Kaiser Announce 8th Year of Award-Winning Rap-It-Up Campaign to Combat HIV/AIDS
PRNewswire - January 31, 2005
-- African-American Cable Network Highlights 2005 Campaign Efforts WASHINGTON, Jan. 31 /PRNewswire/ -- BET and the Kaiser Family Foundation announced today the continuation of their partnership, Rap-It-Up -- the largest public education effort on HIV/AIDS and related issues directed specifically toward African American


BET's Rap-It-Up Partners with Laila Ali to Bring Award-Winning Campaign to Atlanta February 5 - 12
PRNewswire - January 31, 2005
-- Rap-It-Up Joins Absoloot Awarenesss Foundation and Outreach Inc. to Educate Young Adults about HIV/AIDS WASHINGTON, Jan. 31 /PRNewswire/ -- Rap-It-Up, BET s award-winning, national grassroots campaign heads to the city of Atlanta to host a series of community events to educate the public about the devastating affect


L.A. County Shuts Down HIV Testing in Bathhouses, Says AHF
PRNewswire - January 31, 2005
As Public Awaits Action on Long-Delayed County Ordinance to Regulate Bathhouses and Sex Clubs, L.A. Health Department Stops All Funding of Testing and Prevention Services at Venues. Since December 31st, AHF Has Continued Services, & Unsuccessfully Sought No Cost Extension Contract From County What: PRESS CONFERENCE


New Treatment Guidelines Recommend VALCYTE(R) for AIDS-Related CMV Retinitis - New Opportunistic Infections Guidelines Released by CDC, NIH, and HIVMA/IDSA
PRNewswire - January 31, 2005
NUTLEY, N.J., Jan. 31 /PRNewswire/ -- VALCYTE(R) (valganciclovir), a potent oral treatment for AIDS-related cytomegalovirus ( CMV ) retinitis, received positive recommendations in new treatment guidelines issued by the CDC, The National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society


Philadelphia AIDS Consortium Announces RFP Release
PRNewswire - January 31, 2005
PHILADELPHIA, Jan. 31 /PRNewswire/ -- The Philadelphia AIDS Consortium hereby announces the availability of approximately $2,691,278 in Ryan White CARE Act Title II and $842,810 in Commonwealth of PA 106 funds for the delivery of HIV/AIDS prevention and care services in the five counties of southeastern Pennsylvania, i


Mymetics Announces That Professor Stanley Plotkin, MD, Renowned Vaccinologist, Has Joined the Company's Board of Directors
PRNewswire - January 28, 2005
NYON, Switzerland , Jan. 28 /PRNewswire-FirstCall/ -- Mymetics Corporation (OTC Bulletin Board: MYMX) announced today that the Company has elected to its Board of Directors Dr. Stanley A. Plotkin, a renowned expert in virology who has developed many vaccines, including the Rubella vaccine which is now exclusively used


IFESH Launches Program to Prevent Mother to Child HIV/AIDS Transmission in Nigeria
PRNewswire - January 27, 2005
SCOTTSDALE, Ariz., Jan. 27 /PRNewswire/ -- IFESH, The International Foundation for Education and Self-Help, today announced a grant from the Centers for Disease Control (CDC) in Atlanta to help prevent the transmission of mother to child HIV/AIDS in Rivers State, Nigeria , Africa. Sub-Saharan Africa now has nearly


Initial Study Shows Needle-free Administration of FUZEON(R) Achieves Equivalent Drug Levels Compared to Standard Needle Administration
PRNewswire - January 27, 2005
NUTLEY, N.J. and MORRISVILLE, N.C., Jan. 27 /PRNewswire-FirstCall/ -- Data recently presented at HIV DART -- Frontiers in Drug Development for Antiretroviral Therapies show that patients who were administered a single FUZEON(R) ( enfuvirtide ) dose with a needle-free injection device (Biojector(R) 2000) achieved equiva


Global AIDS Alliance: At Davos, WHO Announces $2 Billion Gap in Financing for AIDS Treatment
PRNewswire - January 26, 2005
WASHINGTON, Jan. 26 /PRNewswire/ -- Today, at the Davos World Economic Forum in Switzerland , the World Health Organization (WHO) released a report showing a rapid expansion in the number of people living in poor countries gaining access to life-saving AIDS treatment. The WHO has set a goal for 2005 of getting anti


AHF Welcomes FDA's First-Ever Approval of Generic AIDS Drugs: US' Largest AIDS Group Urges PEPFAR Officials to Quickly Incorporate Less Costly ARVs Regimens From Aspen Pharmacare Into Ambitious Global AIDS Treatment Efforts
PRNewswire - January 25, 2005
LOS ANGELES, Jan. 25 /PRNewswire/ -- AIDS Healthcare Foundation (AHF) the largest US-based AIDS organization with free AIDS treatment clinics in the US, Africa, Central America and Asia, welcomed the news today that the United States Food and Drug Administration ( FDA ) has approved generic AIDS drugs produced by South


Viacom and Kaiser Launch Year Three of KNOW HIV/AIDS Campaign
PRNewswire - January 24, 2005
* Ad placement value estimated at $220 million in 2005 * Six new PSAs to run across television, radio and outdoor media * TV shows incorporate HIV/AIDS storylines Recent Research Underscores Effectiveness of PSAs and HIV-Themed Show Combination * Half of targeted viewers said they had talked with a partner about saf


Serono Announces Completion of Patient Enrollment in Phase III Trial of Serostim(R) (Somatropin [rDNA Origin] for Injection) in HIV-Associated Adipose Redistribution Syndrome (HARS)
PRNewswire - January 24, 2005
GENEVA, Switzerland and ROCKLAND, Massachusetts, January 24 /PRNewswire-FirstCall/ -- Serono Inc., the US affiliate of global biotechnology leader Serono (virt-x: SEO and NYSE: SRA), announced today that it has completed enrollment in its second multi-center, phase III trial of Serostim(R) (somatropin [rDNA origin] for


MedMira Launches Rapid HIV Test into Retail OTC Market: Ships New MiraCare(TM) OTC Product to Retail Pharmacies
PRNewswire - January 24, 2005
HONG KONG, Jan. 24 /PRNewswire-FirstCall/ - MedMira Inc., ( MedMira ) (TSX Venture: MIR, NASDAQ:MMIRF) the global market leader in rapid flow- through diagnostic technology, today announced the launch of its MiraCare(TM) HIV Rapid Antibody Test, its first Over-The-Counter (OTC) test, into the global marketplace, starti


Ranbaxy HIV Update - January 24, 2005
PRNewswire - January 24, 2005
NEW DELHI, India , Jan. 24 /PRNewswire/ -- Ranbaxy Laboratories Limited (Ranbaxy) announced today that the Company has made three fresh filings of its Anti-Retrovirals (ARVs) agents to the WHO for its approvals. Earlier this month, Ranbaxy had announced that it had begun filing data for its range of ARVs


Award-Winning Film Hotel Rwanda Creates Renewed Interest in The Jireh Project, an AIDS Resource Center for Rwandan Victims
PRNewswire - January 21, 2005
DALLAS, Jan. 21 /PRNewswire/ -- As the powerful, new movie, Hotel Rwanda , makes its appearance on movie screens around the globe recalling the Rwandan Civil War and one of the greatest human tragedies of modern times, it is also bringing worldwide attention to The Jireh Project begun by Mary Dunham Faulkner, who is cr


SOHU and Miss World Organization Join Hands to Raise AIDS Awareness in China
PRNewswire - January 21, 2005
BEIJING, Jan. 21 /Xinhua-PRNewswire-FirstCall/ -- SOHU.COM Inc. (Nasdaq: SOHU), China s leading online media, communications, commerce and mobile value-added services company, and the Miss World Organization, represented by its Chairperson, Miss World and Miss China, have held a joint press conference in Beijing today


AIDS Healthcare Foundation, Abbott Laboratories, Boehringer-Ingelheim & Gilead Pharmaceuticals to Sponsor Workshop on 'Unclogging the ARV Drug Pipeline'
PRNewswire - January 20, 2005
-- Officials From the Pharmaceutical Industry, Non-profit Care Providers and Government Health Bodies to Meet in Amsterdam January 20th to Discuss Improving Access to ARVs in the Developing World AMSTERDAM, Jan. 20 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the largest AIDS organization in the US and current ope


NIH Begins Second Phase I Clinical Trial of HIV Vaccine Produced in Collaboration With GenVec
PRNewswire - January 19, 2005
GAITHERSBURG, Md., Jan. 19 /PRNewswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC) announced today that the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), has begun the second Phase 1 clinical trial in healthy adult volunteers of an HIV vaccine candidate jointly develo


Altor BioScience Establishes Collaboration with Leading MGH Investigator to Develop TCR-based Agents to Detect and Treat HIV and HCV Infection
PRNewswire - January 19, 2005
MIRAMAR, Fla., Jan. 19 /PRNewswire/ -- Altor BioScience Corporation today announced that it has established a collaboration with Massachusetts General Hospital (MGH) and Howard Hughes Medical Institute to use viral specific T-cell receptors (TCR) for research, diagnosis and treatment of HIV and hepatitis C (HCV) infect


MedMira Remains Number One in U.S. Hospitals For 2nd Year: 2004 CDC Report Demonstrates Excellent Performance of MedMira's Rapid HIV Test
PRNewswire - January 18, 2005
HALIFAX, Jan. 18 /PRNewswire-FirstCall/ - MedMira Inc., ( MedMira ) (TSX Venture: MIR, NASDAQ:MMIRF) the global market leader in rapid flow-through diagnostic technology, announced today that the results of the 2004 U.S. CDC (Centers for Disease Control and Prevention) HIV Rapid Testing performance evaluation showed th


Medical Services New HIV Test Kit Well Received
PRNewswire - January 18, 2005
EDMONTON, Alberta, Jan. 18 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pinksheets: MSITF) had previously announced that it had developed a rapid test kit that detects the HIV virus within 2 to 11 days of infection. The latest generation of the VScan HIV test kits has the unique ability to detect the


Protecting Healthcare Workers Worldwide the Focus of New AIDS Prevention Initiative: African Project 'Joey(TM)aid' Scheduled for 2005 Kick-off
PRNewswire - January 18, 2005
SAN ANTONIO, Jan. 18 /PRNewswire/ -- A new international program aimed at reducing HIV and Hepatitis C infections among African healthcare workers performing childbirth procedures is being launched today by Dr. Richard Watson, program director of Joeyaid. At the forefront of the program is the Joey(TM) Umbilical Safety


HIV Compound SPD754 Out-Licensed to Anti-Infectives Specialist, Avexa Ltd
PRNewswire - January 17, 2005
BASINGSTOKE, England and PHILADELPHIA, Pennsylvania, January 17 /PRNewswire-FirstCall/ -- Shire Pharmaceuticals Group plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced today that it has out-licensed its HIV compound, SPD754, to Avexa Limited, a publicly-listed Australian specialty anti-infectives company. This is one o


Medical Services Develops the Next Generation of HIV Test Kit
PRNewswire - January 14, 2005
EDMONTON, Alberta, Jan. 14 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pinksheets: MSITF) is pleased to announce that it has developed a rapid test kit that detects the HIV virus within 2 to 11 days of infection. The latest generation of the VScan HIV test kits has the unique ability to detect the Ig


The Abbey's Annual Awards Night Bash, 'The Envelope Please' Benefiting AIDS Project Los Angeles
PRNewswire - January 14, 2005
-- Esquire Magazine Will Sponsor Benefit for the Young Hollywood Set WEST HOLLYWOOD, Calif., Jan. 14 /PRNewswire/ -- This year s hottest Awards Night party for the young Hollywood set, The Envelope Please, will be held at The Abbey on Robertson Boulevard, dubbed Oscar Alley, on Sunday night, February 27, 2005. Prod


Sod-Turning Ceremony Marks Start of Construction of First Pediatric HIV/AIDS Medical Center in Swaziland: Funding Provided by Bristol-Myers Squibb's SECURE THE FUTURE(R) Initiative
PRNewswire - January 13, 2005
MBABANE, Swaziland , Jan. 13 /PRNewswire-FirstCall/ -- With the Right Honorable Absalom Themba Dlamini, prime minister of Swaziland, presiding, a sod-turning ceremony here today marked the start of construction of the first pediatric HIV/AIDS medical center in this southern African nation, among the world s countries h


Next Generation HIV Vaccine Research Collaboration Between Vaccine Research Center and GenVec Under New Contract Extension
PRNewswire - January 12, 2005
GAITHERSBURG, Md., Jan. 12 /PRNewswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC) announced a $10 million one-year contract extension of its HIV vaccine development work with the Vaccine Research Center (VRC), part of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The VRC will


Kendle Expands Into South Africa: New Location Provides Global Biopharmaceutical Customers Ready Access to New Patient Population Across a Broad Spectrum of Therapeutic Areas
PRNewswire - January 12, 2005
CINCINNATI, Jan. 12 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced the establishment of a new office in Johannesburg, South Africa , expanding its access to patients across a broad spectrum of therapeutic areas, including HIV/AIDS, cancer,


$100K of Donation From 'Oprah's Angel Network' to 'Keep a Child Alive' Will Fund AIDS Treatment for New Patients at Durban, South Africa 'Ithembalabantu' AIDS Clinic Says AHF
PRNewswire - January 11, 2005
-- Oprah s Angel Network Awards $250K in Funding to Keep a Child Alive (KCA) Through KCA Ambassador Alicia Keys. KCA s Donation Will Help Provide Anti-Retroviral Therapy and Care for Clients at Free South African AIDS Clinic Run by the AIDS Healthcare Foundation (AHF), the US Largest AIDS Group, and the Network of AIDS


Obie-Winning 'Foreign Aids' Offers Boston's Only Special Post-Performance Reception With Pieter-Dirk Uys to Benefit AIDS Action Committee and Partners in Health
PRNewswire - January 11, 2005
BOSTON, Jan. 11 /PRNewswire/ -- The American Repertory Theatre s presentation of Foreign Aids is making Boston theatergoers and reviewers laugh until it hurts. On Tues., Jan. 18, patrons will get a unique treat for $75: Boston s one-time-only post-performance reception with Pieter-Dirk Uys to help fight HIV/AIDS becaus


Sundance Channel Acquires Rights to Controversial Documentary The Origins of AIDS: Multiple Award-Winner to Premiere on February 7th at 9:00pm ET/PT
PRNewswire - January 11, 2005
NEW YORK, Jan. 11 /PRNewswire/ -- Sundance Channel has acquired pay television rights to the controversial, award-winning documentary The Origins of AIDS, directed by Peter Chappell and Catherine Peix. The Origins of AIDS premieres on February 7th at 9:00pm. The deal was negotiated by Christian Vesper, Vice President A


KV Pharmaceutical Company Licenses Two Women's Health Products for Marketing in Mexico
PRNewswire - January 10, 2005
-- KV Signs Agreements with RIMSA Covering Market Leader Gynazole-1(R) and Recently Approved Clindesse(TM) ST. LOUIS, Jan. 10 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE: KVa/KVb) announced today that it has entered into agreements with Representaciones E Investigaciones Medicas, S.A. de C.V. (RIMSA) for


Ranbaxy HIV Update - January 2005
PRNewswire - January 10, 2005
PRINCETON, N.J., Jan. 10 /PRNewswire/ -- Ranbaxy Laboratories Limited (Ranbaxy) announced today that the Company has so far made three filings of its Anti-Retrovirals (ARVs) to the U.S. FDA for its approval under the expedited review process of the President s Emergency Plan for AIDS Relief (PEPFAR). Earlier, in Ju


Clinton Foundation and UNICEF Launch Tsunami Water and Sanitation Fund: Partnership to Address Emergency Need for Safe Water and Clean Sanitation as Well as Long-Term Health and Development of Families
PRNewswire - January 10, 2005
NEW YORK, Jan. 10 /PRNewswire/ -- Former U.S. President Bill Clinton and UNICEF Executive Director Carol Bellamy today announced the creation of a joint initiative that will bring safe drinking water and sanitation systems to children and families affected by the Indian Ocean tsunami. The Tsunami Water and Sanitation F


Human Genome Sciences Reports On Progress Of Clinical Trials And Announces Goals for 2005 at JPMorgan Healthcare Conference
PRNewswire - January 10, 2005
-- New CEO H. Thomas Watkins to Present - -- 2005 Company Focus on Commercialization Priorities - -- FDA Clearance Received to Initiate Clinical Trials of Novel Compound to Treat HIV/AIDS ROCKVILLE, Md., Jan 10 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) on Wednesday will announce its 2005 goal


Human Genome Sciences Receives FDA Clearance to Initiate Clinical Development of a New Compound for the Treatment of HIV/AIDS
PRNewswire - January 10, 2005
ROCKVILLE, Md., Jan. 10 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) announced today that it has received clearance from the U.S. Food and Drug Administration ( FDA ) of its Investigational New Drug (IND) application to begin clinical trials of CCR5 mAb for the treatment of HIV/AIDS. CCR5 mAb (


Medical Services VScan HIV Rapid Test Kits Go Retail in SE Asia
PRNewswire - January 7, 2005
EDMONTON, Alberta, Jan. 7 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pinksheets: MSITF) is pleased to announce that its VScan HIV 1&2 rapid test kits are being carried as of January 2005 on a retail level in Watson s Pharmacies in Hong Kong . The delay in getting the VScan test kits on the re


Potential Cure for Lymphoma in HIV Patients
PRNewswire - January 7, 2005
WASHINGTON, Jan. 7 /PRNewswire/ -- Stem cell transplants have become the standard of care for patients with relapsed lymphoma, but not for patients who suffer from both this disease and HIV. A new study showing that this treatment is a viable option for select patients with HIV-associated lymphoma will be published in


Former Surgeon General C. Everett Koop Honored
PRNewswire - January 4, 2005
WASHINGTON, Jan. 4 /PRNewswire/ -- U.S. Surgeon General VADM Richard H. Carmona today awarded former Surgeon General C. Everett Koop, VADM (Ret. USPHS), with the Surgeon General s Medallion, the highest award the Surgeon General may bestow upon a civilian. Dr. Koop served as the 13th Surgeon General of the Public Healt


Zingy Lets Consumers Personalize Their Mobile Phones with New Aaliyah Song While Contributing to a Good Cause
PRNewswire - January 4, 2005
-- Zingy Distributes Aaliyah Mobile Content; Percentage of Proceeds To Fund Alzheimer s, AIDS and Breast Cancer Research NEW YORK, Jan. 4 /PRNewswire/ -- Zingy (http://www.zingy.com), the Americas leading mobile media company, has signed an exclusive agreement with Aaliyah, LLC to distribute previously unreleased Aaliy


Is the US Stingy in Providing Foreign Aid?
PRNewswire - January 4, 2005
WASHINGTON, Jan. 4 /PRNewswire/ -- Global AIDS Alliance supports full- scale, emergency assistance to the affected countries, as well as relief of Indonesia s massive debt. The US response to the tsunami crisis has recently been ramped up considerably. Several issues, however, are cause for serious concern, fully explo


Bio-Rad Receives FDA Approval for New HIV-1/HIV-2 Rapid Test: First FDA-Approved Single Use Test Available in the U.S. to Differentiate Between HIV-1 and HIV-2 Antibodies
PRNewswire - January 4, 2005
HERCULES, Calif., Jan. 4 /PRNewswire-FirstCall/ -- Bio-Rad Laboratories, Inc. (Amex: BIO; BIOb), a multinational manufacturer and distributor of life science research products and clinical diagnostics, announced today that it recently received approval from the U.S. Food and Drug Administration ( FDA ) for it


Isolated Indian Fishing Villages on The Bay Of Bengal Hit Hard By the Recent Tsunami Face Monumental Task of Rebuilding Homes, Boats, Nets and Other Equipment and Caring for Those Who Lost Loved Ones
PRNewswire - January 1, 2005
-- FXB India Uses its Network of HIV/AIDS Projects in India s 35 States and Union Territories to Support families in These Coastal Fishing Communities PONDICHERRY, India, Jan. 1 /PRNewswire/ -- An Indian non-governmental organization (NGO) that implements HIV/AIDS prevention, education and treatment programs in all 35



This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1980, 2005. AEGiS.